https://www.rpharms.com/News instancehttps://www.rpharms.com/news/details//RPS-hosts-sustainability-roundtable-at-Holyrood-On 18 March, Royal Pharmaceutical Society in Scotland brought together politicians, Royal Colleges, the pharmaceutical industry and key stakeholders from across Scotland’s health system for a roThu, 02 Apr 2026 15:08:31 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-appoints-justine-scanlan-as-director-of-pharmacyThe Royal Pharmaceutical Society (RPS) is pleased to announce the appointment of Dr Justine Scanlan FRPharmS as its new Director of Pharmacy, a key leadership role as the organisation transitions to bThu, 02 Apr 2026 09:28:08 GMThttps://www.rpharms.com/news/details//rps-marks-international-womens-day-with-give-to-gain-eventWe brought pharmacy professionals together on Thursday 26 March for our annual free International Women’s Day event, held at RPS in London, and online. The event explored this year’s themTue, 31 Mar 2026 11:03:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Bio-Products-Laboratory-Limited-Rabies-Human-normal-Immunoglobulin-500IU-solution-for-InjectionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for Human normal immunoglobulin 500IU solution for Injection. Bio Products Laboratory Limited isMon, 30 Mar 2026 13:46:37 GMThttps://www.rpharms.com/news/details//Freedom-of-Information-Scotland-Act-2002-and-Environmental-Information-Scotland-Regulations-2004The Scottish government has published an updated version of the Section 60 Code of Practice on the discharge of functions by Scottish public authorities under the Freedom of Information (Scotland) ActMon, 30 Mar 2026 08:20:56 GMThttps://www.rpharms.com/news/details//new-national-pharmacy-advisory-councils-elect-president-for-the-royal-college-of-pharmacyThe Royal Pharmaceutical Society today (27 March) announced that the newly established National Pharmacy Advisory Councils for England, Scotland and Wales, which will develop pharmacy policy and practFri, 27 Mar 2026 11:09:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Sandoz-Limited-Apixaban-25mg-and-5mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA)has published a Class 4 Medicines Defect Notification for Apixaban 2.5mg and 5mg Tablets. Sandoz Ltd. have informed the MHRA that the PatThu, 26 Mar 2026 14:51:13 GMThttps://www.rpharms.com/news/details//rps-assembly-update-march-2026The Royal Pharmaceutical Society Assembly met on 25 March 2026 for its final meeting before the organisation becomes the Royal College of Pharmacy. The Assembly, which is responsible for setting the SThu, 26 Mar 2026 11:49:21 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Quadrant-Pharmaceuticals-Limited-Vesomni-6-mg04-mg-modified-release-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Notification for Vesomni 6 mg/0.4 mg modified release tablets. Quadrant Pharmaceuticals LimitedThu, 26 Mar 2026 10:36:10 GMThttps://www.rpharms.com/news/details//medicines-shortages-rps-publishes-one-year-on-reportThe Royal Pharmaceutical Society (RPS) has today published Medicines Shortages: One Year On, a report assessing progress since the launch of Medicines Shortages: Solutions for Empty Shelves in DecembeTue, 24 Mar 2026 00:00:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Regent-Medical-Limited--Mlnlycke-Health-Care-Hibiwash-500mlThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml. Mölnlycke Health Care is recMon, 23 Mar 2026 16:52:43 GMThttps://www.rpharms.com/news/details//rps-urges-clarity-in-gphc-draft-standards-for-responsible-and-superintendent-pharmacistsThe Royal Pharmaceutical Society (RPS) has submitted its response to the General Pharmaceutical Council’s consultation on draft rules and standards for Responsible Pharmacists and SuperintendentFri, 20 Mar 2026 15:56:54 GMThttps://www.rpharms.com/news/details//rps-welcomes-uk-covid-19-inquiry-reportThe RPS has welcomed a report by the UK COVID-19 Inquiry on the impact of the pandemic on healthcare systems in the UK. The report finds that the UK entered the COVID-19 pandemic ‘ill-prepared Thu, 19 Mar 2026 13:37:00 GMThttps://www.rpharms.com/news/details//Update-Outbreak-of-invasive-meningococcal-disease-South-East-England-The UK Health Security Agency has issued an alert outlining priority steps in managing suspected cases, potential contacts of cases, and to reduce the risk of infection spreading. Note that this is a Wed, 18 Mar 2026 16:39:07 GMThttps://www.rpharms.com/news/details//rps-comments-on-meningitis-b-outbreakWe acknowledge the deep concern of those affected by the outbreak of meningococcal disease linked to University of Kent and the area of Canterbury, and the profound impact of the shocking and tragic dWed, 18 Mar 2026 14:15:06 GMThttps://www.rpharms.com/news/details//Outbreak-of-meningococcal-disease-linked-to-University-of-Kent-and-the-area-of-Canterbury-EnglandThe Interim Chief Medical Advisor, (UKHSA) and Medical Director, (NHS England) have issued a letter regarding the outbreak of meningococcal disease linked to University of Kent and the area of CanterbWed, 18 Mar 2026 11:32:06 GMThttps://www.rpharms.com/news/details//Statement-Assisted-Dying-for-Terminally-Ill-Adults-Scotland-BillThe Assisted Dying for Terminally Ill Adults (Scotland) Bill was debated and voted on in the Scottish Parliament on 17 March, and the Bill was defeated by 69 votes to 57. This was the final vote on thWed, 18 Mar 2026 10:52:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-launches-new-pharmacogenomics-resource-to-support-safe-effective-and-personalised-prescribingThe Royal Pharmaceutical Society (RPS) has today launched A Pharmacogenomic Resource to Support the Competency Framework for All Prescribers, a new resource designed to help prescribers integrate pharWed, 18 Mar 2026 09:22:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Baxter-Healthcare-Corporation-Onkotrone-Injection-2-mgml-concentrate-for-solution-for-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Onkotrone Injection 2 mg/ml concentrate for solution for infusion. Baxter HealWed, 18 Mar 2026 09:04:21 GMThttps://www.rpharms.com/news/details//Statement-RPS-opposes-the-Assisted-Dying-Bill-in-ScotlandThe Royal Pharmaceutical Society in Scotland oppose the Assisted Dying for Terminally Ill Adults (Scotland) Bill following the removal of vital protections to protect pharmacists who may wish to conscFri, 13 Mar 2026 12:43:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-announces-results-of-first-elections-to-the-national-pharmacy-advisory-councilsThe Royal Pharmaceutical Society (RPS) has today announced the results of the inaugural elections for the three National Pharmacy Advisory Councils in England, Scotland and Wales that form a key part Fri, 13 Mar 2026 12:00:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Rokshaw-Limited-Trading-as-Curaleaf-Laboratories-Curaleaf-Oil-FS-10mgml-THC-10mgml-CBD-30mlThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 Medicines Recall for specific batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml). Curaleaf LaboratoriesThu, 12 Mar 2026 14:54:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Bayer-Plc-Various-ProductsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 Medicines Recall for various products manufactured by Bayer Plc. Bayer Plc is recalling specific batches of GastThu, 12 Mar 2026 12:14:00 GMThttps://www.rpharms.com/news/details//help-capture-the-story-of-the-20102026-rps-yearsThe Royal Pharmaceutical Society (RPS) has launched a new project to document and celebrate the progress made across the profession between 2010 and 2026, its final chapter before becoming the Royal CThu, 12 Mar 2026 00:00:00 GMThttps://www.rpharms.com/news/details//rps-announces-privy-council-approval-of-royal-charter-changesFollowing a meeting of the Privy Council yesterday (10 March 2026), the Royal Pharmaceutical Society (RPS) can today announce that His Majesty King Charles III has approved the application to amend ouWed, 11 Mar 2026 16:07:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Crescent-Pharma-Limited-Ramipril-5mg-capsules1The Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for ramipril 5mg capsules. Crescent Pharma Limited is recalling one batch of Ramipril 5 mg CapsuFri, 06 Mar 2026 16:17:06 GMThttps://www.rpharms.com/news/details//rps-invites-feedback-on-regulations-for-the-new-royal-college-of-pharmacyThe Royal Pharmaceutical Society (RPS) is inviting Members and Fellows to share their feedback on the new Regulations for the Royal College of Pharmacy. The Regulations mark a significant milestone inFri, 27 Feb 2026 00:00:00 GMThttps://www.rpharms.com/news/details//new-gp-contract-must-support-integrated-primary-care-to-deliver-10-year-health-plan-says-rpsThe Royal Pharmaceutical Society (RPS) has responded to the new GP Contract announced by NHS England, highlighting the need for integrated primary care and full use of pharmacy expertise to help delivWed, 25 Feb 2026 10:36:43 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Rayner-Pharmaceuticals-Limited-Dropodex-01-wv-Eye-DropsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Dropodex 0.1% w/v Eye Drops. Rayner Pharmaceuticals limited have informed the MWed, 25 Feb 2026 09:07:11 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Falsified-Mounjaro-KwikPen-15mg-pre-filled-pensThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Mounjaro KwikPen 15mg pre-filled pens. A falsified version of Mounjaro (tirzepatide) KwikPen 15mg soTue, 24 Feb 2026 15:03:05 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Sterling-Pharmaceuticals-Ltd-specials-manufacturer-MS-32515-KidNaps-Melatonin-1mg-in-1ml-Oral-SolutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for KidNaps (Melatonin) 1mg in 1ml Oral Solution. Sterling Pharmaceuticals Ltd and Veriton PharmMon, 23 Feb 2026 12:05:50 GMThttps://www.rpharms.com/news/details//Proposed-changes-to-Assisted-Dying-for-Terminally-Ill-Adults-Scotland-BillRoyal Pharmacuetical Society, along with six othermedical and healthcare membership organisations in Scotland hasissued a joint consensus statement warning significant concern regarding changes now beMon, 23 Feb 2026 10:47:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//voting-opens-for-first-ever-elections-to-the-royal-college-of-pharmacyVoting is now open for the inaugural elections to the new National Pharmacy Advisory Councils of the future Royal College of Pharmacy. RPS members and Fellows have until 5pm 11 March to make their voiMon, 23 Feb 2026 08:59:00 GMThttps://www.rpharms.com/news/details//rps-president-visits-pharmacy-teams-in-south-walesRPS President, Professor Claire Anderson, recently visited pharmacy teams in South Wales to see first‑hand how community and hospital pharmacy services are delivering high‑quality, patient‑centred carThu, 19 Feb 2026 13:40:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Norgine-Limited-MOVICOL-Ease-Citrus-Powder-for-oral-solution-137-gThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 3 medicines recall for a specific batch of Movicol Ease Citrus Powder for oral solution. Norgine Limited is recalliTue, 17 Feb 2026 10:50:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-IXCHIQ-Chikungunya-vaccine---updates-to-restrictions-of-use-following-safety-reviewThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for IXCHIQ Chikungunya vaccine. Following the completion of a safety review and the recommendations of tThu, 12 Feb 2026 13:14:40 GMThttps://www.rpharms.com/news/details//rps-responds-to-ukpplab-statement-about-the-royal-college-of-pharmacyRPS is one of eight pharmacy professional leadership bodies and specialist professional groups, along with independent expert members, that comprise the UK Pharmacy Professional Leadership Advisory BoThu, 12 Feb 2026 11:00:00 GMThttps://www.rpharms.com/news/details//Food-Standards-Agency-Danone-recalls-several-Aptamil-and-Cow--Gate-First-Infant-Milk-and-Follow-on-Milk-formula-products-because-of-the-possible-presence-of-cereulide-toxin-Danone is recalling several Aptamil and Cow & Gate First Infant Milk and Follow on Milk formula products because cereulide toxin may be present in some batches of the products. This recall is an eMon, 09 Feb 2026 10:40:37 GMThttps://www.rpharms.com/news/details//rps-publishes-digital-skills-and-capability-resource-for-pharmacy-teamsThe Royal Pharmaceutical Society (RPS) has published a free, open-access digital resource to support pharmacy teams across Great Britain to build the digital skills and capabilities needed for modern Fri, 06 Feb 2026 09:24:13 GMThttps://www.rpharms.com/news/details//Semaglutide-Wegovy-Ozempic-and-Rybelsus-risk-of-Non-arteritic-Anterior-Ischemic-Optic-Neuropathy-NAIONThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update. Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioraThu, 05 Feb 2026 14:20:11 GMThttps://www.rpharms.com/news/details//rps-and-gphc-set-out-actions-to-close-differential-attainment-gapsThe Royal Pharmaceutical Society (RPS) and the General Pharmaceutical Council (GPhC) have reinforced their shared commitment to tackling differential attainment and degree awarding gaps across pharmacThu, 05 Feb 2026 13:00:56 GMThttps://www.rpharms.com/news/details//candidates-confirmed-for-inaugural-national-pharmacy-advisory-council-electionsA total of 38candidates are standing in the inaugural elections to the National Pharmacy Advisory Councils of England, Scotland and Wales. The Councils will play a central role in shaping pharmacy polThu, 05 Feb 2026 10:03:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Aspar-Pharmaceuticals-Ltd-Ibuprofen-200mg-Tablets-Ibucalm-200mg-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 3 medicines recall for ibuprofen 200mg tablets and Ibucalm 200mg tablets. Aspar Pharmaceuticals Ltd is recalling spWed, 04 Feb 2026 15:25:36 GMThttps://www.rpharms.com/news/details//rps-seeks-trustees-to-join-the-board-of-the-royal-college-of-pharmacyThe Royal Pharmaceutical Society (RPS) is inviting applications for up to three skilled trustees to join the first Board of the future Royal College of Pharmacy. The new royal college will be a regisWed, 04 Feb 2026 09:56:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Syri-Limited-TA-SyriMed-Baclofen-10mg5ml-Oral-SolutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Baclofen 10mg/5ml oral solution. Syri Limited, T/A SyriMed is recalling specific batches of Tue, 03 Feb 2026 14:12:52 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Accord-Healthcare-Ltd-Carmustine-100-mg-Powder-and-Solvent-for-Concentrate-for-Solution-for-Infusion-1-vial-100mg-powder-1-vial-of-3-mL-solventThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Carmustine 100 mg powder and solvent for concentrate for solution for infusion (1 vial 100mgMon, 02 Feb 2026 11:39:16 GMThttps://www.rpharms.com/news/details//Food-Alert-Danone-recalls-Aptamil-First-Infant-Formula-because-cereulide-toxin-has-been-found-in-this-batchThe Food standards agency (FSA) has published a food alert for Danone Aptamil First Infant Formula. Danone is recalling Aptamil First Infant Formula because cereulide toxin has been found in the produFri, 30 Jan 2026 09:51:14 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-GLP-1-receptor-agonists-and-dual-GLP-1GIP-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-casesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update. The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucThu, 29 Jan 2026 15:46:32 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Class-1-Medicines-Recall-Notification-Recall-of-Quetiapine-Oral-Suspension-unlicensed-medicine-manufactured-by-Eaststone-Limited-due-to-a-potential-for-overdosingThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 1 medicines recall for Quetiapine Oral Suspension (unlicensed medicine). Eaststone Limited is initiating a recall oThu, 29 Jan 2026 14:36:06 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Viatris-Products-Ltd-Arixtra-solution-for-injection-pre-filled-syringesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Notification for Arixtra solution for injection, pre-filled syringes. Viatris has informed the Wed, 28 Jan 2026 11:39:41 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Blumont-Pharma-Limited-Ocumont-Eye-Ointment-1--wwThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Ocumont Eye Ointment 1% w/w. Blumont Pharma Limited has informed the MHRA abouTue, 27 Jan 2026 11:57:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-ukpplab-open-letterThe Royal Pharmaceutical Society (RPS) is one of eight pharmacy professional leadership bodies and specialist professional groups, along with independent expert members, that comprise the UK Pharmacy Fri, 23 Jan 2026 10:50:54 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Isotretinoin--changes-to-prescribing-guidance-and-additional-risk-minimisation-measuresThe Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. Healthcare profesFri, 23 Jan 2026 10:22:16 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Glenmark-Pharmaceuticals-Europe-Limited-Fingolimod-Glenmark-05-mg-Hard-CapsulesThe Medicines and Health products Regulatory Agency (MHRA) has published a class 3 recall for Fingolimod Glenmark 0.5 mg hard capsules. Glenmark Pharmaceuticals Europe Limited is recalling one batch aWed, 21 Jan 2026 11:54:18 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Mercury-Pharmaceuticals-Ltd-Paliperidone-Mercury-Pharma-prolonged-release-suspension-for-injection-in-pre-filled-syringesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for paliperidone 50mg, 75mg, 100mg and 150mg prolonged-release suspension for injection in pre-fTue, 20 Jan 2026 14:28:16 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Reminder---Epimax-Ointment-and-Epimax-Paraffin-Free-Ointment---reports-of-ocular-surface-toxicity-and-ocular-chemical-injuryThe Medicines and Healthcare products Regulatory Agency (MHRA) is continuing to receive reports of ocular surface toxicity and ocular chemical injury where patients have been prescribed or advised to Fri, 16 Jan 2026 15:22:40 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-AlertNational Patient Safety Alert: Steriflex® No. 109 (1L) and No. 171 (2L): Potassium Chloride 0.15%, Sodium Chloride 0.45%, Glucose 2.5% Bags The Department of Health and Social Care (DHSC) has pubThu, 15 Jan 2026 10:41:34 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Improving-Information-Supplied-with-Gabapentinoids-PregabalinGabapentin-Benzodiazepines-and-Z-DrugsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update following a review of the warnings regarding addiction, dependence, withdrawal, and tolerance for gabaThu, 08 Jan 2026 13:19:59 GMThttps://www.rpharms.com/news/details//limit-nasal-decongestant-spray-use-to-seven-days-says-rpsDuring the cold and flu season, the Royal Pharmaceutical Society (RPS) is reminding the public that nasal decongestant sprays should not be used for longer than seven days in a row. Longer use can cauThu, 08 Jan 2026 10:02:00 GMThttps://www.rpharms.com/news/details//Food-Standards-Agency-Nestl-recalls-several-SMA-Infant-Formula-and-Follow-On-Formula-as-a-precaution-because-of-the-possible-presence-of-cereulide-toxinThe Food Standards Agency has published an alert for SMA Infant Formula and Follow-On Formula. Nestlé has taken the precautionary step of recalling several batches SMA Infant Formula and Follow-On ForThu, 08 Jan 2026 09:10:00 GMThttps://www.rpharms.com/news/details//election-nominations-for-future-royal-college-now-openNominations are officially open from today (05 January) for the inaugural elections to the National Pharmacy Advisory Councils in England, Scotland and Wales. The elections offer a unique opportunityMon, 05 Jan 2026 10:57:55 GMThttps://www.rpharms.com/news/details//interim-chair-elected-to-rps-welsh-pharmacy-boardThe Royal Pharmaceutical Society (RPS) is pleased to announce that Liz Hallett has been elected as the interim Chair of the Welsh Pharmacy Board. Liz will serve until the inaugural elections to the thMon, 22 Dec 2025 00:00:00 GMThttps://www.rpharms.com/news/details//rps-announces-results-of-regulations-consultation-and-thanks-those-who-took-partA decision was made at a Special Assembly meeting in October 2025 to amend RPS Regulations to enable the smooth transition towards becoming the Royal College of Pharmacy in 2026, and to hold electionsMon, 22 Dec 2025 00:00:00 GMThttps://www.rpharms.com/news/details//RPS-and-health-professional-leadership-bodies-launch-health-and-climate-manifestoToday, health professional leadership bodies across Scotland - led by the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP Scotland) - have launched a manifesto for health and climateFri, 19 Dec 2025 11:16:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Drug-Safety-Update-Rybelsus-semaglutide-tablets-transition-to-new-formulation-and-risk-of-medication-errorThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug safety Update for Rybelsus (semaglutide) tablets. There is a risk of patient harm arising through medication error dThu, 18 Dec 2025 11:37:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Activase-Pharmaceuticals-Limited-Prednisolone-5mg-Soluble-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for prednisolone 5mg soluble tablets. Activase Pharmaceuticals Limited is recalling two batches Mon, 15 Dec 2025 14:16:00 GMThttps://www.rpharms.com/news/details//rps-appoints-director-of-finance-and-technologyThe Royal Pharmaceutical Society (RPS) is pleased to announce the appointment of Alan de Sousa Caires as its new Director of Finance and Technology, a key leadership role as the organisation transitioMon, 15 Dec 2025 09:22:56 GMThttps://www.rpharms.com/news/details//Pharmacists-will-be-able-to-choose-whether-to-participate-in-Assisted-Dying-in-ScotlandFollowing influencing activity from RPS in Scotland, pharmacists will be able to choose whether to participate in Assisted Dying in Scotlandaccording to their conscience, if the draft legislation becoFri, 12 Dec 2025 13:45:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//The-Human-Medicines-Authorisation-by-Pharmacists-and-Supervision-by-Pharmacy-Technicians-Order-2025--The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 was approved by Parliament and the Privy Council on the 11th December. These legislative changes Fri, 12 Dec 2025 10:50:00 GMThttps://www.rpharms.com/news/details//rps-announces-inaugural-elections-for-the-future-royal-collegeThe Royal Pharmaceutical Society (RPS) today announces details of the inaugural elections for the future Royal College of Pharmacy, to be held in early 2026 and with nominations opening on 5 January 2Thu, 11 Dec 2025 14:44:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Hameln-Pharma-Ltd-Clarithromycin-500-mg-powder-for-concentrate-for-solution-for-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 Medicines Recall forclarithromycin 500 mg powder for concentrate for solution for infusion. Hameln Pharma Ltd is Thu, 11 Dec 2025 12:00:06 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Flamingo-Pharma-UK-Ltd-Amitriptyline-Hydrochloride-10mg-25mg-50mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Notification foramitriptyline hydrochloride 10mg, 25mg and 50mg tablets. Flamingo Pharma UK LtdWed, 10 Dec 2025 15:03:17 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Mesalazine-and-idiopathic-intracranial-hypertensionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update on mesalazine. Idiopathic intracranial hypertension (IIH) has been very rarely reported in patients tFri, 05 Dec 2025 10:05:21 GMThttps://www.rpharms.com/news/details//rps-responds-to-government-consultation-on-pharmacist-flexibilitiesThe Royal Pharmaceutical Society (RPS) has submitted its response to the Department of Health and Social Care’s consultation on enabling pharmacist flexibilities when dispensing medicines. The Wed, 03 Dec 2025 09:02:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Supply-of-licensed-and-unlicensed-epidural-infusion-bagThe Department of Health and Social Care (DHSC) has published a National Patient Safety Alert regarding supply issues affecting epidural infusion bags. There are supply issues affecting epidural bagsTue, 02 Dec 2025 12:39:55 GMThttps://www.rpharms.com/news/details//rps-launches-consultation-on-new-pharmacogenomic-resource-for-all-prescribersThe Royal Pharmaceutical Society (RPS) has opened a consultation to gather views on its upcoming Pharmacogenomic Resource for all Prescribers. Commissioned by the NHSE Network of Excellence in PharmaMon, 01 Dec 2025 09:20:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Special-Concept-Development-UK-Limited-Baclofen-10mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for baclofen 10mg tablets. Special Concept Development UK Limited has informed the Thu, 27 Nov 2025 13:34:17 GMThttps://www.rpharms.com/news/details//pharmacy-teams-must-be-fully-integrated-into-palliative-care-says-rpsThe Royal Pharmaceutical Society (RPS) is calling for reforms that place pharmacists and their teams at the heart of palliative and end of life care so that patients and their families can access the Thu, 27 Nov 2025 00:00:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-greater-resource-so-pharmacy-can-deliver-on-neighbourhood-careRPS Director for England Amandeep Doll gave evidence today at the Health and Social Care Select Committee session on workforce and Neighbourhood Health. Speaking alongside the Royal College of GPs anWed, 26 Nov 2025 13:03:28 GMThttps://www.rpharms.com/news/details//rps-welcomes-new-chief-executive-and-registrar-of-the-general-pharmaceutical-councilCommenting on the appointment of Kathie Cashell to lead the General Pharmaceutical Council (GPhC), RPS Chief Executive Paul Bennett said: “I’m delighted to welcome Kathie Cashell as the nWed, 26 Nov 2025 00:00:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Lexon-UK-Ltd-Moclobemide-150mg-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect notification for moclobemide 150mg tablets. Lexon UK Ltd has informed the MHRA that the Patient Tue, 25 Nov 2025 14:50:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-november-2025The Royal Pharmaceutical SocietyPanel of Fellows has designated the following 17 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy: Mari Beddis ShanTue, 25 Nov 2025 09:39:53 GMThttps://www.rpharms.com/news/details//rps-announces-appointment-of-inaugural-chair-of-the-trustee-board-to-steer-the-future-royal-college-charityThe Royal Pharmaceutical Society (RPS) today, Monday 24 November,announcesthe appointment of Joe Irvin OBE as the inaugural Chair of the Board of Trustees of the future Royal College of Pharmacy (RCPhMon, 24 Nov 2025 12:55:50 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Sun-Pharmaceutical-Industries-Limited-Fingolimod-SUN-05mg-hard-capsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Fingolimod SUN 0.5mg hard capsules. Sun Pharma UK Limited is conducting a precautionary recaThu, 20 Nov 2025 12:17:20 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Harm-from-incorrect-recording-of-a-penicillin-allergy-as-a-penicillamine-allergyNHS England has published a National Patient Safety Alert, in collaboration with the Royal Pharmaceutical Society, Royal College of Physicians and Royal College of General Practitioners on the risk ofThu, 20 Nov 2025 12:01:00 GMThttps://www.rpharms.com/news/details//rps-assembly-update-november-2025TheRPS Assemblyis the primary governance body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following discussion pThu, 20 Nov 2025 11:15:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-to-host-Parliamentary-exhibitionIn December, RPS will be hosting a three-day exhibition for MSPs at The Scottish Parliament, entitled, Delivering Environmental Sustainability in Pharmacy. RPS has a long-standing interest in environThu, 13 Nov 2025 11:01:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//RPS-involved-in-high-level-advocacy-across-GB-on-Assisted-Dying-RPS is actively engaging with policymakers in both the UK and Scottish Parliaments, as two separate Bills on assisted dying progress through both legislatures. If both Bills pass, Assisted Dying will Thu, 13 Nov 2025 10:58:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-appoints-louise-goldring-as-director-of-educationThe Royal Pharmaceutical Society (RPS) is pleased to announce the appointment of Louise Goldring as its new Director of Education, a key leadership role as the organisation transitions to become the RThu, 13 Nov 2025 09:22:00 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-cuts-to-integrated-care-boardsChair of the RPS in England Ms Tase Oputu has responded to news that the Government has approved the next steps for cuts to headcounts in Integrated Care Boards and NHS England. “Pharmacists Wed, 12 Nov 2025 13:06:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Sun-Pharmaceutical-Industries-Limited-Atorvastatin-20mg-and-80mg-film-coated-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 3 medicine recall for atorvastatin 20mg and 80mg film-coated tablets. Sun Pharma UK Limited is recalling specific bTue, 11 Nov 2025 13:12:20 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Zambon-SpA-Emylif-50mg-orodispersible-filmThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 3 medicines recall for Emylif 50mg orodispersible film. Zambon SpA is recalling a specific batch as a precautionaryMon, 10 Nov 2025 13:41:25 GMThttps://www.rpharms.com/news/details//rps-calls-for-pharmacy-workforce-supportThe Royal Pharmaceutical Society has called for pharmacists and pharmacy to be at the heart of the forthcoming NHS workforce plan, in our response to a Government call for evidence. Following the pubMon, 10 Nov 2025 09:38:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-stronger-measures-to-manage-medicine-shortages-at-lords-committeeAmandeep Doll, Director for England at the Royal Pharmaceutical Society (RPS), gave oral evidence on 5 November to the House of Lords Public Services Committee Inquiry into medicines security across tThu, 06 Nov 2025 11:18:59 GMThttps://www.rpharms.com/news/details//rps-gives-wide-ranging-evidence-on-assisted-dying-at-westminsterLaura Wilson, Director for Scotland at the Royal Pharmaceutical Society (RPS), gave oral evidence today to the House of Lords committee examining the proposed Terminally Ill Adults (End of Life) Bill.Wed, 05 Nov 2025 14:10:06 GMThttps://www.rpharms.com/news/details//Influenza-Season-202526-Early-season-activity-and-implications-for-clinical-practiceUKHSA surveillance data indicates that influenza is circulating in the community earlier than usual this season with a drifted strain of Influenza A(H3N2) predominating. Clinicians should continue toWed, 05 Nov 2025 11:07:52 GMThttps://www.rpharms.com/news/details//rps-launches-2025-workforce-wellbeing-survey-The Royal Pharmaceutical Society (RPS), in partnership with Pharmacist Support, the British Pharmaceutical Students’ Association (BPSA) and the Pharmacy Schools Council (PhSC), has launched its Tue, 04 Nov 2025 00:00:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-stronger-safeguards-in-private-prescribingRPS has responded to the Government’s call for evidence on private prescribing, urging a series of reforms to improve patient safety, transparency and accountability, particularly in online and Mon, 03 Nov 2025 00:00:00 GMThttps://www.rpharms.com/news/details//celebrating-black-history-month-2025Throughout October, we celebrated Black History Month by recognising the invaluable contributions of Black people to British society and pharmacy. This year’s Black History Month theme, StandinFri, 31 Oct 2025 00:00:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Baxter-Healthcare-Limited-Compound-Sodium-Lactate-Solution-for-Infusion-BP-Hartmanns-Solution-for-infusion-in-Viaflo-1000mlThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for sodium lactate solution for infusion BP (Hartmann's Solution for infusion). Baxter HealtTue, 28 Oct 2025 11:33:29 GMThttps://www.rpharms.com/news/details//Drug-safety-Update-Isotretinoin-updates-to-prescribing-guidance-and-survey-of-servicesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update on isotretinoin. The Commission on Human Medicines (CHM) has endorsed changes to isotretinoin prescribMon, 27 Oct 2025 14:37:41 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Accord-Healthcare-Ltd-Ipratropium-Bromide-500-microgram--2ml-Nebuliser-SolutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution. Accord Healthcare Ltd is recalliThu, 23 Oct 2025 12:39:58 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Relonchem-Ltd-Various-ProductsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for specific batches of losartan potassium/Hydrochlorothiazide coated tablets and rThu, 23 Oct 2025 12:26:22 GMThttps://www.rpharms.com/news/details//bnf-partnership-translates-cautionary-and-advisory-labels-into-the-uks-most-spoken-languagesBNF Partnership comprising BMJ Group, Pharmaceutical Press, RCPCH, and NPPG has translated British National Formulary (BNF) and BNF for Children (BNFC) cautionary and advisory labels (CALs) into the UWed, 22 Oct 2025 11:13:24 GMThttps://www.rpharms.com/news/details//rps-invites-members-to-share-views-on-interim-regulationsThe Royal Pharmaceutical Society (RPS) has publisheddraft interim Regulations, that will support its transition to becoming the Royal College of Pharmacy and is inviting members to share their views aMon, 20 Oct 2025 09:42:00 GMThttps://www.rpharms.com/news/details//rps-country-boards-meeting-summaryThe recent country Board meetings held across England, Scotland and Wales brought together pharmacy leaders to discuss key policy priorities for the profession and pharmacy practice. You can find outThu, 16 Oct 2025 08:03:01 GMThttps://www.rpharms.com/news/details//our-response-to-local-medical-committee-pharmacy-first-letterIn response to a letter by members of a Local Medical Committee criticising the Pharmacy First service, reported in The Times, the RPS joined national community pharmacy bodies in writing a letter to Wed, 15 Oct 2025 12:24:01 GMThttps://www.rpharms.com/news/details//professor-cathy-mckenzie-appointed-to-uks-first-professional-role-in-intensive-care-pharmacyThe Royal Pharmaceutical Society (RPS) congratulates Professor Cathy McKenzie on her appointment as Professor of Intensive Care Pharmacy at the University of Southampton-the first role of its kind in Fri, 10 Oct 2025 11:14:00 GMThttps://www.rpharms.com/news/details//rps-wales-give-evidence-to-senedd-inquiry-on-the-future-of-general-practiceThe Royal Pharmaceutical Society in Wales has given oral evidence to the Senedd’s Health and Social Care Committee’s inquiry into the future of general practice. Representing RPS Wales weFri, 10 Oct 2025 11:08:36 GMThttps://www.rpharms.com/news/details//professor-amira-guirguis-appointed-as-rps-chief-scientistThe Royal Pharmaceutical Society (RPS) is pleased to announce the appointment of Professor Amira Guirguis as its new Chief Scientist. Amira is currently a Professor of Pharmacy, Deputy Pro Vice ChancWed, 08 Oct 2025 09:56:57 GMThttps://www.rpharms.com/news/details//we-are-calling-for-digital-and-ai-skills-to-become-a-core-competency-for-healthcare-professionalsWe're callingfor digital skills to be recognised as a core competency for all healthcare professionals, following a roundtable event that brought together leaders in pharmacy education, digital inMon, 06 Oct 2025 07:01:00 GMThttps://www.rpharms.com/news/details//celebrating-east-and-south-east-asian-heritage-month-2025Throughout September, the Royal Pharmaceutical Society celebrated East and Southeast Asian (ESEA) Heritage Month by recognising the resilience, heritage and contributions of ESEA communities in pharmaTue, 30 Sep 2025 05:00:00 GMThttps://www.rpharms.com/news/details//welsh-government-commissions-review-of-pharmacy-professionals-in-general-practiceThe Welsh Government has commissioned the Royal Pharmaceutical Society (RPS) to lead an independent review of the role of pharmacy professionals working in and for general practice in Wales. The annouFri, 26 Sep 2025 08:55:34 GMThttps://www.rpharms.com/news/details//new-three-year-goals-launched-to-advance-pharmacy-services-in-walesNew goals to transform pharmacy services across Wales over the next three years have been launched today, setting out the next steps in Pharmacy: Delivering a Healthier Wales, the long-term 2030 visioThu, 25 Sep 2025 08:25:00 GMThttps://www.rpharms.com/news/details//MHRA-Drug-Safety-Update-Paracetamol-and-pregnancy---reminder-that-taking-paracetamol-during-pregnancy-remains-safeThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for paracetamol in pregnancy. A recent US announcement suggested a link between paracetamol use in preWed, 24 Sep 2025 08:56:40 GMThttps://www.rpharms.com/news/details//dr-geraldine-mccaffrey-appointed-as-rps-director-for-walesFollowing a rigorous and structured appointment process, RPS is pleased to announce the appointment of Dr Geraldine McCaffrey, MRPharmS as its new Director for Wales. Geraldine, who is currently PrinWed, 24 Sep 2025 08:54:20 GMThttps://www.rpharms.com/news/details//rps-launching-new-e-learning-module-to-tackle-polypharmacy-and-drug-interactionsThe Royal Pharmaceutical Society (RPS), in partnership with EL Healthcare Education, is launching a new e-learning module to help healthcare professionals safely manage polypharmacy and reduce the risTue, 23 Sep 2025 08:16:39 GMThttps://www.rpharms.com/news/details//use-of-paracetamol-during-pregnancyFollowing recent comments from the US Administration suggesting a link between paracetamol use during pregnancy and autism, President of the Royal Pharmaceutical Society Professor Claire Anderson saidTue, 23 Sep 2025 07:12:00 GMThttps://www.rpharms.com/news/details//rps-launches-new-programme-in-collaboration-with-idorsia-to-help-pharmacists-support-patients-with-insomniaThe Royal Pharmaceutical Society (RPS) has launched a new national learning programme, developed in collaboration with Idorsia Pharmaceuticals UK Ltd, to support pharmacists in identifying and managinTue, 16 Sep 2025 08:00:04 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-alert-Harm-from-delayed-administration-of-rasburicase-for-tumour-lysis-syndromeNHS England has published a National Patient Safety Alert on harm from delayed administration of rasburicase for tumour lysis syndrome. The alert requires action to prevent delays in the administratioTue, 09 Sep 2025 09:57:00 GMThttps://www.rpharms.com/news/details//dr-adam-pattison-rathbone-receives-rps-barnett-award-2025The Royal Pharmaceutical Society is proud to announce that Dr Adam Pattison Rathbone has been awarded the RPS Barnett Award, recognising his exceptional commitment to mentorship and professional develTue, 09 Sep 2025 06:58:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Hikma-Farmacutica-Gemcitabine-2g526ml-concentrate-for-solution-for-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Gemcitabine 2g/52.6ml concentrate for solution for infusion. Hikma FarmacêuticaThu, 04 Sep 2025 13:27:20 GMThttps://www.rpharms.com/news/details//rps-president-prof-claire-anderson-receives-fip-distinguished-service-awardProfessor Claire Anderson received the award from FIP President Paul Sinclair The Royal Pharmaceutical Society (RPS) is proud to celebrate its President, Professor Claire Anderson, who has been awardMon, 01 Sep 2025 08:22:00 GMThttps://www.rpharms.com/news/details//rps-launches-new-consultation-to-strengthen-inclusion-diversity-and-equity-in-pharmacyThe Royal Pharmaceutical Society (RPS) has launched a new profession-wide consultation to better understand inclusion, diversity and equity across the pharmacy sector. The consultation explores pharmaTue, 26 Aug 2025 14:10:08 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Ipca-Laboratories-UK-Limited-Various-ProductsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification. Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information LeafleTue, 26 Aug 2025 12:52:18 GMThttps://www.rpharms.com/news/details//rps-fellow-dr-raliat-onatade-named-pharmacist-of-the-year-at-the-black-healthcare-awards-2025The Royal Pharmaceutical Society is proud to celebrate RPS Fellow Dr Raliat Onatade, who has been awarded Pharmacist of the Year at the Black Healthcare Awards 2025. The Black Healthcare Awards, hostFri, 22 Aug 2025 10:53:52 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Fexofenadine-Hydrochloride-120mg-film-coated-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines notification for fexofenadine hydrochloride 120mg film-coated tablets. Chanelle Medical Unlimited CompaThu, 21 Aug 2025 11:50:41 GMThttps://www.rpharms.com/news/details//rps-sets-course-for-royal-college-with-the-announcement-of-leadership-changesTheRoyal Pharmaceutical Society(RPS) has announced plans for changes to its leadership team as part of its journey to becoming a royal college. The changes are announced as the organisation navigatesTue, 19 Aug 2025 10:47:00 GMThttps://www.rpharms.com/news/details//MHRA-Press-Release-Parents-and-caregivers-advised-to-stop-all-use-of-Nutrition-Ignition-Kids-Magnesium-Glycinate-Gummies-due-to-the-presence-of-undeclared-melatoninThe Medicines and Healthcare products Regulatory Agency (MHRA) is advising parents and caregivers to stop all use of Nutrition Ignition Kids Magnesium Glycinate Gummies, due to the presence of undeclaMon, 18 Aug 2025 13:19:07 GMThttps://www.rpharms.com/news/details//celebrating-south-asian-heritage-month-2025Did you catch our celebrations forSouth Asian Heritage Month, which exploresthe history and identity of British South Asians? We collaborated with Association of Pharmacy Technicians UK, British PharSun, 17 Aug 2025 23:00:00 GMThttps://www.rpharms.com/news/details//MHRA-Class-4-Medicines-Defect-Notification-Levetiracetam-Accord-100mgml-oral-solutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines defect notification for Levetiracetam Accord 100mg/ml oral solution. Accord Healthcare Limited, UK has infThu, 14 Aug 2025 12:52:32 GMThttps://www.rpharms.com/news/details//rps-invites-profession-to-help-shape-future-royal-college-strategyThe Royal Pharmaceutical Society (RPS) is inviting pharmacists, pharmaceutical scientists,students and the wider pharmacy community to take part in a new series of online events this autumn to help shWed, 13 Aug 2025 13:00:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-government-move-to-ease-medicine-shortagesThe Royal Pharmaceutical Society (RPS) has today welcomed the Government’s announcement that it will consult on enabling pharmacists to have the flexibility to amend prescriptions in response toMon, 11 Aug 2025 10:32:00 GMThttps://www.rpharms.com/news/details//Laura-McIver--recently-retired-Chief-Pharmacist-reflects-on-her-CBE‘I’m delighted to be awarded a CBE. This is well-deserved recognition for the whole pharmacy profession and team.’ Laura McIver CBE, recently retired Chief Pharmacist at Healthcare Mon, 11 Aug 2025 10:22:07 GMTRoss Barrowhttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Topiramate-Zydus-Pharmaceuticals-UK-20mgml-Oral-Solution-Zydus-Pharmaceuticals-UK-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution (pack size 150ml and Thu, 07 Aug 2025 09:27:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Fucidin-250-mg-Tablets-LEO-Laboratories-Ltd-trading-as-LEO-PharmaThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for Fucidin 250 mg Tablets. LEO Pharma is recalling a specific batch as a precautionary measure Mon, 04 Aug 2025 13:34:10 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Olmesartan-medoxomil-10mg-and-20mg-film-coated-tablets-Jubilant-Pharmaceuticals-NVThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for olmesartan medoxomil 10mg and 20mg film-coated tablets. Jubilant PharmaceuticalThu, 31 Jul 2025 11:11:32 GMThttps://www.rpharms.com/news/details//-National-Patient-Safety-Alert-Shortage-of-Antimicrobial-Agents-Used-in-Tuberculosis-TB-TreatmentThe Department of Health and Social Care has published a National Patient Safety Alert on the Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment. The following antimicrobial medicineWed, 30 Jul 2025 09:06:35 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-ChloraPrep-1mL-Clear-Sterile-SolutionApplicator-Becton-Dickinson-UK-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for ChloraPrep 1mL Clear Sterile Solution/Applicator. Becton Dickinson UK Ltd has informed the MMon, 28 Jul 2025 11:19:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Flutiform-250-micrograms--10-micrograms-per-actuation-pressurised-inhalation-suspension-The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation suspension. CD PhThu, 24 Jul 2025 13:15:50 GMThttps://www.rpharms.com/news/details//rps-updated-humanitarian-statement-july-2025RPS fully recognises the appalling position in which innocent people find themselves because of the ongoing conflict in Gaza. We share the concern of our members for the welfare of civilians and healtWed, 23 Jul 2025 10:40:00 GMThttps://www.rpharms.com/news/details//rps-outlines-priorities-ahead-of-2026-devolved-electionsRoyal Pharmaceutical Society (RPS) has published a list of asks for the next Governments of Wales and Scotland, ahead of the Parliamentary Elections both taking place in May 2026. RPS is actively engWed, 23 Jul 2025 06:18:00 GMThttps://www.rpharms.com/news/details//Device-safety-information-Trinity-Biotech-Premier-Hb9210-HbA1c-Analyser-Risk-of-Positive-Bias-and-Updates-to-Instructions-for-Use-including-use-as-a-diagnostic-aid-in-diabetes-mellitusThe Medicines and Healthcare products Regulatory Agency (MHRA) has received reports describing a positive bias in HbA1c results delivered by the Trinity Biotech Premier Hb9210 HbA1c analyser, which haTue, 22 Jul 2025 14:07:14 GMThttps://www.rpharms.com/news/details//rps-publishes-48th-edition-of-medicines-ethics-and-practiceThe Royal Pharmaceutical Society (RPS) has published the 48th edition of Medicines, Ethics and Practice (MEP). Reflecting the growing complexity of pharmacy practice, this year’s edition includMon, 21 Jul 2025 05:06:00 GMThttps://www.rpharms.com/news/details//rps-assembly-update-july-2025TheRPS Assemblyis the primary governance body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following discussionFri, 18 Jul 2025 05:27:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-draft-legislation-on-pharmacy-supervisionThe Royal Pharmaceutical Society (RPS) has welcomed the publication of draft legislation from the Department of Health and Social Care (DHSC) and devolved governments following the 2023 consultation oThu, 17 Jul 2025 04:54:00 GMThttps://www.rpharms.com/news/details//position-statement-on-facilitated-self-selection-of-pharmacy-medicinesRPS is supportive of the adoption of models that enable the facilitated self-selection of Pharmacy (P) medicines, where a community pharmacy chooses to implement such models. When setting up these serMon, 14 Jul 2025 05:25:00 GMThttps://www.rpharms.com/news/details//Updated-National-Patient-Safety-Alert-Shortage-of-bumetanide-1mg-tabletsThe Department of Health and Social Care (DHSC) has provided an update that bumetanide 1mg tablets are now in limited supply until late July 2025. The supply disruption is caused by a combination of mFri, 11 Jul 2025 14:57:45 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Zaditen-025-mgml-eye-drops-solutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for Zaditen 0.25 mg/ml, eye drops, solution. Laboratoires Théa trading as Thea Pharmaceuticals LimiMon, 07 Jul 2025 13:16:17 GMThttps://www.rpharms.com/news/details//elen-jones-to-become-pharmacy-dean-at-heiwAfter 11 years at RPS, Elen Jones will be leaving the organisation in October to take up the position of Pharmacy Dean at Health Education and Improvement Wales (HEIW). RPS CEO Paul Bennett said: &lMon, 07 Jul 2025 08:00:00 GMThttps://www.rpharms.com/news/details//rps-comments-on-nhs-10-year-plan-for-englandCommenting on the Government’s new 10 Year Health Plan for England, RPS England Board Chair Tase Oputu said: “We welcome the Government’s ambition to transform the NHS, deliver moFri, 04 Jul 2025 12:05:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-bumetanide-1mg-tabletsBumetanide 1mg tablets are out of stock until mid August 2025. The supply disruption is caused by a combination of manufacturing issues and a resulting increase in demand to other suppliers. BumetanidFri, 04 Jul 2025 06:15:00 GMThttps://www.rpharms.com/news/details//UK-Government-restrictions-on-the-use-of-Puberty-Suppressing-Hormones-Puberty-Blockers-additional-information-for-prescribers-and-pharmacistsdispensing-doctors-ScotlandThe Chief Medical Officer (CMO) and the Chief Pharmaceutical Officer (CPhO) for Scotlandhas issued a letter with additional information on the restrictions on use of puberty supressing hormones.This iThu, 03 Jul 2025 15:51:47 GMThttps://www.rpharms.com/news/details//MHRA-Class-4-Medicines-Defect-Notification-Simvastatin-10mg-Tablet-Crescent-Pharma-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for simvastatin 10mg Tablet. Crescent Pharma Limited has informed the MHRA of an erThu, 03 Jul 2025 15:45:12 GMThttps://www.rpharms.com/news/details//Aurum-pre-filled-syringes-phased-introduction-of-new-10ml-CONNECT-syringe-barrel-Importance-of-selecting-compatible-needle-free-connectors-to-minimise-the-risk-of-syringe-blockageThe Medicines and Healthcare products Regulatory Agency (MHRA) has published device safety information for Aurum pre-filled syringes. Due to a phased introduction of the new 10ml CONNECT barrel desiTue, 01 Jul 2025 11:29:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Erythromycin-Stearate-BP-250mg-Tablets-Amdipharm-UK-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for erythromycin stearate BP 250mg tablets. Amdipharm UK Ltd has informed the MHRA Tue, 01 Jul 2025 11:26:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Tamoxifen-20mg-Film-Coated-Tablets-Wockhardt-UK-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for tamoxifen 20mg film-coated tablets. Wockhardt UK Limited is recalling a batch as a precautioMon, 30 Jun 2025 13:46:19 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Omeprazole-20-mg15-ml-Oral-Solution-Glenmark-Pharmaceuticals-Europe-LtdThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Omeprazole 20 mg/15 ml Oral Solution. Glenmark Pharmaceuticals Europe Ltd is recalling a speMon, 30 Jun 2025 11:01:27 GMThttps://www.rpharms.com/news/details//joint-winners-of-the-outstanding-pharmacy-early-career-researcher-awardQonita Anjani, Research fellow at Queen’s University Belfast and Jennifer Stevenson, Lead pharmacist for older adults at Guy’s and St. Thomas’ NHS Foundation Trust have been announceMon, 30 Jun 2025 06:33:00 GMThttps://www.rpharms.com/news/details//ukpplab-invite-to-pharmacy-professional-leadership-conversationRPS is one of eight pharmacy professional leadership bodies and specialist professional groups, along with independent expert members, that comprise the UK Pharmacy Professional Leadership Advisory BoFri, 27 Jun 2025 12:44:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Potential-contamination-of-non-sterile-alcohol-free-skin-cleansing-wipes-with-Burkholderia-spp-measures-to-reduce-patient-riskThe UK Health Security Agency (UKHSA) is investigating an outbreak of Burkholderia stabilis involving individuals across the UK, linked to wipes. Following testing, Burkholderia spp (full identificatiFri, 27 Jun 2025 09:24:55 GMThttps://www.rpharms.com/news/details//Updated-UKHSA-Immunisation-Training-standards-and-Quality-criteriaThe UK Health Security Agency (UKHSA) has published updated guidance on National Minimum Standards and Core Curriculum for Vaccination Training. This document sets the standards and lists the essentiaFri, 27 Jun 2025 09:02:54 GMThttps://www.rpharms.com/news/details//professor-mahendra-g-patel-obe-awarded-honorary-fellowship-by-the-rcgpThe Royal College of General Practitioners (RCGP) has awarded an Honorary Fellowship to Professor Mahendra G Patel OBE, recognising his exceptional contributions to healthcare, research equity and croThu, 26 Jun 2025 06:07:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Depo-Medrone-80-mg-in-2-mL-suspension-for-injectionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for Depo-Medrone 80 mg in 2 mL suspension for injection, Maxearn Limited. A batch of Depo-Medrone hWed, 25 Jun 2025 13:21:20 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Kimmtrak-200-microgramsmL-concentrate-for-solution-for-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Kimmtrak 200 micrograms/mL concentrate for solution for infusion. Immunocore Limited is recaWed, 25 Jun 2025 11:05:53 GMThttps://www.rpharms.com/news/details//rps-led-group-to-tackle-racial-disparities-for-black-pharmacy-studentsThe Royal Pharmaceutical Society (RPS) has convened the first meeting of its cross-sector Differential Attainment Oversight Group, dedicated to tackling differential attainment among Black student andFri, 20 Jun 2025 09:10:00 GMThttps://www.rpharms.com/news/details//rps-appoints-to-director-for-england-roleThe Royal Pharmaceutical Society has appointed Amandeep Doll to the role of Director for England following a competitive and rigorous recruitment process. Amandeep is currently Head of Engagement &amMon, 16 Jun 2025 08:51:35 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Inhixa-12000IU-120mg08mL-solution-for-injectionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for Inhixa 12,000IU (120mg)/0.8mL solution for injection. Maxearn Limited have informed the MHRA thThu, 12 Jun 2025 14:12:12 GMThttps://www.rpharms.com/news/details//rps-response-to-government-spending-reviewCommenting on the Government’s Spending Review, Professor Claire Anderson, RPS President, said: “Today’s Spending Review is a testament to the crucial role of our health service aWed, 11 Jun 2025 13:21:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-access-to-learning-support-fund-for-pharmacy-studentsThe RPS has welcomed the inclusion of pharmacy students in the Learning Support Fund, following joint calls for change with the British Pharmaceutical Students' Association and Pharmacy Schools CoWed, 11 Jun 2025 08:48:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Valproate-updated-safety-and-educational-materials-to-support-patient-discussion-on-reproductive-risksThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, EWed, 11 Jun 2025 08:15:38 GMThttps://www.rpharms.com/news/details//-Scottish-Parliament-votes-for-the-creation-of-integrated-digital-patient-care-records-MSPs have voted for the creation of digital patient care records in Scotland, during a debate on the Care Reform (Scotland) Bill. Royal Pharmaceutical Society (RPS) in Scotland has been consistently Wed, 11 Jun 2025 06:01:43 GMTRoss Barrowhttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Dulcolax-Adult-5-mg-Gastro-resistant-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Dulcolax Adult 5 mg Gastro-resistant Tablets. Opella Healthcare UK LTD has infoTue, 10 Jun 2025 11:11:14 GMThttps://www.rpharms.com/news/details//rps-to-deliver-nhse-foundation-trainee-pharmacist-e-portfolio-for-202526The Royal Pharmaceutical Society (RPS) has been awarded the contract to deliver the NHS England Foundation Trainee Pharmacist Programme e-Portfolio for 2025/26, powered byAxia Digital. The e-portfoliTue, 10 Jun 2025 07:27:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Paracetamol-500mg-Tablets-Chelonia-Healthcare-LimitedThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall. Chelonia Healthcare Limited is recalling specific batches of paracetamol 500mg tablets (100 potMon, 09 Jun 2025 09:18:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Various-products-from-Zentiva-Pharma-UK-LimitedThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Notification for various products from Zentiva Pharma UK Limited. Zentiva Pharma UK Limited has informed tMon, 02 Jun 2025 13:29:32 GMThttps://www.rpharms.com/news/details//rps-2024-annual-credentialing-reportThe Royal Pharmaceutical Society (RPS) has published its 2024 annual credentialing report, presenting data and assessor insights from its credentialing assessments for post-registration foundation, adFri, 30 May 2025 07:00:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-may-2025The Royal Pharmaceutical Society (RPS) Panel of Fellows has designated the following 28 members as Fellows of the RPS for Distinction in the Profession of Pharmacy: James Allen Andrew Boyle Nathan BuWed, 28 May 2025 05:55:00 GMThttps://www.rpharms.com/news/details//rps-launches-new-mentoring-development-programme-to-support-pharmacistsThe Royal Pharmaceutical Society (RPS) is proud to launch ‘Your Journey to Becoming an Effective Mentor’ - a new mentoring development programme designed to help pharmacists build confidenTue, 27 May 2025 07:00:00 GMThttps://www.rpharms.com/news/details//professor-david-jones-receives-rps-hanbury-medal-2025The Royal Pharmaceutical Society (RPS) is proud to announce that Professor David Jones, Professor of Pharmaceutical and Biomaterial Engineering at Queen’s University Belfast, has been awarded thFri, 23 May 2025 06:49:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Mercaptopurine-50mg-Tablets-Aspen-Pharma-Trading-LimitedThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall. Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a Thu, 22 May 2025 10:44:42 GMThttps://www.rpharms.com/news/details//rps-updates-welsh-language-guide-to-support-pharmacists-across-the-ukThe Royal Pharmaceutical Society (RPS) is proud to announce the update to its Welsh Language guide. The guide aids pharmacists in utilising and promote the Welsh language in their daily practice. TheTue, 20 May 2025 07:16:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-BD-ChloraPrep-Clear---1mL-ApplicatorThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for BD ChloraPrep Clear - 1mL Applicator. Becton Dickinson UK Ltd has informed the MHRA that some uMon, 19 May 2025 13:24:46 GMThttps://www.rpharms.com/news/details//Influenza-season-202425-ending-the-prescribing-and-supply-of-antiviral-medicines-in-primary-careUK Health Security Agency (UKHSA) surveillance data indicates that circulation of influenza in the community has returned to baseline levels. In accordance with NICE guidance and Schedule 2 to the NaThu, 15 May 2025 13:45:54 GMThttps://www.rpharms.com/news/details//rps-wins-exemption-clause-for-pharmacists-in-assisted-dying-billThe Royal Pharmaceutical Society (RPS) has successfully secured a key exemption for pharmacists in the Terminally Ill Adults (End of Life) Bill, which returns to the House of Commons for debate tomorrThu, 15 May 2025 08:51:50 GMThttps://www.rpharms.com/news/details//Scottish-Assisted-Dying-Bill-Passes-First-VoteThe Assisted Dying for Terminally Ill Adults (Scotland) Bill has passed a stage one vote in the Scottish Parliament. The Bill, which has been introduced to the Scottish Parliament as a Private MembersWed, 14 May 2025 10:37:31 GMTRoss Barrowhttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Chemidex-Pharma-Ltd-various-topical-steroid-products-The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Notification for Chemidex Pharma Ltd topical steroid products.Chemidex Pharma Ltd has informed the MHRA thTue, 13 May 2025 10:49:12 GMThttps://www.rpharms.com/news/details//royal-pharmaceutical-society-offers-professional-liability-insurance-for-membersRoyal Pharmaceutical Society offers professional liability insurance for members The Royal Pharmaceutical Society (RPS) is proud to announce the launch of a new professional liability insurance policFri, 09 May 2025 06:29:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Chloramphenicol-Eye-OintmentThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Notification for Chloramphenicol 1% w/w Eye Ointment. Blumont Pharma Limited has informed the MHRA Thu, 08 May 2025 13:51:00 GMThttps://www.rpharms.com/news/details//rps-wales-welcomes-expansion-of-clinical-community-pharmacy-servicesThe Royal Pharmaceutical Society has welcomed the announcement of new funding that will support the rollout of two key clinical services in community pharmacies across Wales in 2025. The additional iTue, 06 May 2025 10:29:00 GMThttps://www.rpharms.com/news/details//rps-awarded-extended-contract-for-prescribing-training-in-WalesThe Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW) are proud to announce a three-year extension of their successful learning programme tailored to support pharmacThu, 01 May 2025 10:49:50 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Pregabalin-25mg-50mg-75mg-100mg-150mg-200mg-225mg-300mg-Capsules-Jubilant-Pharmaceuticals-NVThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg capsules. JubilaTue, 29 Apr 2025 11:25:00 GMThttps://www.rpharms.com/news/details//prescription-charge-in-england-frozen-for-2025Commenting on the Government's announcement today that the cost of the prescription charge and pre-payment certificates in England have been frozen for 2025/2026, Chair of RPS England Tase Oputu sMon, 28 Apr 2025 12:00:00 GMThttps://www.rpharms.com/news/details//rps-to-launch-new-prescribing-development-programme-for-pharmacistsThe Royal Pharmaceutical Society (RPS) is proud to announce it will be launching a comprehensive new prescribing development programme designed to support pharmacists across all stages of their prescrMon, 28 Apr 2025 09:00:00 GMThttps://www.rpharms.com/news/details//rps-credentialed-candidates-reach-highest-ever-pass-rateThe Royal Pharmaceutical Society (RPS) is proud to announce a further 13 pharmacists have successfully completed Core Advanced Credentialing as part of the latest assessment cohort, representing a 93%Fri, 25 Apr 2025 09:57:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Brilique-90mg-Tablets-ticagrelorThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 4 medicines defect notification for Brilique 90mg Tablets. G Pharma Ltd has informed the MHRA that there is an erroThu, 24 Apr 2025 12:25:52 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Short-acting-beta-2-agonists-SABA-salbutamol-and-terbutaline-reminder-of-the-risks-from-overuse-in-asthma-and-to-be-aware-of-changes-in-the-SABA-prescribing-guidelinesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update on short-acting beta 2 agonists (SABA) (salbutamol and terbutaline). Healthcare professionals are remiThu, 24 Apr 2025 11:21:46 GMThttps://www.rpharms.com/news/details//rps-to-recruit-director-for-englandThe Royal Pharmaceutical Society is recruiting a new Director for England as part of its commitment to support health policy across Great Britain. The role will drive professional leadership for the pTue, 22 Apr 2025 04:55:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Lercanidipine-HCl-20mg-Tablets-Recordati-IndustriaThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for lercanidipine HCl 20mg Tablets. Recordati Pharmaceuticals Limited has informed the MHRA of an eThu, 17 Apr 2025 14:17:00 GMThttps://www.rpharms.com/news/details//rps-pledges-support-for-pharmacist-support-gift-in-wills-initiativeThe Royal Pharmaceutical Society (RPS) is delighted to announce that it is supporting the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with their birthday celebrations Tue, 15 Apr 2025 07:06:00 GMThttps://www.rpharms.com/news/details//rps-unveils-innovative-new-learning-resources-for-membersThe Royal Pharmaceutical Society (RPS) is proud to announce the launch of RPS Learn, a new online learning platform designed to support the practice, development and career advancement of RPS members.Mon, 14 Apr 2025 08:06:44 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Synalar-GEL-30g-and-Synalar-GEL-60gThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for Synalar GEL 30g and Synalar GEL 60g (fluocinolone acetonide 0.025%). It has been identified thaTue, 08 Apr 2025 12:34:00 GMThttps://www.rpharms.com/news/details//new-rps-greener-pharmacy-toolkit-reduces-environmental-impactThe new RPS Greener Pharmacy Toolkit is easy to use and provides prompts to introduce more sustainable practices to reduce emissions, improve patient care, prevent ill health, tackle medicines waste aTue, 08 Apr 2025 08:31:08 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Renacet-475-mg-and-950-mg-Tablets-calcium-acetateThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Notification for Renacet 475 mg and 950 mg Tablets (calcium acetate). RenaCare NephroMed GmbH has iMon, 07 Apr 2025 14:25:56 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Urospir-50mg5ml-Oral-Solution-The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Urospir 50mg/5ml Oral Solution. Rosemont Pharmaceuticals Limited is recalling a single batchWed, 02 Apr 2025 12:49:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Utrogestan-Vaginal-200-mg-Capsules-progesteroneThe Medicine and Healthcare products regulatory Agency (MHRA) has issued a class 2 medicines recall for Utrogestan Vaginal 200 mg Capsules. Uni Health Distribution Ltd has informed the MHRA of a typogTue, 01 Apr 2025 10:51:18 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Sirdupla-25-microgram250-microgram-per-metered-dose-pressurised-inhalation-suspensionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect notification for Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suMon, 31 Mar 2025 13:36:28 GMThttps://www.rpharms.com/news/details//rps-welcomes-new-funding-settlement-for-community-pharmacyThe Royal Pharmaceutical Society has welcomed the funding settlement for community pharmacy, which will improve patient access to care and medicines and addresses a decade of underinvestment in the seMon, 31 Mar 2025 07:42:00 GMThttps://www.rpharms.com/news/details//senedd-told-of-pressures-facing-pharmacy-teams-in-walesThe health and wellbeing of the pharmacy profession came into sharp focus this month as RPS Wales met with Members of the Senedd/Welsh Parliament at a dedicated briefing event. Hosted by RPS, the eveFri, 28 Mar 2025 09:41:30 GMThttps://www.rpharms.com/news/details//rps-assembly-update-march-2025TheRPS Assemblyis the primary governance body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following discussion pThu, 27 Mar 2025 09:44:00 GMThttps://www.rpharms.com/news/details//rps-members-vote-in-favour-of-change-and-royal-collegeRPS is delighted to announce today (Wednesday 26 March 2025), that Members have voted in favour by way of a Special Resolution Vote (SRV), in support of proposed changes to the RPS’ Royal CharteWed, 26 Mar 2025 10:02:51 GMThttps://www.rpharms.com/news/details//UKHSA-Urgent-Public-Health-Message--Mpox-Clade-I-mpox-is-no-longer-classed-as-a-high-consequence-infectious-diseaseThe UK Health Security Agency has published an urgent public health message to all NHS trusts, GP practices and independent healthcare providers regarding the derogation of clade I mpox from a high coWed, 19 Mar 2025 14:11:22 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Discontinuation-of-Promixin-colistimethate-1-million-unit-powder-for-nebuliser-solution-unit-dose-vialsPromixin® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) are being discontinued from early May 2025, with stocks anticipated to be exhausted by this date. Mon, 17 Mar 2025 14:16:28 GMThttps://www.rpharms.com/news/details//develop-your-leadership-skills-with-fmlms-clinical-fellow-schemesThe Faculty of Medical Leadership and Management (FMLM) is offering an exciting opportunity for clinicians to enhance their leadership skills and contribute to the future of healthcare. The Chief PhaFri, 14 Mar 2025 11:06:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-pharmacy-support-amid-nhs-england-abolitionIn response to the announcement that Prime Minister Keir Starmer will abolish NHS England, Tase Oputu, RPS England Pharmacy Board Chair, said: “We recognise the hard work and dedication of our Thu, 13 Mar 2025 15:01:29 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Prolonged-release-opioids-Removal-of-indication-for-relief-of-post-operative-painThe Medicines and Healthcare product Regulatory Agency (MHRA) has published a drug safety update on prolonged-release opioids. The indication for the treatment of post-operative pain has been removed Thu, 13 Mar 2025 09:43:10 GMThttps://www.rpharms.com/news/details//vote-now-for-rps-to-become-the-royal-college-of-pharmacyWe are urging our Members and Fellows to vote from today to approve the proposed changes to our Royal Charter, paving the way for our transformation to the Royal College of Pharmacy. This historic SpThu, 13 Mar 2025 08:52:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Notification-Azithromycin-250-mg-Capsules-The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect notification for specific batches of azithromycin 250mg capsules. Jubilant Pharmaceuticals NV has iTue, 11 Mar 2025 15:37:29 GMThttps://www.rpharms.com/news/details//uk-chief-pharmaceutical-officers-back-royal-college-of-pharmacy-voteThe UK’s Chief Pharmaceutical Officers have given their support to our proposals to become a Royal College, calling it “a historic opportunity” to strengthen pharmacy leadership and Tue, 11 Mar 2025 15:30:00 GMThttps://www.rpharms.com/news/details//Gail-Caldwell-receives-RPS-Charter-Award-2024The Royal Pharmaceutical Society (RPS) is proud to announce that RPS Fellow, Gail Caldwell, is the latest recipient of the Charter Award, in recognition of her exceptional contributions to pharmacy anTue, 11 Mar 2025 10:17:00 GMThttps://www.rpharms.com/news/details//open-letter-to-the-pda-following-their-statement-about-the-rps-special-resolution-vote-processWe are disappointed by the position taken by the Pharmacists’ Defence Association (PDA) regarding the RPS forthcoming Special Resolution Vote (SRV) of Members and Fellows of the Royal PharmaceutMon, 10 Mar 2025 17:31:00 GMThttps://www.rpharms.com/news/details//strengthening-our-partnership-with-pharmacist-supportAt the Royal Pharmaceutical Society, we’ve always valued our strong partnership with Pharmacist Support, and we’re committed to continuing to work together to support the profession. With Mon, 10 Mar 2025 15:50:00 GMThttps://www.rpharms.com/news/details//ukpplab-backs-our-royal-college-ambitionsThe UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) has given its support to our proposals to become a Royal College, calling them “a historic opportunity to raise the profile of phFri, 07 Mar 2025 10:34:30 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Boots-Paracetamol-500-mg-tablets-16sThe Medicine and Healthcare products Regulatory Agency (MHRA) has published a class 2 drug recall for Boots Paracetamol 500 mg tablets. Aspar Pharmaceuticals Limited have informed the MHRA of an errorTue, 04 Mar 2025 15:02:55 GMThttps://www.rpharms.com/news/details//Update-Class-2-Medicines-Recall-Sun-Pharmaceutical-Industries-Europe-BV-Pemetrexed-1000MG100ML-10mgml--800MG100ML-8mgml-Infusion-bagPlease note this alert has been updated to correct a typographical error in the strength of one product. The Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 recallTue, 04 Mar 2025 14:09:00 GMThttps://www.rpharms.com/news/details//MHRA-Class-3-Medicines-Recall-Azacitidine-100-mgvial-and-150-mgvial-Powder-for-Suspension-for-Injection-The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 recall for Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection. Accord Healthcare Limited isMon, 03 Mar 2025 12:07:00 GMThttps://www.rpharms.com/news/details//renew-or-join-by-28-february-to-vote-on-royal-college-status-says-rpsRPS is urging pharmacists to renew their membership (if it is due) by 28thFebruary 2025, or to join by that date, to be eligible to take part in the upcoming Special Resolution Vote (SRV) on its propoFri, 21 Feb 2025 09:03:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Glucophage-SR-500-mg-750mg-and-1000mg-Prolonged-release-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Glucophage SR 500 mg, 750mg and 1000mg Prolonged-release tablets. All batches of the named pThu, 20 Feb 2025 14:39:17 GMThttps://www.rpharms.com/news/details//Foysol-Choudhury-MSP-visits-Barnton-Pharmacy-EdinburghOn 17 February, Foysol Choudhury MSP for Lothian, visited the pharmacy team at Barnton Pharmacy in Edinburgh to witness the fantastic work they are doing to provide care to their local community. The Wed, 19 Feb 2025 15:33:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Food-Standards-Agency-TriOn-Pharma-recalls-Aactive-D3-2000iuml-supplements-because-of-excess-levels-of-Vitamin-D3TriOn Pharma is recalling two food supplement products. Aactive D3 Drops and Aactive D3 Solution because they contain higher levels of vitamin D3 than written on the label. This alert was published oTue, 18 Feb 2025 09:53:36 GMThttps://www.rpharms.com/news/details//workforce-survey-highlights-strain-medicine-shortages-place-on-pharmacy-teamsThe results of the sixth annual RPS Workforce Wellbeing Survey, in partnership with Pharmacist Support and in collaboration with the Association of Pharmacy Technicians UK (APTUK), highlight the intenTue, 18 Feb 2025 08:59:42 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Valproate-Belvo-Convulex-Depakote-Dyzantil-Epilim-Epilim-Chrono-or-Chronosphere-Episenta-Epival-and-Syonell-review-by-two-specialists-is-required-for-initiating-valproate-but-not-for-male-patients-already-taking-valproateThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for Valproate products. The Commission on Human Medicines (CHM) has advised a review by two specialistThu, 13 Feb 2025 18:02:00 GMThttps://www.rpharms.com/news/details//rps-unveils-proposed-changes-to-royal-charter-and-vote-details-in-royal-college-bidThe Royal Pharmaceutical Society (RPS) has announced proposed changes to its Royal Charter and details of an all-member vote that will pave the way for its transition to become a Royal College. The &lWed, 12 Feb 2025 10:07:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Lansoprazole-Gastro-resistant-Hard-Capsules-15mgThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Notification for Lansoprazole Gastro-resistant Hard Capsules 15mg. Teva UK Limited has reported a minor tyTue, 11 Feb 2025 12:04:33 GMThttps://www.rpharms.com/news/details//reclassification-will-help-unlock-access-to-medicines-says-rpsThe Royal Pharmaceutical Society welcomes the news from the Department of Health and Social Care encouraging more reclassification applications to the Medicines and Healthcare Products Regulatory AgenFri, 07 Feb 2025 09:07:00 GMThttps://www.rpharms.com/news/details//rps-wales-welcomes-new-report-on-chronic-conditionsThe Royal Pharmaceutical Society (RPS) has welcomed a new report from the Senedd Health and Social Care Committee following its inquiry into supporting people with chronic conditions. The report makeWed, 05 Feb 2025 14:36:08 GMThttps://www.rpharms.com/news/details//-Class-2-Medicines-Recall-Nitrofurantoin-CNX-Therapeutics-100-mg-Prolonged-Release-capsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 medicines recall for specific batches of nitrofurantoin 100mg prolonged-release capsules. CNX therapeutics is recallWed, 05 Feb 2025 11:36:03 GMThttps://www.rpharms.com/news/details//rps-response-to-gphcs-updated-guidance-on-online-pharmacy-servicesThe Royal Pharmaceutical Society (RPS) welcomes the updated guidance issued by the General Pharmaceutical Council (GPhC) on the provision of pharmacy services at a distance, including online services.Tue, 04 Feb 2025 09:02:00 GMThttps://www.rpharms.com/news/details//Scottish-Parliamentary-Reception-highlights-The-Daffodil-Standards-On 28 January, a Parliamentary reception, ‘The Daffodil Standards for Community Pharmacy’, was held at Holyrood to raise awareness and highlight the role of pharmacists in providing high qFri, 31 Jan 2025 12:04:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//RPS-comments-on-proposed-rise-in-GPhC-feesCommenting on the General Pharmaceutical Council’s proposal to increase its fees by 6% annually over the next two years, RPS CEO Paul Bennett said: “We fully recognise the importance of eThu, 30 Jan 2025 14:16:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Bristol-Laboratories-Limited-Amlodipine-Bristol-Lab-25-mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specified batches of Bristol Laboratories Limited, Amlodipine Bristol Lab 2.5 mg Tablets. The sThu, 30 Jan 2025 11:37:59 GMThttps://www.rpharms.com/news/details//GLP-1-and-dual-GIPGLP-1-receptor-agonistspotential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedationThe Medicine and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for GLP-1 and dual GIP/GLP-1 receptor agonists. Healthcare professionals should be aware of the potentiWed, 29 Jan 2025 14:06:18 GMThttps://www.rpharms.com/news/details//Scottish-Pharmacy-Board-Chair-seeks-assurances-from-First-Minister-on-support-for-PharmacyYesterday (27 January), Jonathan Burton MBE, Chair of the Scottish Pharmacy Board, attended a speech by the Scottish First Minister, John Swinney, and used the opportunity to seek assurances that ScotTue, 28 Jan 2025 11:26:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-submits-to-call-for-evidence-on-assisted-dyingThe Royal Pharmaceutical Society (RPS) has responded to a call for evidence by a House of Commons committee examining legislation on assisted dying. On 29 November 2024, the Terminally Ill Adults (EnTue, 28 Jan 2025 10:18:20 GMThttps://www.rpharms.com/news/details//collaborative-vision-for-pharmacy-professional-leadershipThe UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) has launched a series of webinars during February so that pharmacists, pharmacy technicians and wider pharmacy team members can collaboMon, 27 Jan 2025 08:56:00 GMThttps://www.rpharms.com/news/details//rps-speaks-to-the-bbc-on-finasteride-safety-concernsFormer RPS Director for England, James Davies, and RPS Welsh Pharmacy Board member Lowri Puw recently spoke to the BBC about Finasteride, a prescription drug for prostate enlargement and hair loss. TFri, 24 Jan 2025 10:27:36 GMThttps://www.rpharms.com/news/details//polypharmacy-featured-on-bbcs-morning-liveRPS Fellow Steve Williams appeared on BBC1's Morning Live to discuss the challenges of polypharmacy—the use of multiple medicines by one person—and how to manage it effectively. TakinWed, 22 Jan 2025 16:01:04 GMThttps://www.rpharms.com/news/details//rps-submits-evidence-to-appg-inquiry-into-medicines-shortages-in-englandThe Royal Pharmaceutical Society has submitted evidence to the All-Party Parliamentary Group (APPG) on Pharmacy inquiry into medicines shortages in England, examining their impact, causes and potentiaWed, 22 Jan 2025 12:18:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Tesco-Health-Dry-Cough-Relief-200ml-Asda-Strong-Dry-Tickly-Cough-200ml-Almus-Dry-Cough-Relief--Bells-Dual-Action-Dry-CoughThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for Tesco Health Dry Cough Relief 200ml, Asda Strong Dry Tickly Cough 200ml, Almus Dry Cough ReliefTue, 21 Jan 2025 15:05:00 GMThttps://www.rpharms.com/news/details//MSP-drop-in-on-patient-recordsOn Thursday (16 January), the RPS Scotland Team held a drop-in event on access to patient records for pharmacists in the community, for MSPs at The Scottish Parliament.The event was kindly sponsored bFri, 17 Jan 2025 16:25:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//professor-amira-guirguis-appointed-to-advisory-council-on-misuse-of-drugsProfessor Amira Guirguis, Chair of the Royal Pharmaceutical Society’s (RPS) Science and Research Committee and RPS Fellow, has been appointed to the prestigious Advisory Council on the Misuse ofWed, 15 Jan 2025 10:00:29 GMThttps://www.rpharms.com/news/details//rps-launches-new-policy-on-artificial-intelligence-in-pharmacyWe'vepublished a new policy outlining how artificial intelligence (AI) can be used to support pharmacy practice and improve patient care. Developed in consultation with RPS members, Expert AdvisoTue, 14 Jan 2025 09:06:11 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Irbesartan-150-mg-and-300-mg-film-coated-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines notification for Irbesartan 150 mg and 300 mg film-coated tablets. Jubilant Pharmaceuticals NV has infoMon, 13 Jan 2025 12:30:42 GMThttps://www.rpharms.com/news/details//new-rps-report-unveils-roadshow-debates-about-its-proposals-for-changeThe Royal Pharmaceutical Society (RPS) has published a report which captures the conversations and questions that were a key part of 15 ‘roadshow’ events held across Great Britain in OctobFri, 10 Jan 2025 15:39:00 GMThttps://www.rpharms.com/news/details//government-responds-to-pharmacy-Inquiry-reportThe Health and Social Care Committee has published the Government’s response to its Inquiry report on pharmacy. The new Committee Chair Layla Moran MP has noted that before the general electionFri, 10 Jan 2025 15:05:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Rabeprazole-sodium-10mg-and-20mg-gastro-resistant-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines notification for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets. Bristol Laboratories LimiteThu, 09 Jan 2025 13:47:57 GMThttps://www.rpharms.com/news/details//Original-pack-dispensing-From 1 January 2025,NHS community pharmacists and their teams can dispense up to 10% more or less than the quantity prescribed of eligible medicines on NHS prescriptions if it means the medicine can bFri, 03 Jan 2025 09:43:11 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Argenx-BV-Vyvgart-1000-mg-solution-for-injectionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines notification for Argenx BV, Vyvgart 1000 mg solution for injection. Argenx BV has informed the MHRA thaThu, 19 Dec 2024 11:59:28 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-Pancreatic-enzyme-replacement-therapy-PERT-NatPSA2024013DHSC---Additional-actions-A National Patient Safety Alert has been issued on the shortage of pancreatic enzyme replacement therapy (PERT). This alert contains actions which are in addition to those outlined in the National PatWed, 18 Dec 2024 16:18:19 GMThttps://www.rpharms.com/news/details//Indefinite-ban-on-the-supply-of-puberty-blockers-to-children-and-young-people-under-18-years-of-ageSince 3 June 2024, temporary emergency restrictions have been in place preventing the private sale and supply of gonadotrophin releasing hormone (GnRH) analogues used to suppress puberty as part of trTue, 17 Dec 2024 12:23:00 GMThttps://www.rpharms.com/news/details//impact-of-medicines-shortages-on-patients-and-pharmacists-highlighted-at-the-seneddMembers of the Senedd (MS) (Welsh Parliament) have heard how medicine shortages are affecting patients and leading to increased workloads and stress for pharmacy teams at an RPS Wales briefing. The eFri, 13 Dec 2024 15:15:53 GMThttps://www.rpharms.com/news/details//Why-community-pharmacists-should-have-access-to-patient-recordsThe below comment piece was published in The Times (Scotland edition) newspaperon Tuesday 10 December, 2024. Community pharmacists prescribe medication multiple times a day, but they could do more Thu, 12 Dec 2024 13:35:57 GMThttps://www.rpharms.com/news/details//rps-calls-for-national-commissioning-of-free-emergency-contraception-in-englandThe Royal Pharmaceutical Society has joined the Faculty of Sexual and Reproductive Healthcare to call for a nationally commissioned service to provide free oral emergency contraception through communiTue, 10 Dec 2024 09:59:18 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Wockhardt-UK-Limited-WockAIR-160-microgram45-microgram-inhalation-powder-budesonideformoterol-fumarate-dihydrateThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 drug recall for Wockhardt UK Limited, WockAIR 160 microgram/4.5 microgram, inhalation powder. Wockhardt UK Limited iMon, 09 Dec 2024 14:03:13 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Brillpharma-Limited-Oxybutynin-hydrochloride-Brillpharma-25-mg5-ml-Oral-SolutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Brillpharma Limited, Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral SolutWed, 04 Dec 2024 11:59:36 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Kent-Pharma-UK-Phenoxymethylpenicillin-250mg5ml-Oral-Solution-Sugar-FreeThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Kent Pharma UK, Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free. Kent Pharma UK iTue, 03 Dec 2024 16:05:59 GMThttps://www.rpharms.com/news/details//Influenza-Season-202425-Use-Of-Antiviral-Medicines-in-EnglandUK Health Security Agency (UKHSA) surveillance data indicates that influenza is circulating in the community. While some areas continue to see low levels of influenza activity, surveillance indicatorsTue, 03 Dec 2024 11:06:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Rosemont-Pharmaceuticals-Limited-Mycophenolate-Mofetil-1g5ml-Oral-SuspensionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicine defect information for Rosemont Pharmaceuticals Limited, Mycophenolate Mofetil 1g/5ml Oral Suspension. RoseMon, 02 Dec 2024 15:55:30 GMThttps://www.rpharms.com/news/details//Legislative-changes-to-widen-access-to-naloxone-Following a consultation by the Department of Health and Social Care (DHSC), the Human Medicines Regulations (2012) (HMR) have been changed to widen access to naloxone. These changes come into force tMon, 02 Dec 2024 15:30:00 GMThttps://www.rpharms.com/news/details//work-of-amr-pharmacists-recognised-at-the-welsh-seneddAntimicrobial Resistance Awareness Week was recently marked at the Welsh Senedd. Plaid Cymru’s Health and Social Care Spokesperson made a short statement highlighting the urgency of addressing aFri, 29 Nov 2024 15:23:04 GMThttps://www.rpharms.com/news/details//RPS-awards-new-Fellowships-in-ScotlandRPS in Scotland is delighted to announce that thirteen pharmacists based in Scotland have been recognised by the profession this week with the awarding of new Fellowships of RPS for distinction in theFri, 29 Nov 2024 09:58:59 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-rps-fellows-2024The RPS Panel of Fellows has designated the following 39 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhFri, 29 Nov 2024 09:30:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Strides-Pharma-UK-Ltd-Liothyronine-Sodium-5--20-micrograms-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information. Strides Pharma UK Ltd has informed the MHRA of an error in the patient information leaThu, 28 Nov 2024 13:08:40 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Morningside-Healthcare-Limited-Tramadol-Hydrochloride-50-mg-capsules--Tramadol-Hydrochloride-Morningside-50-mg-Prolonged-Release-capsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information for Morningside Healthcare Limited, Tramadol Hydrochloride 50 mg capsules & TramadoWed, 27 Nov 2024 15:18:00 GMThttps://www.rpharms.com/news/details//rps-assembly-update-november-2024TheRPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following discussion Wed, 27 Nov 2024 09:23:00 GMThttps://www.rpharms.com/news/details//rps-calls-on-secretary-of-state-for-health-to-create-medicines-shortages-strategyThe Royal Pharmaceutical Society in England and 19 other organisations have written to the Secretary of State for Health and Social Care, Wes Streeting, calling for a cohesive cross-government strategWed, 27 Nov 2024 08:51:00 GMThttps://www.rpharms.com/news/details//RPS-in-Scotland-calls-for-Government-action-to-tackle-medicine-shortages-A new report from the Royal Pharmaceutical Society (RPS), backed by charities and patient groups, calls on Governments across the UK to work together on a strategy to manage medicine shortages. The rTue, 26 Nov 2024 09:49:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-calls-for-government-action-to-tackle-medicines-shortagesA new report from the Royal Pharmaceutical Society (RPS), backed by charities and patient groups, calls on the Government to create a national strategy to manage medicine shortages and to change legisTue, 26 Nov 2024 08:56:00 GMThttps://www.rpharms.com/news/details//pharmacists-highlighted-for-key-role-in-mental-health-support-at-the-seneddThe Royal Pharmaceutical Society in Wales recently showcased the important role pharmacists play in mental health care and support during a multi-professional briefing at the Welsh Parliament, Senedd.Tue, 26 Nov 2024 07:00:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Syri-Limited-TA-SyriMed-Baclofen-10mg5ml-Oral-SolutionThe Medicines and Healthcare products regulatory Agency (MHRA) has issued a Class 3 medicine recall for Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution. Syri Limited, T/A SyriMed is recalliMon, 25 Nov 2024 15:13:14 GMThttps://www.rpharms.com/news/details//Folic-acid-supplementation-continued-advice-for-those-who-are-planning-a-pregnancy-or-newly-pregnantTheUK Chief Medical Officers, UK Chief Nursing Officers and UK Chief Midwifery Officers have published a letter with advice for healthcare professionals on folic acid supplementation for those who areMon, 25 Nov 2024 15:12:06 GMThttps://www.rpharms.com/news/details//RPS-advises-Parliamentary-Committee-on-Assisted-DyingToday, Fiona McIntyre, Policy and Practice Lead at Royal Pharmaceutical Society in Scotland, provided evidence to the Health, Social Care and Sport Committee at The Scottish Parliament as part of its Tue, 19 Nov 2024 12:35:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Takeda-UK-Limited-Entyvio-vedolizumab108mg-solution-for-injection-in-pre-filled-syringeThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information for Takeda UK Limited, Entyvio (vedolizumab)108mg solution for injection in pre-filled Mon, 18 Nov 2024 16:43:13 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Leeds-Trading-Company-LTC-Ltd-TA-LTC-Healthcare-EXS-Delay-Spray-PlusLTC Healthcare has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that they have been selling a medicinal product containing lidocaine without authorisation from the MHRA. ThiThu, 14 Nov 2024 10:29:53 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Viatris-UK-Healthcare-Ltd-Omeprazole-40-mg-Powder-for-solution-for-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Omeprazole 40 mg Powder for solution for infusion. Generics (U.K.) Limited (MarkTue, 12 Nov 2024 11:38:52 GMThttps://www.rpharms.com/news/details//rps-presents-inaugural-barnett-award-at-annual-conferenceThe RPS is proud to present Dr Joanne Brown with the inaugural Barnett Award today at its Annual Conference, celebrating her exceptional commitment to mentorship and professional development in pharmaFri, 08 Nov 2024 07:48:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Ennogen-Healthcare-Limited-Zoledronic-Acid-Ennogen-4mg5ml-concentrate-for-solution-for-infusion1The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Ennogen Healthcare Limited, Zoledronic Acid Ennogen 4mg/5ml concentrate for soluThu, 07 Nov 2024 15:03:00 GMThttps://www.rpharms.com/news/details//Puberty-blockers-temporary-ban-extended1We published apharmacy alerton 31 May 2024 on new restrictions on the sale and supply of gonadotrophin releasing hormone (GnRH) analogues when used to suppress puberty as part of treatment for gender Thu, 07 Nov 2024 14:14:45 GMThttps://www.rpharms.com/news/details//celebrating-black-history-month-2024Throughout October, we celebrated Black History Month (BHM) by hosting an event at our London office sharing blogs and resources on our social media channels. Catch up on our highlights from the monthFri, 01 Nov 2024 11:31:00 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-government-budget-for-autumn-2024Commenting on the Government’s budget delivered today, Chair of RPS in England Tase Oputu said: “Pharmacists are crucial to enhancing patient safety and supporting the best use of medicinWed, 30 Oct 2024 16:49:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-GLP-1-receptor-agonists-reminder-of-the-potential-side-effects-and-to-be-aware-of-the-potential-for-misuseThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for glucagon-like peptide-1 receptor agonists (GLP-1RAs). Healthcare professionals are reminded to infWed, 30 Oct 2024 10:08:14 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Tillomed-Laboratories-Limited-Labetalol-200mgThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 drug recall for a specific batch of Labetalol 200mg tablets. Tillomed Laboratories Limited is recalling one batch ofWed, 30 Oct 2024 09:30:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-Molybdenum-99Technetium99m-generatorsThe Department of Health and Social Care (DHSC) has issued a National Patient Safety Alert on the shortage of Molybdenum-99/Technetium99m generators. There are limited supplies of Molybdenum-99 used tMon, 28 Oct 2024 13:06:24 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Kent-Pharma-UK-Parasolve-Paracetamol-500mg-effervescent-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Parasolve (Paracetamol) 500mg Effervescent Tablets. Kent Pharma UK has informed Mon, 28 Oct 2024 13:01:32 GMThttps://www.rpharms.com/news/details//our-response-to-guild-of-healthcare-pharmacists-open-letterFollowing the open letter sent to us by the Guild of Healthcare Pharmacists (GHP), we have responded to them and have set out our response below. Dear Rob, Thank you for your recent letter concerniFri, 25 Oct 2024 08:55:00 GMThttps://www.rpharms.com/news/details//UPDATE-Class-3-Medicines-Recall-Glenmark-Pharmaceuticals-Europe-Ltd-Cyanocobalamin-50-mcg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update to the Class 3 drug recall for cyanocobalamin 50 mcg tablets published on 3 October 2024. This recall notification Thu, 24 Oct 2024 07:35:00 GMThttps://www.rpharms.com/news/details//rps-president-visits-pharmacy-teams-in-walesRPS President, Professor Claire Anderson, recently visited pharmacy teams in South-East Wales to see first-hand the innovative work driving forward the implementation of pharmacy’s 2030 vision iWed, 23 Oct 2024 14:42:35 GMThttps://www.rpharms.com/news/details//MHRA-Class-2-Medicines-Recall-Bristol-Laboratories-Ltd-Phenobarbital-Bristol-Labs-15mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 drug recall for phenobarbital Bristol Labs 15mg Tablets. Bristol Laboratories Ltd. are recalling one batch of phenobWed, 23 Oct 2024 12:12:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Update-Discontinuation-Of-Kay-Cee-L-Potassium-Chloride-375mgMl-Potassium-Chloride-5mmol5ml-Syrup-Kay-Cee-L®(potassium chloride 5mmol/5ml) syrup will be discontinued from late November 2024 due to manufacturing and commercial issues. This alert supersedes the previous alert published on 26th JMon, 21 Oct 2024 15:35:44 GMThttps://www.rpharms.com/news/details//government-launches-consultation-on-10-year-health-planThe UK Government has launched a consultation to help inform a proposed 10-Year Health Plan and build an NHS ‘fit for the future’. Members of the public, as well as healthcare staff and eMon, 21 Oct 2024 12:02:40 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Kent-Pharma-UK-Paracetamol-500mg-Effervescent-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Paracetamol 500mg Effervescent Tablets. Kent Pharma UK has informed the MHRA thaMon, 21 Oct 2024 11:16:07 GMThttps://www.rpharms.com/news/details//rps-pharmacist-support-and-aptuk-launch-workforce-wellbeing-surveyThe sixth annual RPS Workforce Wellbeing Survey, in partnership with Pharmacist Support and in collaboration with the Association of Pharmacy Technicians UK (APTUK), is now live as part of our long-ruFri, 18 Oct 2024 07:59:35 GMThttps://www.rpharms.com/news/details//pharmacists-role-in-mental-health-highlighted-at-plaid-cymru-conferenceThe crucial role pharmacists play in mental health care was discussed at the recent Plaid Cymru Autumn Conference. During a main stage panel hosted by the Royal College of Psychiatrists in Wales, RPSWed, 16 Oct 2024 10:12:35 GMThttps://www.rpharms.com/news/details//Safe-Spaces-ProgrammeThe Home Office has announced that it will be winding down the Ask for ANI emergency codeword scheme that was launched during the pandemic. Ask for ANI will conclude from 4th November 2024. The Safe Tue, 15 Oct 2024 14:39:37 GMThttps://www.rpharms.com/news/details//Guidance-on-reporting-safety-concerns-with-diabetes-management-equipment-to-the-Yellow-Card-schemeThe Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on how to report suspected adverse incidents and safety concerns with diabetes management equipment to the Yellow Thu, 10 Oct 2024 14:52:31 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Ltd-Linezolid-600-mg-film-coated-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for linezolid 600mg film-coated tablets. Sandoz Ltd. has informed the MHRA that therThu, 10 Oct 2024 10:42:55 GMThttps://www.rpharms.com/news/details//RPSs-Parliamentary-evidence-on-remote-and-rural-healthcare-highlighted-The Health, Social Care and Sport Committee has published its final report on healthcare in remote and rural areas. Royal Pharmaceutical Society (RPS) provided both written and oral evidence to this Wed, 09 Oct 2024 06:24:43 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-rps-and-rcgp-repeat-prescribing-toolkit-will-improve-safety-and-efficiencyNew RPS and RCGP Repeat Prescribing Toolkit will improve safety and efficiency The Royal Pharmaceutical Society (RPS) and the Royal College of GPs (RCGP) have developed a practical toolkit designed tTue, 08 Oct 2024 05:53:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Viatris-UK-Healthcare-Ltd-Trandolapril-2mg-and-4mg-capsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 drug recall for Trandolapril 2mg and 4mg capsules. Generics (UK) Ltd T/A Mylan UK is recalling specific batches oMon, 07 Oct 2024 10:44:43 GMThttps://www.rpharms.com/news/details//rps-responds-to-consultation-on-puberty-blockersRPS has responded to the Government’s consultation on the proposed change to the availability of puberty blockers. In our response, we have consolidated our position expressed in our earlier stFri, 04 Oct 2024 10:59:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Glenmark-Pharmaceuticals-Europe-Ltd-Cyanocobalamin-50-mcg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 drug recall for Cyanocobalamin 50 mcg tablets. Glenmark Pharmaceuticals Europe Ltd is recalling the affected batcThu, 03 Oct 2024 14:22:48 GMThttps://www.rpharms.com/news/details//pharmacy-pressures-highlighted-in-welsh-seneddMembers of the Senedd (MSs) have been hearing about the pressures community pharmacists and their teams are facing and the support that’s required for the sector. In a joint event by RPS and CoThu, 03 Oct 2024 10:58:57 GMThttps://www.rpharms.com/news/details//celebrating-esea-heritage-month-2024For the first time, we celebrated East and Southeast Asian Heritage Month, embracing this year’s theme “Changing Seasons” to acknowledge the evolving experiences, cultures and identiTue, 01 Oct 2024 13:29:43 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Ltd-Rosuvastatin-20mg-40mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Rosuvastatin 20mg and 40mg Tablets. Sandoz Ltd. has informed the MHRA that thereTue, 01 Oct 2024 10:30:27 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Pfizer-Limited-Oxbryta-500mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published aClass 2 medicines recall.Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited hasMon, 30 Sep 2024 11:56:00 GMThttps://www.rpharms.com/news/details//next-steps-for-pharmacy-in-wales-2030-vision-announced-at-rps-wales-conferenceRPS Wales will once again take the lead in developing updated 3-year goals to help enable pharmacy in Wales to reach its 2030 vision, outlined in ‘Pharmacy: Delivering a Healthier Wales’ (Fri, 27 Sep 2024 09:35:32 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Ltd-Risperidone-1mg-2mg-3mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Risperidone 1mg, 2mg and 3mg and Tablets. Sandoz Ltd. has informed the MHRA thatThu, 26 Sep 2024 13:08:33 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-pharmacy-closures-dataHealthwatch England has today publisheddata from its report “Pharmacy – what people want”, highlighting frustrations from patients when their local pharmacy is closed permanently, orThu, 26 Sep 2024 08:42:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Risk-of-oxytocin-overdose-during-labour-and-childbirthNHS England has issued a National Patient Safety Alert on the risk of oxytocin overdose during labour and childbirth. This instructs all relevant NHS funded maternity care providers to cease pre-prepaTue, 24 Sep 2024 15:04:45 GMThttps://www.rpharms.com/news/details//rps-launches-two-new-advanced-pharmacist-curriculaWe have launched two new pioneer curricula that define advanced pharmacist practice in mental healthandcritical care. These were developed collaboratively with the College of Mental Health Pharmacy (CMon, 23 Sep 2024 09:03:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Orion-Pharma-UK-Ltd-Eldepryl-5mg-Tablets-selegilineThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 drug recall for Eldepryl 5mg Tablets (selegiline). Orion Pharma (UK) Ltd is recalling a specific batch of EldepryWed, 18 Sep 2024 08:19:00 GMThttps://www.rpharms.com/news/details//one-in-five-patients-in-england-struggle-to-access-medicinesNew data from the Office for National Statistics reveals that 20% of patients in England face difficulties accessing their medicines due to shortages in the supply chain, posing significant challengesMon, 16 Sep 2024 09:06:00 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-darzi-nhs-reportThe Royal Pharmaceutical Society has responded to the publication of a report by the Independent Investigation of the National Health Service in England, led by Lord Darzi. Chair of the RPS in EnglanFri, 13 Sep 2024 07:23:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Theramex-HQ-UK-Ltd-Evorel-Sequi1The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for a batch of Evorel Sequipatches. Theramex has informed the MHRA that some cartons of Evorel SThu, 12 Sep 2024 10:51:19 GMThttps://www.rpharms.com/news/details//rps-announces-proposal-to-become-a-royal-collegeThe Royal Pharmaceutical Society (RPS), the professional leadership body for pharmacists and pharmaceutical scientists in Great Britain, is today (12 September) announcing proposals to seek to registeThu, 12 Sep 2024 07:45:00 GMThttps://www.rpharms.com/news/details//rps-presents-evidence-at-uk-covid-19-inquiry-hearingRPS has given evidenceat the opening of a new phase of the UK COVID-19 Inquiry. Public hearings have now begun for Module 3 of the Inquiry, which is examining the impact of the pandemic on healthcareWed, 11 Sep 2024 10:40:16 GMThttps://www.rpharms.com/news/details//weight-loss-medicines-in-the-newsAs the demand for weight loss medicines increases but supply remains limited, the risk of people turning to unregulated websites and social media to buy them grows. Medicines obtained from such sitesMon, 09 Sep 2024 13:45:38 GMThttps://www.rpharms.com/news/details//rps-hosts-uk-wide-summit-on-advanced-practice-credentialingOn 3 September RPS hosted the Advanced Credentialing Summit, which brought together pharmacists, education bodies and system leaders from across the UK to discuss advanced practice for pharmacists. AMon, 09 Sep 2024 12:16:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Valproate-use-in-men-as-a-precaution-men-and-their-partners-should-use-effective-contraceptionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for valproate use in men. A retrospective observational study has indicated a possible association beThu, 05 Sep 2024 13:11:00 GMThttps://www.rpharms.com/news/details//rps-epb-chair-tase-oputu-appointed-to-nhs-assemblyRPS England Pharmacy Board Chair Tase Oputu has been appointed to the NHS Assembly to represent the pharmacy profession. The NHS Assembly is a national forum of stakeholders from across the health anSun, 01 Sep 2024 20:09:00 GMThttps://www.rpharms.com/news/details//Management-of-eye-conditions-in-primary-care-for-contact-lens-wearing-patients-Following discussion with the College of Optometrists we would like to highlight our guidance on Chloramphenicol (P Medicines). This includes a section on advice for contact lens wearers. People presWed, 28 Aug 2024 13:31:30 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Chemidex-Pharma-Ltd-Ponstan-250mg-Capsules--500mg-Tablets-mefenamic-acidThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for specific batches of Ponstan 250mg Capsules and 500mg Tablets. Chemidex Pharma LtTue, 27 Aug 2024 12:50:45 GMThttps://www.rpharms.com/news/details//Puberty-blockers-temporary-ban-extendedWe published apharmacy alerton 31 May 2024 on new restrictions on the prescription and supply of puberty blockers. Since 3 June 2024, in Great Britain, temporary emergency restrictions have been in plFri, 23 Aug 2024 14:36:25 GMThttps://www.rpharms.com/news/details//The-ability-of-pharmacists-to-conscientiously-object-to-Assisted-Dying-is-essential-This week, Royal Pharmaceutical Society in Scotland published our consultation response to the Scottish Parliament’s Health, Social Care and Sport Committee on the Assisted Dying for Terminally Fri, 23 Aug 2024 09:14:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//php-and-nhs-wales-partner-to-provide-unlimited-access-to-medicines-completeNew Pharmaceutical Press and NHS Wales partnership ensures health professionals across Wales have unlimited access to trusted, independent medicines information to increase patient safety. PharmaceutTue, 20 Aug 2024 13:21:05 GMThttps://www.rpharms.com/news/details//Statement-on-drug-related-deaths-in-ScotlandThe Royal Pharmaceutical Society (RPS) notes statistics released from National Records of Scotland today,which show 1,172 people died due to drug misuse in Scotland in 2023, which is an increase of 12Tue, 20 Aug 2024 09:35:00 GMThttps://www.rpharms.com/news/details//rps-makes-landmark-investment-in-dosiumDosium’s clinical decision support technology aims to improve the speed, consistency and safety of prescribing.Now the Royal Pharmaceutical Society (RPS), on behalf of Pharmaceutical Press, the Tue, 20 Aug 2024 08:24:00 GMThttps://www.rpharms.com/news/details//celebrating-south-asian-heritage-month-2024Did you catch our celebrations forSouth Asian Heritage Month, which exploresthe history and identity of British South Asians? We collaborated with Female Pharmacy Leaders Network, Pharmacy TechnicianMon, 19 Aug 2024 09:53:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Glenmark-Pharmaceuticals-Europe-Ltd-Fingolimod-05-mg-Hard-CapsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 3 recall for Fingolimod 0.5 mg Hard Capsules. Glenmark Pharmaceuticals Europe Ltd is recalling specific batches after Mon, 19 Aug 2024 09:45:00 GMThttps://www.rpharms.com/news/details//Clade-I-mpox-virus-infection-UpdateFollowing the notification of the urgent public health message regarding Clade I mpox virus (MPXV) infection, the UK Health Security Agency (UKHSA) hasmade updates to the Management of Cases section. Fri, 16 Aug 2024 12:39:00 GMThttps://www.rpharms.com/news/details//Clade-I-mpox-virus-infectionThe UK Health Security Agency has issued an urgent public health message to all NHS service providers regarding Clade I mpox virus (MPXV) infection. The guidance includes information on: Actions toFri, 16 Aug 2024 07:18:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Strides-Pharma-UK-Limited-Loperamide-Hydrochloride-Capsules-2mgThe Medicines and Healthcare products Regulatory Agency (MHRA) has published aClass 2 medicines recall for a specified batch of Strides Pharma UK Limited, Loperamide Hydrochloride Capsules 2mg. StrideThu, 15 Aug 2024 08:22:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Dawa-Limited-Trazodone-Hydrochloride-50mg--100mg-Capsules-and-Trazodone-Hydrochloride-50mg5ml-Oral-SolutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for specific Trazodone products. Dawa Limited has informed the MHRA of an error withWed, 14 Aug 2024 12:20:48 GMThttps://www.rpharms.com/news/details//mark-drakeford-ms-appointed-cabinet-secretary-for-health-and-social-careWales’s new First Minister, Eluned Morgan has appointed Mark Drakeford MS to Cabinet Secretary for Health and Social Care. Commenting on the announcement Elen Jones, Director of RPS Wales, saidWed, 14 Aug 2024 09:50:07 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Star-Pharmaceuticals-Limited-Diflucan-Oral-Suspension-40mgmlThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines notification for Diflucan Oral Suspension 40mg/ml. Star Pharmaceuticals Limited has informed the MHRA tMon, 12 Aug 2024 11:21:34 GMThttps://www.rpharms.com/news/details//Pharmacy-initiative-increases-sustainable-disposal-of-inhalersA pharmacy initiative in NHS Lothian has resulted in a 300% increase in the number of inhalers being returned to community pharmacies for sustainable disposal. The simple initiative involved stickersMon, 12 Aug 2024 09:50:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-and-npa-urges-action-on-dppsThe Royal Pharmaceutical Society in England (RPS) and National Pharmacy Association (NPA) have published a new report examining the challenges in accessing designated prescribing practitioners in commMon, 12 Aug 2024 05:47:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Accord-UK-Ltd-Trandolapril-05mg-2mg-4mg-CapsulesAccord-UK Ltd is recalling various batches of Trandolapril 0.5mg, 2mg and 4mg capsules after retesting showed out of specification results. The batches are being recalled as a precautionary measure afThu, 08 Aug 2024 10:54:01 GMThttps://www.rpharms.com/news/details//continuing-violence-and-its-impact-on-pharmacyRPS is an anti-racist organisation and we stand with the pharmacy community against all forms of racism, religious hatred and intolerance. The violent disorder that has been perpetrated across cities Wed, 07 Aug 2024 12:57:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Limited-Omeprazole-productsThe Medicines and Healthcare regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Information for a number of Omeprazole products. Sandoz Ltd. has informed the MHRA that there is missing safWed, 07 Aug 2024 12:41:50 GMThttps://www.rpharms.com/news/details//rps-launches-biggest-ever-medicines-ethics-and-practice-mepThe Royal Pharmaceutical Society has launched its latest edition of Medicines, Ethics and Practice (MEP). At 258 pages, this edition is the largest ever, reflecting a 30% increase in content from the Fri, 02 Aug 2024 06:34:00 GMThttps://www.rpharms.com/news/details//Puberty-Suppressing-Hormones-Judicial-Review-and-RPS-position-statementWe published a pharmacy alert on 31 May 2024 on new restrictions on the prescription and supply of puberty blockers. This legislative change introduced a temporary ban (ending on 3 September) on the pWed, 31 Jul 2024 13:20:13 GMThttps://www.rpharms.com/news/details//pharmacists-must-not-be-criminalised-over-puberty-blocking-hormones-warns-rpsIn light of confirmation by Judicial Review that the emergency prohibition order for puberty blocking hormones remains valid, The Royal Pharmaceutical Society is concerned about the potential criminalWed, 31 Jul 2024 10:47:51 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Glenmark-Pharmaceuticals-Europe-Ltd-Atomoxetine-10mg-18mg-25mg-40mg-60mg-80mg--100mg-Hard-CapsulesGlenmark Pharmaceuticals Europe Ltd is recalling various batches of atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg Hard Capsules after retesting showed out of specification results. The batcTue, 30 Jul 2024 09:47:15 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert--Shortage-of-Kay-Cee-L-potassium-chloride-375mg5ml-potassium-chloride-5mmol5ml-syrupKay-Cee-L(potassium chloride 5mmol/5ml) syrup will be out of stock from late September 2024. The resupply date is to be confirmed. The supply disruption is caused by an amendment to the manufacturingFri, 26 Jul 2024 10:40:25 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Aspen-Pharma-Trading-Limited-Co-trimoxazole-80mg400mg-per-5ml-adult-suspensionAspen Pharma Trading Limited has informed The Medicines and Healthcare Regulatory Agency (MHRA)that an error has been found in the Patient Information Leaflet (PIL) for Co-trimoxazole 80mg/400mg per 5Thu, 25 Jul 2024 14:00:44 GMThttps://www.rpharms.com/news/details//rps-endorses-call-for-improved-womens-reproductive-healthThe Royal Pharmaceutical Society (RPS), alongside 60 other organisations, has signed an FSRH open letter from Dr. Janet Barter, President of the Faculty of Sexual and Reproductive Health (FSRH), calliWed, 24 Jul 2024 16:23:44 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Fresenius-Kabi-Limited-Hartmanns-Solution-for-Injection-BP-as-Steriflex-No-11-or-freeflexThe Medicines and Healthcare Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Fresenius Kabi Limited, Hartmann's Solution for Injection BP as Steriflex No. 11 or fWed, 24 Jul 2024 13:21:38 GMThttps://www.rpharms.com/news/details//Epimax-Ointment-and-Epimax-Paraffin-Free-Ointment-reports-of-ocular-surface-toxicity-and-ocular-chemical-injuryThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update due to reports of ocular surface toxicity and ocular chemical injury for Epimax Ointment and Epimax ParafTue, 23 Jul 2024 15:46:55 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Glaxo-Wellcome-UK-Limited-trading-as-GlaxoSmithKline-UK-Flolan-15-mg-Powder-and-Solvent-for-Solution-for-InfusionThe Medicines and Healthcare products regulatory Agency (MHRA) has published as Class 2 medicines recall for Flolan 1.5 mg Powder and Solvent for Solution for Infusion. Glaxo Wellcome UK Ltd (GSK) hasTue, 23 Jul 2024 08:30:51 GMThttps://www.rpharms.com/news/details//structure-medication-reviews-are-essential-says-rps-englandRPS England has called for greater focus on the delivery of Structure Medication Reviews (SMRs) in primary care to ensure that pharmacists can continue to deliver these important medicines optimisatioTue, 23 Jul 2024 07:50:59 GMThttps://www.rpharms.com/news/details//rps-assembly-update-july-2024TheRPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance and met on 17 July. The Assembly confirmThu, 18 Jul 2024 06:04:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Sun-Pharma-UK-Limited-Pemetrexed-1000MG100ML-10mgml--1100MG100ML-11mgml-Infusion-BagSun Pharmaceutical Industries Europe B.V. is recalling specified batches of Pemetrexed 1000mg/100ml (10mg/ml) and 1100mg/100ml (11mg/ml) infusion bag as a precautionary measure due to visible particulTue, 16 Jul 2024 10:14:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Sun-Pharma-UK-Limited-GemcitabineSun Pharma UK Ltd is recalling specified batches as a precautionary measure due to a small number of leaks found intermittently in the infusion bags. Advice for healthcare professionals is to use preMon, 15 Jul 2024 10:19:00 GMThttps://www.rpharms.com/news/details//call-for-evidence-on-facilitated-self-selection-of-p-medicinesWe've published a call for evidence on the facilitated self-selection of P medicines following changes made by the regulator, the General Pharmaceutical Council (GPhC), enabling more pharmacies toFri, 12 Jul 2024 04:16:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Chelonia-Healthcare-Limited-Propantheline-Tablets-15mg-Chelonia Healthcare Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that an error relating to the product description was identified in the Patient Information LeafTue, 09 Jul 2024 11:01:15 GMThttps://www.rpharms.com/news/details//government-must-turn-to-priorities-for-patients-and-pharmacyThe health service has been one of the key issues throughout the election campaign and there are clear priorities for patients and pharmacy which must now be addressed. Following the general electionTue, 09 Jul 2024 10:39:00 GMThttps://www.rpharms.com/news/details//Implementing-Pharmacy-2030-in-ShetlandIn June, RPS President, Claire Anderson, visited pharmacy teams across Shetland, to witness their innovative practice and implementation of RPS’s vision for the future of pharmacy, Pharmacy 2030Tue, 09 Jul 2024 06:53:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//RPS-responds-to-review-of-RSHE-statutory-guidanceThe Royal Pharmaceutical Society (RPS) has responded to the Government’s consultation on the review of the relationships, sex and health education (RSHE) statutory guidance. The RPS welcomes theMon, 08 Jul 2024 13:47:00 GMThttps://www.rpharms.com/news/details//rps-comments-on-the-general-election-outcomeCommenting on the results of the General Election, RPS Prsident Professor Claire Anderson said: "It's fantastic we now have two pharmacists elected to Parliament. I would like to warmly congFri, 05 Jul 2024 06:32:00 GMThttps://www.rpharms.com/news/details//MHRA-Class-2-Medicines-Recall-Kent-Pharma-UK-Itraconazole-10mgml-Oral-SolutionKent Pharma UK is recalling specified batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence Thu, 04 Jul 2024 12:18:50 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Accord-Healthcare-Ltd-Atomoxetine-10mg-18mg-25mg-40mg-60mg-80mg-100mg-Hard-CapsulesAccord Healthcare Ltd is recalling various batches of atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg Hard Capsules after retesting showed out of specification results. The batches are being Tue, 02 Jul 2024 12:30:18 GMThttps://www.rpharms.com/news/details//rps-attend-pride-in-cardiffOn Saturday 22nd June, for the first time, RPS members took part in Cardiff Pride to celebrate, raise awareness, and advocate for equal rights for LGBTQIA+ people. RPS Director for Wales Elen Jones sFri, 28 Jun 2024 02:40:00 GMThttps://www.rpharms.com/news/details//Introduction-of-new-NHS-vaccine-programmes-against-respiratory-syncytial-virus-RSV-Scotland-The Chief Medical Officer has issued a letter that information on a new vaccination programme in Scotland which aims to protect vulnerable groups against Respiratory Syncytial Virus (RSV) and its compWed, 26 Jun 2024 09:41:23 GMThttps://www.rpharms.com/news/details//Introduction-of-new-NHS-vaccine-programmes-against-respiratory-syncytial-virus-RSV-EnglandThe UK Health Security Agency (UKHSA) and NHS England have published a letter which sets out the details of respiratory syncytial virus (RSV)vaccination programmes. Following guidance from the Joint CWed, 26 Jun 2024 09:38:36 GMThttps://www.rpharms.com/news/details//rps-calls-for-a-national-ehc-service-in-englandThe Royal Pharmaceutical Society, the Company Chemists’ Association, the National Pharmacy Association and the Faculty of Sexual and Reproductive Healthcareare calling for the next government toTue, 25 Jun 2024 10:55:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-PHARMATHEN-SA-Grepid-75-mg-film-coated-tablets-Kent-Pharma-LiveryThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Information for Grepid 75mg film coated tablets. PHARMATHEN S.A. has informed the MHRA that the outMon, 24 Jun 2024 13:03:46 GMThttps://www.rpharms.com/news/details//winner-of-opera-award-2024-announcedSion Scott, a lecturer in behavioural medicine and lead postgraduate research tutor at the University of Leicester, has won the 2024 ‘Outstanding Pharmacy Early-Career Researcher Award’ (OMon, 24 Jun 2024 10:24:00 GMThttps://www.rpharms.com/news/details//rps-statement-on-the-self-selection-of-p-medicines-At the RPS Board meeting 19th June, a discussion took place in the Open Business section of the agenda on the self-selection of P medicines. Enabled by the General Pharmaceutical Council, we understaThu, 20 Jun 2024 10:52:00 GMThttps://www.rpharms.com/news/details//Topiramate-Topamax-introduction-of-new-safety-measures-including-a-Pregnancy-Prevention-ProgrammeThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update on the introduction of new safety measures, including a Pregnancy Prevention Programme for topiramate. ToThu, 20 Jun 2024 10:41:00 GMThttps://www.rpharms.com/news/details//elections-to-rps-boards-and-assembly-2024Elections to vacant positions on the RPS Scottish and English Country Boards took place at the meeting on June 18th and the results are as follows: The Scottish Pharmacy Board The Board elected JonaWed, 19 Jun 2024 08:56:49 GMThttps://www.rpharms.com/news/details//rps-charter-award-presented-to-ade-williams-mbeThe Royal Pharmaceutical Society (RPS) is proud to announce that Adeyemi (Ade) Williams MBE, FRPharmS is the latest recipient of our Charter Award, in recognition of his exceptional contributions to pWed, 19 Jun 2024 06:57:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Teva-UK-Limited-GoResp-DigihalerTeva UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it plans to withdraw from further sale all batches of GoResp Digihaler (budesonide and formoterol fumarTue, 18 Jun 2024 14:28:40 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Viatris-UK-Healthcare-Ltd-Oxcarbazepine-Mylan-150-mg-300mg-600mg-Film-Coated-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Information for Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets. Viatris UK HealthcareMon, 17 Jun 2024 16:11:59 GMThttps://www.rpharms.com/news/details//Glasgow-South-Candidate-for-Westminster-visits-local-Community-Pharmacy-Scottish Labour’s Glasgow South Candidate for Westminster, Gordon McKee, visited Right Dose Pharmacy on Cathcart Road to meet with the pharmacy team and discuss RPS’s vision for the futureMon, 17 Jun 2024 14:58:59 GMThttps://www.rpharms.com/news/details//rps-signs-letter-to-party-leaders-to-end-prescription-chargesIn partnership with the Prescription Charges Coalition (PCC), RPS England Board Chair Tase Oputu has signed an open letter to Party Leaders today calling on them to commit to scrapping prescription chThu, 13 Jun 2024 10:14:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-visit-to-Dumfries-and-Galloway-In June, Laura Wilson, Director for Scotlandand Fiona McIntyre, Policy and Practice Lead,met withthe Dumfries & Galloway pharmacy team, where they observedpharmacy services in both primary and secThu, 13 Jun 2024 07:54:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Dawa-Limited-Paracetamol-500mg-1000mg-Film-Coated-TabletDawa Limited has informed the MHRA that certain batches of paracetamol have been packed with an outdated Patient Information Leaflet (PIL). The PIL does not contain the most up to date information on Wed, 12 Jun 2024 10:22:27 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Desitin-Pharma-UK-Ltd-Lamotrigine-Desitin-10mgml-Oral-SuspensionDesitin Pharma UK Ltd is recalling all batches of Lamotrigine Desitin 10mg/ml Oral Suspension as a precautionary measure due to an out of specification observation in the appearance of samples during Fri, 07 Jun 2024 08:39:47 GMThttps://www.rpharms.com/news/details//call-to-action-for-political-parties-ahead-of-general-electionAhead of the General Election, we’ve written an open letter calling on political parties to support our joint manifesto for community pharmacy. We’ve joined Community Pharmacy England, thFri, 07 Jun 2024 08:09:13 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Neuraxpharm-UK-Ltd-Atomoxetine-10mg-18mg-25mg-40mg-CapsulesNeuraxpharm UK Ltd is recalling specific batches ofAtomoxetine 10mg, 18mg, 25mg, 40mg Capsules after retesting showed out of specification results. Specified batches are being recalled as a precautionWed, 05 Jun 2024 13:10:00 GMThttps://www.rpharms.com/news/details//New-UK-Government-restrictions-on-the-supply-of-Puberty-Suppressing-Hormones-Puberty-Blockers-Information-of-prescribers-and-pharmacistsdispensing-doctorsWe published a pharmacy alert on 31 May 2024 on new restrictions on the prescription and supply of puberty blockers. The Chief Pharmaceutical Officer and Chief Medical Officer for Wales have issued a Mon, 03 Jun 2024 11:46:25 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Manx-Healthcare-Ltd-Betamethasone-Valerate-01-OintmentThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines defect information for Betamethasone Valerate 0.1% Ointment. Manx Healthcare Ltd. has informed MHRA thaMon, 03 Jun 2024 09:40:00 GMThttps://www.rpharms.com/news/details//New-restrictions-on-the-prescription-and-supply-of-puberty-blockersThere will be upcoming legislative changes that introduce new restrictions on the prescribing and supply of puberty supressing hormones known as ‘puberty blockers’, to children and young pFri, 31 May 2024 07:58:00 GMThttps://www.rpharms.com/news/details//a-new-chapter-for-martindale-the-complete-drug-referenceAs the 41st edition of Martindale: The Complete Drug Reference is released, the long-time publisher of this highly respected and trusted publication, Pharmaceutical Press, the Royal Pharmaceutical SocThu, 30 May 2024 10:15:23 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Topical-steroids-introduction-of-new-labelling-and-a-reminder-of-the-possibility-of-severe-side-effects-including-Topical-Steroid-Withdrawal-ReactionsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for topical steroids. Topical steroid products are safe and highly effective treatments for the manageWed, 29 May 2024 15:31:24 GMThttps://www.rpharms.com/news/details//health-committee-publishes-pharmacy-reportThe RPS has welcomed a new report by the House of Commons Health and Social Care Select Committee, following its inquiry into pharmacy. We engaged extensively with the Committee throughout the procesWed, 29 May 2024 11:46:03 GMThttps://www.rpharms.com/news/details//rps-launches-new-prescribing-support-serviceWe’re excited to announce the launch of our new Prescribing Support Service, an extension of our Professional Support Service tailored to queries about prescribing. With prescribing now a part Wed, 29 May 2024 08:12:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-Pancreatic-enzyme-replacement-therapy-PERTThere are limited supplies of pancreatic enzyme replacement therapies (PERT). • Creon® 10,000 and 25,000 capsules are in limited supply until 2026. • Nutrizym® 22 capsules are out Fri, 24 May 2024 15:39:40 GMThttps://www.rpharms.com/news/details//rps-joins-call-to-improve-child-health-outcomes-in-walesThe Royal Pharmaceutical Society, alongside a newly established group of 20 royal colleges and professional bodies, has written to the First Minister of Wales to ask how his government will improve chFri, 24 May 2024 09:20:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-may-2024The RPS Panel of Fellows has designated the following 19 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhFri, 24 May 2024 08:07:02 GMThttps://www.rpharms.com/news/details//help-put-pharmacy-at-the-forefront-of-the-general-electionOur general election manifesto highlights key issues facing the next Government after the election on July 4th. We need your help to ask local candidates to show their support for pharmacy and ensureThu, 23 May 2024 13:44:00 GMThttps://www.rpharms.com/news/details//new-pj-app-available-for-downloadWe have launcheda new app forThe Pharmaceutical Journal. The redesignedPJapp features a simplified sign-in process and allows users to bookmark their favourite articles, share pages to social media, Thu, 23 May 2024 10:06:04 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Fresenius-Kabi-Limited-Sodium-Chloride-09-Intravenous-Infusion-BP-Freeflex-and-Freeflex-PlusFresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS. Further information, advice and detaiWed, 22 May 2024 13:22:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Defect-Information-Doncaster-Pharma-Limited-Keppra-500mg-film-coated-tabletsThe MHRA has re-issued this notification as Class 3 recall based on further assessment. Please note the new actions for healthcare professionals listed within the notification. Doncaster Pharma LimiteWed, 22 May 2024 10:31:58 GMThttps://www.rpharms.com/news/details//rps-election-results-2024Commenting on the results of the elections to the three RPS national Pharmacy Boards, RPS Chief Executive Paul Bennett said: "I am delighted to welcome all our newly elected Board members acrossTue, 21 May 2024 13:38:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Cygnus-Pharma-Ltd-Trazodone-Hydrochloride-50mg5ml-Oral-SolutionCygnus Pharma Ltd. has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the European Article Number (EAN) barcode printed on various packs of Trazodone Hydrochloride 50mg/5Mon, 20 May 2024 13:57:47 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Doncaster-Pharma-Limited-Keppra-500mg-film-coated-tabletsDoncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V. Approximately 70% of thWed, 15 May 2024 13:50:25 GMThttps://www.rpharms.com/news/details//prof-ryan-donnelly-awarded-2024-rps-harrison-medalWe’re pleased to announce that Professor Ryan Donnelly has been awarded the RPS Harrison Memorial Medal for 2024 for his outstanding contribution to advancing pharmaceutical science. The medal iWed, 15 May 2024 06:48:00 GMThttps://www.rpharms.com/news/details//his-majesty-the-king-becomes-new-patron-of-rpsWe are proud to announce His Majesty The King has agreed to become the new Patron of RPS. Buckingham Palace confirmed the news to mark the first anniversary of the Coronation of His Majesty The King Mon, 13 May 2024 07:54:00 GMThttps://www.rpharms.com/news/details//rps-report-highlights-collaboration-to-enhance-workforce-wellbeingOur new report published today details the outcomes of the RPS second roundtable on workforce wellbeing in conjunction with the profession’s independent charity Pharmacist Support (PS). PharmacThu, 09 May 2024 07:45:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-Of-Erelzi-Etanercept-50mg-Solution-For-Injection-In-Pre-Filled-PenErelzi (etanercept) 50mg solution for injection in pre-filled pen will be out of stock from early May until mid-July 2024. Homecare providers (Alcura, Healthnet and Sciensus) have sufficient stock to Fri, 03 May 2024 11:11:25 GMThttps://www.rpharms.com/news/details//NHS-England-Influenza-Season-202324-Ending-The-Prescribing-And-Supply-Of-Antiviral-Medicines-In-Primary-CareUK Health Security Agency (UKHSA) surveillance data indicates that circulation of influenza in the community has returned to baseline levels. In accordance with NICE guidance and Schedule 2 to the NaFri, 03 May 2024 10:43:07 GMThttps://www.rpharms.com/news/details//RPS-at-CPCAre you going to Clinical Pharmacy Congress on 10-11 May? Then staff from the Royal Pharmaceutical Society would love to say "hello". Our friendly team will be chairing sessions, giving preFri, 03 May 2024 04:23:00 GMThttps://www.rpharms.com/news/details//new-fip-president-visits-rpsRPS President, Professor Claire Anderson and Chief Executive, Paul Bennett, warmly welcomed Paul Sinclair, FIP President, to the RPSon Wednesday 1 May. It was Paul’s first visit to RPS as the eThu, 02 May 2024 12:26:00 GMThttps://www.rpharms.com/news/details//rps-and-pharmacist-support-agree-partnershipThe Royal Pharmaceutical Society (RPS) and Pharmacist Support are proud to announce a formal agreement that will enable the two organisations to align plans and work more effectively together to increWed, 01 May 2024 08:10:52 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-healthwatch-report-on-pharmacyHealthwatch England has today published its report “Pharmacy – what people want”, exploring the current state of pharmacy services and offering actions for healthcare leaders and theTue, 30 Apr 2024 10:25:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Finasteride-reminder-of-the-risk-psychiatric-side-effects-and-of-sexual-side-effects-which-may-persist-after-discontinuation-of-treatmentA patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunctiTue, 30 Apr 2024 10:22:19 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Montelukast-Reminder-of-the-risk-of-neuropsychiatric-reactionsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update to remind healthcare professionals to be alert to the of the risk of neuropsychiatric reactions in peoTue, 30 Apr 2024 10:20:37 GMThttps://www.rpharms.com/news/details//rps-condemns-rise-in-prescription-chargeAhead of the prescription charge rise in England tomorrow, increasing from £9.65 to £9.90 per item, Tase Oputu, Chair of the Royal Pharmaceutical Society in England, said: “This is Tue, 30 Apr 2024 09:44:21 GMThttps://www.rpharms.com/news/details//rps-antimicrobial-expert-shares-insights-at-eccmid-2024Mark Gilchrist FRPharmS, Chair of the RPS Antimicrobial Expert Advisory Group (AMEAG), has today presented on penicillin allergy at the 34th European Congress of Clinical Microbiology and Infectious DMon, 29 Apr 2024 10:28:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Neon-Healthcare-Ltd-Suprefact-1-mgml-solution-for-injection-Cheplapharm--Canadian-LiveryNeon Healthcare Ltd is recalling a specific batch of Suprefact 1 mg/ml solution for injection as a precautionary measure. This is because the batch is being distributed in packaging intended for the CTue, 23 Apr 2024 15:09:34 GMThttps://www.rpharms.com/news/details//new-rps-updated-patient-safety-professional-standardsThe Royal Pharmaceutical Society (RPS), in collaboration with the Association of Pharmacy Technicians UK (APTUK) and the Pharmacy Forum Northern Ireland (PFNI), has updated its set of professional staTue, 23 Apr 2024 08:09:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-powers-to-change-prescriptions-and-ease-medicine-shortagesCommenting on new research on medicine shortages from the Nuffield Foundation published today, Director of the Royal Pharmaceutical Society in England James Davies said: “The report demonstrateThu, 18 Apr 2024 05:22:00 GMThttps://www.rpharms.com/news/details//rps-2023-annual-credentialing-reportThe Royal Pharmaceutical Society has released its 2023 annual credentialing report, providing feedback from assessors and assessment outcome data for its advanced and consultant credentials. The repoTue, 16 Apr 2024 08:02:00 GMThttps://www.rpharms.com/news/details//rps-statement-at-uk-covid-19-inquiry-hearingAs the professional leadership body for pharmacists, RPS has given evidenceat a preliminary hearing of the UK COVID-19 Inquiry. Our statement was presented to the Inquiry by the legal team working onThu, 11 Apr 2024 05:07:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Accord-UK-Ltd-Co-Codamol-8500mg-Effervescent-Tablets-Key-Pharmaceuticals-LiveryAccord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery) as a precautionary measure due to the internal tablet blister strips being printed wWed, 10 Apr 2024 10:32:58 GMThttps://www.rpharms.com/news/details//rps-responds-to-draft-standards-for-chief-pharmacistsThe Royal Pharmaceutical Society (RPS) has responded to the General Pharmaceutical Council's (GPhC) draft Standards for Chief Pharmacists. These standards outline the responsibilities and qualificWed, 10 Apr 2024 08:37:00 GMThttps://www.rpharms.com/news/details//new-programme-to-enhance-prescribing-skills-in-walesThe Royal Pharmaceutical Society (RPS) in collaboration with Health Education and Improvement Wales (HEIW) is proud to announce a new comprehensive learning programme tailored to support pharmacists iMon, 08 Apr 2024 13:49:00 GMThttps://www.rpharms.com/news/details//Prescription-charge-price-hike-harms-patients-says-RPSResponding to the news that prescription charges in England will rise from £9.65 per item to £9.90 from 01 May, and the 12-month Prescription Prepayment Certificate will also increase fromThu, 04 Apr 2024 12:40:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-UKHSA-Update-to-advice-provided-for-carbomer-containing-lubricating-eye-productsIn December 2023 the UK Health Security Agency (UKHSA) investigated an outbreak of Burkholderia cenocepacia involving individuals across the UK. This was an emerging issue and, followed testing, B. ceWed, 03 Apr 2024 09:29:57 GMThttps://www.rpharms.com/news/details//rps-museum-releases-new-Covid-19-oral-history-clipsThe RPS museum, in collaboration with the RPS Retired Pharmacist Group, has released four new clips of oral history interviews documenting the profound impact of COVID-19 on the pharmacy profession. Wed, 03 Apr 2024 09:23:00 GMThttps://www.rpharms.com/news/details//rps-supports-pgd-powers-for-pharmacy-techniciansResponding to the Government’s announcement today that pharmacy technicians are amongst a variety of health professionals to be given powers to provide medicines under Patient Group Directions, Thu, 28 Mar 2024 08:07:00 GMThttps://www.rpharms.com/news/details//rps-assembly-update-march-2024The RPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following discussionWed, 27 Mar 2024 16:51:00 GMThttps://www.rpharms.com/news/details//MHRA-Device-Safety-Information-Counterfeits-and-unbranded-copies-of-LifeVac-anti-choking-devices-may-fail-to-work-correctly-or-worsen-choking-incidents-if-usedThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued Device Safety information for counterfeits and unbranded copies of LifeVac anti-choking devices. Anti-choking devices are intMon, 25 Mar 2024 12:28:06 GMThttps://www.rpharms.com/news/details//NHS-England-Clinical-Policy-puberty-suppressing-hormonesNHS England has issued a commissioning position: Puberty suppressing hormones (PSH) are not available as a routine commissioning treatment option for treatment of children and young people who have geFri, 22 Mar 2024 14:45:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Fresenius-Kabi-Limited-Sodium-Chloride-Intravenous-Infusion-FreeflexFresenius Kabi Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA)of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous InfuThu, 21 Mar 2024 14:38:00 GMThttps://www.rpharms.com/news/details//scotlands-first-consultant-pharmacist-appointedA pharmacist from Scotland, Jennifer Laskey, has been appointed Scotland’s first consultant pharmacist by NHS Greater Glasgow and Clyde. Jennifer successfully demonstrated her consultant-level pThu, 21 Mar 2024 11:01:00 GMThttps://www.rpharms.com/news/details//rps-tops-uk-climate-and-health-scorecard-InitiativeThe Royal Pharmaceutical Society (RPS) is proud to announce it has secured the top spot in the Climate and Health Scorecard Initiative category for health associations, colleges, societies and centresThu, 21 Mar 2024 09:27:00 GMThttps://www.rpharms.com/news/details//rps-wales-gives-evidence-to-senedd-chronic-conditions-inquiryThe Royal Pharmaceutical Society in Wales has given oral evidence to the Senedd’s Health and Social Care Committee’s inquiry into chronic conditions, following a written consultation respoWed, 20 Mar 2024 11:30:48 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Besins-Healthcare-UK-Ltd-Oestrogel-Pump-Pack-750microgramsactuation-gel-estradiolBesins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750micrograms/actuation Gel. The product pumps are subject to mechanicaTue, 19 Mar 2024 15:00:55 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Sodiofolin-50-mgml-solution-for-injectioninfusion-folinic-acid-400mg8ml-vialThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for a specific batch of medac GmbH (t/a medac Pharma LLP) Sodiofolin 50 mg/ml, solution for injeTue, 12 Mar 2024 15:39:26 GMThttps://www.rpharms.com/news/details//new-rps-project-investigates-medicines-shortagesThe Royal Pharmaceutical Society (RPS) is leading a new project to examine the causes of the growing challenge of medicines shortages and help tackle their impact on patients and pharmacy practice. ATue, 12 Mar 2024 14:02:00 GMThttps://www.rpharms.com/news/details//international-womens-day-2024Today is International Women’s Day,a global day celebrating the social, economic, cultural, and political achievements of women. The day also marks a call to action for accelerating women's Fri, 08 Mar 2024 11:36:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-government-to-freeze-prescription-chargesPhotography by Jess Hurd We’ve joined with the Prescription Charges Coalition, which represents over 50 organisations, to hand in an open letter to the Department of Health and Social Care (phoThu, 07 Mar 2024 09:33:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-budget-statementCommenting on today’s Budget Statement and a proposed ‘NHS Productivity Plan’, RPS England Chair Tase Oputu said: “Alongside a welcome focus on universal electronic patient reWed, 06 Mar 2024 16:32:00 GMThttps://www.rpharms.com/news/details//pharmacy-bodies-launch-community-pharmacy-manifestoCommunity Pharmacy England, the Company Chemists’ Association, the National Pharmacy Association and the Royal Pharmaceutical Society have today published a joint manifesto for community pharmacTue, 05 Mar 2024 08:04:00 GMThttps://www.rpharms.com/news/details//rps-and-pharmacist-support-host-workforce-wellbeing-roundtableThe Royal Pharmaceutical Society (RPS) and Pharmacist Support brought together professional bodies, employers, trade unions, regulators, students and academics for a roundtable discussion about the crMon, 04 Mar 2024 13:33:00 GMThttps://www.rpharms.com/news/details//nhse-report-emphasises-importance-of-research-in-pharmacy-practiceThe Royal Pharmaceutical Society welcomes the release of NHS England's report on the involvement of pharmacy professionals in research. The report proposes the implementation of a clinical academiFri, 01 Mar 2024 15:27:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-Of-Salbutamol-25mg25ml-And-5mg25ml-Nebuliser-Liquid-Unit-Dose-VialsA Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date is to be confirmed. Further informatMon, 26 Feb 2024 13:40:14 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Orifarm-UK-Ltd-Concerta-XL-18mg--36-mg-prolonged-release-tabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines defect information for Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets. Orifarm Mon, 26 Feb 2024 12:03:30 GMThttps://www.rpharms.com/news/details//Valproate-important-new-regulatory-measures-for-oversight-of-prescribing-to-new-patients-and-existing-female-patientsThe Commission on Human Medicines recommended further restrictions to valproate use to reduce avoidable harm, these were introduced in January. These restrictions are that: Valproate must not be stWed, 21 Feb 2024 16:28:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Novartis-Pharmaceuticals-UK-Limited-Adakveo-10-mgml-concentrate-for-solution-for-infusionNovartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MedicineWed, 21 Feb 2024 11:25:51 GMThttps://www.rpharms.com/news/details//annual-rps-workforce-wellbeing-survey-resultsThe Royal Pharmaceutical Societyhas revealed the results of its fifth annual workforce wellbeing survey, in partnership with the profession’s charity, Pharmacist Support, shedding light on the mWed, 21 Feb 2024 11:15:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-update-Pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-PRES-and-reversible-cerebral-vasoconstriction-syndrome-RCVSThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update for pseudoephedrine. There have been very rare reports of posterior reversible encephalopathy syndrome (PTue, 20 Feb 2024 12:16:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Codeine-linctus-codeine-oral-solutions-reclassification-to-prescription-only-medicineThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update on the reclassification of codeine linctus to a prescription-only medicine (POM). Following a review Tue, 20 Feb 2024 12:09:24 GMThttps://www.rpharms.com/news/details//rps-welcomes-reclassification-of-codeine-linctusThe Royal Pharmaceutical Society welcomes the news that the MHRA has reclassified codeine linctus, a cough syrup for dry coughs containing the opioid painkiller codeine, from a Pharmacy (P) status medTue, 20 Feb 2024 11:34:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-supervision-consultationThe Royal Pharmaceutical Society has responded to the Government’s consultation on pharmacy supervision, following widespread engagementthrough member events, Expert Advisory Groups and board diTue, 20 Feb 2024 09:25:00 GMThttps://www.rpharms.com/news/details//rps-response-to-the-dhsc-prep-roadmapIn response to the Department of Health and Social Care’s PrEP roadmap, James Davies RPS Director for England, said: “The HIV Action plan, published over two years ago, made it clear how Thu, 15 Feb 2024 15:10:00 GMThttps://www.rpharms.com/news/details//community-pharmacies-hit-40m-covid-19-vaccinationsFollowing newsthat community pharmacies in England had administered over 40m Covid-19 vaccinations by the end of 2023, and that the sector has provided a quarter of all covid vaccinations to date, DirWed, 14 Feb 2024 14:03:00 GMThttps://www.rpharms.com/news/details//rps-launches-consultations-on-two-advanced-pioneer-curriculaThe Royal Pharmaceutical Society (RPS) is delighted to launch consultations on two new pioneer curricula defining advanced pharmacist practice in critical care and mental health, developed collaboratiWed, 14 Feb 2024 10:02:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Torrent-Pharma-UK-Limited-Ramipril-125mg-tabletsTorrent Pharma (UK) Limited is recalling specific batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after tTue, 13 Feb 2024 11:52:12 GMThttps://www.rpharms.com/news/details//rps-england-publishes-one-year-on-vision-reportThe RPS in England has published a review of pharmacy policy one year on from the launch of its 10-year Vision For Pharmacy Professional Practice with The King’s Fund. This new paper reflects oTue, 13 Feb 2024 09:40:33 GMThttps://www.rpharms.com/news/details//-Neil-Gray-MSP-Appointed-Cabinet-Secretary-for-NHS-Recovery-Health-and-Social-CareScotland’s First Minister, Humza Yousaf, has appointed Neil Gray MSP to be Cabinet Secretary for NHS Recovery, Health and Social Care. Commenting on the announcement Laura Wilson, Director of RFri, 09 Feb 2024 08:48:09 GMThttps://www.rpharms.com/news/details//Christina-McKelvie-MSP-Appointed-Minister-for-Drugs-and-Alcohol-PolicyScottish Government has announced that Christina McKelvie has been appointed Minister for Drugs and Alcohol policy, following the resignation of Elena Whitham MSP as Drug and Alcohol Minister. Royal Fri, 09 Feb 2024 08:45:57 GMThttps://www.rpharms.com/news/details//rps-urges-action-on-attainment-and-awarding-gap-in-pharmacyThe Royal Pharmaceutical Society has published a new report examining the differential degree awarding gap and registration assessment attainment for Black trainees in initial pharmacy education and tTue, 06 Feb 2024 00:00:00 GMThttps://www.rpharms.com/news/details//Pharmacists-warn-of-impact-of-prescription-charges-on-patient-carePharmacists have warned they are increasingly seeing patients in England declining to take vital medicines due to the cost of prescription charges. Responding to a survey by the Pharmacists’ DeMon, 05 Feb 2024 08:21:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Exeltis-UK-Limited-Gepretix-100mg-CapsulesExeltis UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified Thu, 01 Feb 2024 16:50:26 GMThttps://www.rpharms.com/news/details//New-valproate-safety-measures-apply-from-31-January-2024The Medicines and Healthcare products Regulatory Agency (MHRA) has published a news story on the new regulatory measures for valproate which come into force from 31 January 2024. These new regulatory Wed, 31 Jan 2024 11:09:24 GMThttps://www.rpharms.com/news/details//pharmacy-first-service-a-leap-forwards-says-rpsEngland’s Pharmacy First service is going live today in community pharmacies across the country as part of the Government’s primary care access recovery plan. The service provides treatmeTue, 30 Jan 2024 18:18:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Cadila-Pharmaceuticals-UK-Limited-Pantoprazole-40-mg-Gastro-Resistant-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Pantoprazole 40mg Gastro-Resistant tablets. Crescent Pharma Limited has informedTue, 30 Jan 2024 12:54:42 GMThttps://www.rpharms.com/news/details//rps-refreshes-professional-standards-for-homecare-servicesWe've updated ourProfessional Standards for Homecare Services, providing aframework to support teams involved in planning, commissioning and delivering homecare services. The standards, originallMon, 29 Jan 2024 09:52:38 GMThttps://www.rpharms.com/news/details//rps-wales-launches-new-online-best-practice-hubRPS Wales has unveiled a new online best practice hub aimed at sharing learnings and promoting excellence within the pharmacy profession. The hub, which went live today, provides a platform for pharmaFri, 26 Jan 2024 11:20:00 GMThttps://www.rpharms.com/news/details//Fluoroquinolone-antibiotics-must-now-only-be-prescribed-when-other-commonly-recommended-antibiotics-are-inappropriateSystemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measThu, 25 Jan 2024 13:33:25 GMThttps://www.rpharms.com/news/details//Omega-3-acid-ethyl-ester-medicines-dose-dependent-increased-risk-of-atrial-fibrillation-in-patients-with-established-cardiovascular-diseases-or-cardiovascular-risk-factorsSystematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or carThu, 25 Jan 2024 13:16:00 GMThttps://www.rpharms.com/news/details//Legislative-changes-to-enable-the-prescribing-supply-and-administering-of-controlled-drugs-by-certain-healthcare-professionals-The Home Office has made changes to the Misuse of Drugs Regulations 2001 to enable the prescribing, supply and administering of controlled drugs by certain healthcare professionals. Paramedic indepeWed, 24 Jan 2024 15:07:00 GMThttps://www.rpharms.com/news/details//rps-sets-vision-for-consultant-pharmacists-by-2030The Royal Pharmaceutical Societyhas unveiled its vision for the role of consultant pharmacists by 2030, following its successful consultant pharmacist summit last year. The summit, which brought togetWed, 24 Jan 2024 08:58:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Alert-Valproate-new-safety-and-educational-materials-to-support-regulatory-measures-in-men-and-women-under-55-years-of-ageNew safety and educational materials have been introduced for men and women and healthcare professionals to reduce the harms from valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono Tue, 23 Jan 2024 12:10:04 GMThttps://www.rpharms.com/news/details//rps-revises-position-on-prescribing-and-dispensing-by-same-healthcare-professionalThe Royal Pharmaceutical Societyhas revised and updated its position on the separation of prescribing and dispensing or administration of a medicine by the same healthcare professional in response to Fri, 19 Jan 2024 15:02:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-USV-UK-Limited-Sugammadex-100-mgml-solution-for-injection-2ml-vialUSV UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that a batch of Sugammadex 100 mg/ml solution for injection (2 ml vial) may contain some vials that contain aThu, 18 Jan 2024 13:35:00 GMThttps://www.rpharms.com/news/details//survey-on-prescription-chargesAs proud members of the Prescription Charges Coalition, the Royal Pharmaceutical Society and Pharmacist Defence Association are asking pharmacists to complete a short survey about their experience of Mon, 15 Jan 2024 10:11:00 GMThttps://www.rpharms.com/news/details//dr-amira-guirguis-appointed-chair-of-rps-science-and-research-committeeThe Royal Pharmaceutical Society is pleased to announce the appointment of Dr Amira Guirguis as the new Chair of its Science and Research Committee (SRC), effective from the New Year. Dr Guirguis, an Tue, 09 Jan 2024 11:22:55 GMThttps://www.rpharms.com/news/details//putting-pharmacy-at-the-forefront-of-the-general-electionThe Royal Pharmaceutical Society has published its general election manifesto highlighting key issues facing the next Government. The manifesto calls on general election candidates to show their suppMon, 08 Jan 2024 10:55:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-bbc-investigation-of-online-pharmaciesThe BBC has today published an investigation into the safety checks some online pharmacies carry out when selling prescription-only medicines. The BBCstated that its investigation found 20 online pharFri, 05 Jan 2024 16:15:27 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Quadrant-Pharmaceuticals-Ltd-Cozaar-100mg-film-coated-tabletsQuadrant Pharmaceuticals Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA)of an error with the Patient Information Leaflets (PILs) in the specified batches of Cozaar 100mThu, 04 Jan 2024 10:02:03 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-GLP-1-receptor-agonists-update-The supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to be limited, with supply not expected to return to normal until at least the end of 2024. The supply issues have been caWed, 03 Jan 2024 14:29:00 GMThttps://www.rpharms.com/news/details//Influenza-Season-202324-Use-Of-Antiviral-Medicines-in-ScotlandRecent intelligence provided by Public Health Scotland (PHS) indicates that influenza is circulating in the community.This may lead to an increase in numbers of people presenting with influenza-like iThu, 21 Dec 2023 15:36:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-advises-Parliamentary-Committee-on-remote-and-rural-healthcareToday, Laura Wilson, Director for Scotland at Royal Pharmaceutical Society, provided evidence to the Health, Social Care and Sport Committee as part of their inquiry into Healthcare in remote and ruraTue, 19 Dec 2023 15:48:00 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Vitamin-B12-hydroxocobalamin-cyanocobalamin-advise-patients-with-known-cobalt-allergy-to-be-vigilant-for-sensitivity-reactionsThe medicines used to treat vitamin B12 deficiency (hydroxocobalamin, cyanocobalamin) contain cobalt. There are case reports in the literature describing cobalt sensitivity-type reactions in patients Mon, 18 Dec 2023 16:17:54 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-AripiprazoleThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update for aripiprazole. Healthcare professionals prescribing aripiprazole are reminded to be alert to the riMon, 18 Dec 2023 16:16:38 GMThttps://www.rpharms.com/news/details//pharmacy-teams-are-central-to-delivering-more-integrated-care-says-rps-englandRPS England has welcomed a new report from a House of Lords Committee on the Integration of Primary and Community Care. Following a nine-month-long Inquiry, the report highlights a number of key stepMon, 18 Dec 2023 15:19:00 GMThttps://www.rpharms.com/news/details//Influenza-Season-202324-Use-Of-Antiviral-Medicines-in-EnglandUK Health Security Agency (UKHSA) surveillance data indicates that influenza is circulating in the community. Prescribers working in primary care may now prescribe, and community pharmacists may now Fri, 15 Dec 2023 13:24:49 GMThttps://www.rpharms.com/news/details//thorrun-govind-on-itv-this-morning-when-to-see-a-pharmacistIn a recent appearance on ITV This Morning, Thorrun Govind, RPS England Pharmacy Board member shed light on the invaluable role pharmacists play in providing healthcare support to patients who may be Fri, 15 Dec 2023 11:30:00 GMThttps://www.rpharms.com/news/details//Sustainability-in-Healthcare-Parliamentary-ReceptionA Scottish Parliamentary reception was held at Holyrood this week to raise awareness and highlight the vital importance of environmental sustainability in healthcare. The event was jointly hosted by RThu, 14 Dec 2023 13:53:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Biocon-Pharma-UK-Ltd-Posaconazole-Biocon-100mg-Gastro-resistant-TabletsBiocon Pharma UK Limited are recalling a specific of batch Posaconazole 100mg Gastro-resistant Tablets due to an out of trend result for unspecified impurities during testing for stability. Further iThu, 14 Dec 2023 13:22:26 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Atnahs-Pharma-UK-Limited-Clobazam-Atnahs-5mg5ml-and-10mg5ml-Oral-SuspensionAtnahs Pharma UK Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in the alert do not conWed, 13 Dec 2023 11:37:02 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Potential-for-inappropriate-dosing-of-insulin-when-switching-insulin-degludec-Tresiba-productsA Medicine Supply Notification issued on 24 May 2023, detailed a shortage of Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens. Advice on how to manFri, 08 Dec 2023 11:22:55 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert--Potential-contamination-of-some-carbomer-containing-lubricating-eye-products-with-Burkholderia-cenocepacia--measures-to-reduce-patient-riskUKHSA is investigating an outbreak of Burkholderia cenocepacia involving individuals across the UK. This is an emerging issue and, following testing, B. cenocepacia was recovered from some lubricatingFri, 08 Dec 2023 11:19:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Strandhaven-Ltd-ta-Somex-Pharma-Clarithromycin-250mg-and-500mg-film-coated-tabletsStrandhaven Limited t/a Somex Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA)regarding an error with the Patient Information Leaflets (PILs) that have been packed inWed, 06 Dec 2023 14:02:06 GMThttps://www.rpharms.com/news/details//rps-welcomes-consultation-on-supervision-in-pharmaciesWe welcome the announcement from the Department of Health and Social Care (DHSC) of its long-anticipated consultation on supervision in pharmacies. Our previous extensive engagement with members helpWed, 06 Dec 2023 13:32:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Strandhaven-Ltd-ta-Somex-Pharma-Tramadol-Hydrochloride-50mg-Capsules-HardStrandhaven Limited t/a Somex Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA)regarding an error with the Patient Information Leaflets (PILs) that have been packed inWed, 06 Dec 2023 11:40:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-dhsc-consultation-on-smokefree-generationThe Royal Pharmaceutical Society has responded to the Department of Health and Social Care's (DHSC) consultation on ‘Creating a Smokefree Generation and Tackling Youth Vaping’. DrawinWed, 06 Dec 2023 09:48:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Teva-UK-Ltd-Caramet-25100mg-CR-TabletsTeva UK Ltd. has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of a labelling error on a specific batch of Caramet 25/100mg CR Tablets. The Active Pharmaceutical Ingredient (Mon, 04 Dec 2023 11:59:16 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-AstraZeneca-UK-Ltd-Fluenz-Tetra-nasal-spray-suspensionAstraZeneca UK Ltd. has informed the MHRA that, following routine stability analysis, the printed expiry date for the listed batches of Fluenz Tetra nasal spray suspension is incorrect. Further inforThu, 30 Nov 2023 10:50:47 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Valproate-organisations-to-prepare-for-new-regulatory-measures-for-oversight-of-prescribing-to-new-patients-and-existing-female-patientsThe MHRA is asking organisations to put a plan in place to implement new regulatory measures for sodium valproate, valproic acid and valproate semisodium (valproate). This follows a comprehensive reviWed, 29 Nov 2023 09:30:00 GMThttps://www.rpharms.com/news/details//MHRA-Device-Safety-Information---Carbomer-Gel-Eye-ProductsSpecific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination. There is a potential risk of contamination of specific brands of carbomer eye gels wiFri, 24 Nov 2023 13:24:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-november-2023The RPS Panel of Fellows has designated the following 18 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhFri, 24 Nov 2023 10:05:45 GMThttps://www.rpharms.com/news/details//rps-assembly-update-november-2023The RPS Assembly is the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following decisionsThu, 23 Nov 2023 09:35:00 GMThttps://www.rpharms.com/news/details//benefit-claimants-loss-of-free-prescriptions-incredibly-disappointingResponding to the news in the Chancellor’s Autumn statement today that when claimants lose their benefits they will also lose their right to free prescriptions, Chair of RPS in England Ms Tase OWed, 22 Nov 2023 15:57:00 GMThttps://www.rpharms.com/news/details//rps-in-the-media-on-pharmacy-first-service-in-englandFollowing the recent announcement that a Pharmacy First service, along with contraception and blood pressure services, will shortly begin to rollout in community pharmacies in England, Dr James DaviesWed, 22 Nov 2023 14:06:00 GMThttps://www.rpharms.com/news/details//rps-england-speaks-to-health-committee-inquiry-on-pharmacyDirector for England James Davies spoke to MPs in Parliament today at the Health and Social Care Select Committee’s inquiry on pharmacy. Alongside the Primary Care Pharmacy Association, he highTue, 21 Nov 2023 15:17:00 GMThttps://www.rpharms.com/news/details//ADHD-medicines-supply-disruption-update-A National Patient Safety Alert was issued in September 2023 for a number of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD). Further information has been published on the STue, 21 Nov 2023 12:06:20 GMThttps://www.rpharms.com/news/details//weldricks-pharmacies-adopt-rps-daffodil-standardsThe Royal Pharmaceutical Society (RPS) is proud to announce that leading pharmacy group Weldricks will soon be rolling out the RPS Daffodil Quality Improvement Standards for Community Pharmacy across Mon, 20 Nov 2023 11:43:54 GMThttps://www.rpharms.com/news/details//pharmacys-role-in-climate-action-highlighted-at-the-seneddThe work of pharmacists to make medicines use and the whole NHS more environmentally sustainable was highlighted at the Welsh Senedd this week. At a session co-hosted with the Association of the BritThu, 16 Nov 2023 14:08:39 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-pharmacy-first-rolloutThe Royal Pharmaceutical Society in England has welcomed the announcement that a Pharmacy First service, along with contraception and blood pressure services, will soon be delivered through community Thu, 16 Nov 2023 09:53:21 GMThttps://www.rpharms.com/news/details//rps-england-comments-on-latest-nhs-prescribing-costsThe NHS in England has published the latest figures for prescribing costs in primary and secondary care. The total cost to NHS commissioners for the issue of medicines, appliances, and medical devicesMon, 13 Nov 2023 14:12:00 GMThttps://www.rpharms.com/news/details//rps-presents-three-new-awards-at-annual-conferenceThe Royal Pharmaceutical Society is proud to announce the presentation of three prestigious new awards today at its annual conference. The Daniel Thomas Award, the OPERA Award, and the Barnett Award aThu, 09 Nov 2023 10:09:00 GMThttps://www.rpharms.com/news/details//php-enhances-mental-health-decision-making-via-medicinescompletePharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business has acquired The Psychotropic Drug Directory.The highly regarded 30-year-old publication has been sold by founding ediTue, 07 Nov 2023 17:18:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-increase-in-foundation-training-support-for-202526In response to NHS England's recent announcement of an increase in the foundation trainingsupportfor the 2025/26 academic year, Tase Oputu, RPS England Board Chair, said: “The significant iTue, 07 Nov 2023 14:07:00 GMThttps://www.rpharms.com/news/details//Preparing-for-measles-resurgence-in-EnglandThe UK Health Security Agency (UKHSA) has written to healthcare professionals working in primary care about preparing for measles resurgence in England. The UK Health Security Agency (UKHSA) recentlyFri, 03 Nov 2023 13:06:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-legislative-ban-on-multi-buy-deals-of-paracetamolThe Royal Pharmaceutical Society (RPS) is urging the Government to pass legislation that prohibits retailers from offering multi-buy deals on paracetamol. Multi-buy deals are in direct violation of voFri, 03 Nov 2023 11:01:00 GMThttps://www.rpharms.com/news/details//Isotretinoin-Roaccutane-introduction-of-new-safety-measures-including-additional-oversight-of-the-initiation-of-treatment-for-patients-under-18-years-of-ageThe Medicines and Healthcare Products Regulatory Agency (MHRA) has introduced new safety measures for Isotretinoin (Roaccutane). These new safety measures strengthen the safe use of isotretinoin throuThu, 02 Nov 2023 12:20:05 GMThttps://www.rpharms.com/news/details//rps-museum-covid-19-oral-history-recordingsThe RPS Museum, in collaboration with the RPS Retired Pharmacist Group, has published clips of oral history interviews capturing the impact of Covid-19 on the pharmacy profession. The interviews reveThu, 02 Nov 2023 10:19:00 GMThttps://www.rpharms.com/news/details//celebrating-black-history-month-2023Throughout October, we celebrated Black History Month (BHM) by hosting an event at our London office, celebrating your BHM star nominations via social media, running a quiz and sharing blogs of black Tue, 31 Oct 2023 10:42:48 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Limited-Zinacef-powder-for-solution-for-injection-or-infusion-vials-all-strengths-including-stock-in-GSK-liveryThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Sandoz Limited, Zinacef powder for solution for injection or infusion vials (allTue, 24 Oct 2023 09:43:39 GMThttps://www.rpharms.com/news/details//rps-and-ukcpa-join-forces-to-enhance-specialist-pharmacy-education-and-credentialingThe RPS and the UK Clinical Pharmacy Association (UKCPA) are proud to announce a significant milestone in the field of pharmacy education and credentialing. Over the past two years, the RPS and UKCPA Tue, 24 Oct 2023 09:12:13 GMThttps://www.rpharms.com/news/details//rps-welcomes-the-launch-of-ukpplab-under-sir-hugh-taylorThe RPS welcomes the establishment of the UK Pharmacy Professional Leadership Advisory Board and the appointment of Sir Hugh Taylor as its Independent Chair. We look forward to participating in this cMon, 23 Oct 2023 08:12:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-humanitarian-law-to-be-respected-in-gaza---israel-conflictThe Royal Pharmaceutical Society, as a member organisation of the International Pharmaceutical Federation, is adding its voice to that of FIP, and calling for all parties involved in the Gaza - IsraelThu, 19 Oct 2023 11:18:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-discusses-the-future-pharmacy-workforce-with-Cabinet-SecretaryRoyal Pharmaceutical Society in Scotland discussed the future of the pharmacy workforce with the Cabinet Secretary for Health and Social Care, during a panel discussion on the future of the health andThu, 19 Oct 2023 09:42:53 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-rps-interim-professional-standards-for-virtual-wardsThe Royal Pharmaceutical Society has launched new interim professional standards for pharmacy services for virtual wards to ensure the delivery of high-quality care and optimal outcomes for individualTue, 17 Oct 2023 08:13:00 GMThttps://www.rpharms.com/news/details//rps-in-the-media-on-adhd-medicine-shortagesAmidst the current shortages of Attention-deficit/hyperactivity disorder medication, RPS spokespeople have been talking to the media about how pharmacists can help patients get the medicines they needMon, 16 Oct 2023 12:17:00 GMThttps://www.rpharms.com/news/details//complete-our-workforce-wellbeing-survey-2023Our fifth annual Workforce Wellbeing survey, in partnership with Pharmacist Support, is now live as part of our long-running programme to supportthe mental health and wellbeing of pharmacists. This yMon, 16 Oct 2023 08:41:46 GMThttps://www.rpharms.com/news/details//Full-pack-dispensing-of-valproate-containing-medicinesLegal changes have come into force for England, Scotland and Wales to ensure that all patients (male and female) receive their valproate-containing medicine in the manufacturer’s original full pWed, 11 Oct 2023 10:05:00 GMThttps://www.rpharms.com/news/details//rps-group-to-address-differential-attainment-gapThe Royal Pharmaceutical Society (RPS) is leading a new working group with partners from across the profession to address the differential attainment and awarding gap experienced by Black pharmacy stuMon, 09 Oct 2023 07:49:00 GMThttps://www.rpharms.com/news/details//rps-and-pharmacist-support-publish-roundtable-report-on-wellbeingThe Royal Pharmaceutical Society (RPS) and Pharmacist Support have published a report examining the impact of workforce wellbeing on pharmacy teams and how it can be addressed. The report is the outcoWed, 04 Oct 2023 07:40:00 GMThttps://www.rpharms.com/news/details//first-group-of-advanced-pharmacists-credentialled-by-rpsA first pilot cohort of seven pharmacists havebeen credentialed by the RPS through the innovative pathwayannounced in March this year. The pathway is delivered by RPS in collaboration with NHS EnglandTue, 03 Oct 2023 12:49:00 GMThttps://www.rpharms.com/news/details//we-call-on-government-to-do-more-to-protect-nature-for-the-benefit-of-healthThe Royal Pharmaceutical Society has joined leading health organisations from across the UK who have called on the government to increase action to protect our natural ecosystems for the benefit of thFri, 29 Sep 2023 13:31:37 GMThttps://www.rpharms.com/news/details//pharmacy-technicians-and-use-of-pgdsOur visions for pharmacy in England, Scotland and Wales allhighlight how skill mix is vitally important in delivering modern and efficient pharmacy services. Increasing the opportunities for pharmacy Fri, 29 Sep 2023 08:26:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-verteporfin-15mg-powder-for-solution-for-injectionA National Patient Safety Alert has been issued due to a shortage of verteporfin 15mg powder for solution for injection. Verteporfin is indicated for the treatment of adults with exudative (wet) age-rFri, 29 Sep 2023 08:17:11 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Max-Remedies-Ltd-Max-Healthcare-Paracetamol-500-mg-CapsulesThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 medicines deflection information for Max Healthcare Paracetamol 500 mg Capsules. Max Remedies has identified an iFri, 29 Sep 2023 08:16:41 GMThttps://www.rpharms.com/news/details//rps-welcomes-first-pharmacy-workforce-race-equality-standardThe very first Pharmacy Workforce Race Equality Standard (PWRES)has been published by NHS England to provide greater transparency about representation in senior leadership in the NHS pharmacy professiThu, 28 Sep 2023 10:55:00 GMThttps://www.rpharms.com/news/details//millions-mistakenly-think-they-are-allergic-to-penicillin-Millions of people are potentially missing out on the best antibiotic if they develop an infection because they mistakenly believe they are allergic to penicillin. This means their health could be comThu, 28 Sep 2023 06:00:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-methylphenidate-prolonged-release-capsules-and-tablets-lisdexamfetamine-capsules-and-guanfacine-prolonged-release-tabletsA National Patient Safety Alert has been issued due supply disruptions affecting various strengths of specified medications which are licensed for thetreatment of attention deficit hyperactivity disorWed, 27 Sep 2023 14:11:00 GMThttps://www.rpharms.com/news/details//pharmacists-celebrated-and-thanked-in-the-seneddWorld Pharmacists Day was marked in the Welsh Senedd this week as Chair of the Health and Social Care Committee made a short statement to celebrate the work of pharmacists in Wales. Highlighting the Wed, 27 Sep 2023 10:47:00 GMThttps://www.rpharms.com/news/details//Statement-on-Drug-Consumption-RoomsCommenting on the approval of safe drug consumption rooms in Glasgow, Laura Wilson, Director for Scotland said: “RPS Scotland supports the introduction of Regulated Supervised Drug Consumption Wed, 27 Sep 2023 09:45:00 GMThttps://www.rpharms.com/news/details//RPS-statement-at-COVID-19-Inquiry-hearingThe Royal Pharmaceutical Society has provided a statement to today’s preliminary hearing of the UK COVID-19 Inquiry. Our statement was read to the Inquiry by a solicitor and highlights the vitaWed, 27 Sep 2023 06:30:00 GMThttps://www.rpharms.com/news/details//pharmacists-role-in-chronic-conditions-management-highlightedPharmacists' crucial role in managing chronic conditions was highlighted to members of the Senedd (MSs) this week. To coincide with the Senedd’s Health and Social Care Committee inquiry intTue, 26 Sep 2023 14:48:56 GMThttps://www.rpharms.com/news/details//rps-supports-mandatory-training-on-learning-disability-and-autism-for-pharmacistsThe Royal Pharmaceutical Society is calling for training on learning disabilities and autism to be mandatory for all pharmacists. The law currently says that all health care and social care staff reMon, 25 Sep 2023 09:51:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-financial-support-for-pharmacy-studentsThe RPS in England has joined with the British Pharmaceutical Students' Association and Pharmacy Schools Council to call on the Government to allow pharmacy students to access a financial support Fri, 22 Sep 2023 12:39:00 GMThttps://www.rpharms.com/news/details//RPS-celebrates-new-Fellows-and-Consultants-in-ScotlandSix pharmacists based in Scotland were recognised by the profession this week during a celebratory event at the home of pharmacy in Scotland, RPS’ building on Melville Street, Edinburgh. Four pFri, 22 Sep 2023 09:16:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//welsh-government-accepts-rps-recommendations-for-hospital-pharmacy-transformationThe Welsh government has today published its response to an independent review of clinical pharmacy services at NHS hospitals in Wales undertaken by RPS. Our 110-page review makes 36 recommendations Thu, 21 Sep 2023 09:20:37 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Chiesi-Ltd-Trimbow-8759-mcg-pressurised-inhalation-solutionChiesi Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) about a potential issue with specific batches of Trimbow 87/5/9 mcg pressurised inhalation solution. This is due Wed, 20 Sep 2023 14:53:38 GMThttps://www.rpharms.com/news/details//rps-welcomes-cpe-vision-launchIn response to CPE’s Vision launch, Tase Oputu, RPS England Board Chair, said: “Throughout our work with The King’s Fund last year, we consistently heard from health and care leaderTue, 19 Sep 2023 08:09:00 GMThttps://www.rpharms.com/news/details//Pharmacys-role-in-supporting-end-of-life-care-highlighted-at-Scottish-ParliamentRoyal Pharmaceutical Society (RPS) Scotland, together with Marie Curie, hosted an exhibition for MSPs in the Scottish Parliament in September to raise awareness of the Daffodil Standards, and the vitaMon, 18 Sep 2023 04:42:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Urgent-public-health-message-Food-botulism-outbreak-in-France-involving-British-nationalsThe UK Health Security Agency (UKHSA) has been notified about an outbreak of food botulism in France involving a small number of British nationals. The outbreak has been linked to consumption of home-Fri, 15 Sep 2023 08:51:30 GMThttps://www.rpharms.com/news/details//-National-Naloxone-Emergency-Supply-Service-Introduced-across-ScotlandScottish Government has announced that a new national service will be implemented to provide emergency access to supplies of naloxone. The service is due to start on 30 October. This service will allWed, 13 Sep 2023 11:53:17 GMTRoss Barrowhttps://www.rpharms.com/news/details//Company-led-medicines-recall-Sun-Pharma-UK-Ltd-Gemcitabine-10mgml-Solution-for-InfusionSun Pharma UK Ltd has informed the MHRA of a labelling issue with one batch of Gemcitabine 2000mg/200ml infusion. This recall is being issued as a company-led recall due to a limited number of units bThu, 07 Sep 2023 12:45:19 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Colgate-Palmolive-UK-Limited-Duraphat-5000ppm-Fluoride-ToothpasteColgate-Palmolive (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL), carton and tube of specified batches of Duraphat 5000ppm Fluoride Toothpaste (51g) are missing informThu, 07 Sep 2023 12:41:58 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Theramex-HQ-UK-Ltd-Evorel-SequiTheramex has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that some cartons of Evorel Sequi contain the incorrect combination of patches. An error at the packaging site meanTue, 05 Sep 2023 10:40:13 GMThttps://www.rpharms.com/news/details//New-Policy-and-Practice-Lead-for-RPS-ScotlandWe are delighted to announce that Fiona McIntyre has been appointed as the new Policy and Practice Lead for RPS Scotland. Fiona will lead policy development and professional support for RPS Scotland,Mon, 04 Sep 2023 08:06:30 GMTRoss Barrowhttps://www.rpharms.com/news/details//chief-membership-and-education-officerNeville Carter left his role as Chief Education & Membership Officer (CEMO) at the end of August to pursue new opportunities. RPS Chief Executive Paul Bennett said: "We wish Neville all the Fri, 01 Sep 2023 12:27:15 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Kyowa-Kirin-Limited-Tostran-Testosterone-2-percent-gelThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect information for Tostran (Testosterone, 2% gel). Kyowa Kirin Limited has notified MHRA that the pThu, 31 Aug 2023 12:47:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-call-for-safe-consumption-facilities-from-home-affairs-committeeThe Home Affairs Committee have called for a health-led strategy to address the risks posed by illegal drug use, part of which would be a change in legislation to allow the introduction of safe consumThu, 31 Aug 2023 11:12:35 GMThttps://www.rpharms.com/news/details//Drug-Safety-Updates-Fluoroquinolones-Methotrexate-ValproateThe Medicines and Healthcare products Regulatory Agency (MHRA) has published three new Drug Safety Updates: Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lastingThu, 31 Aug 2023 10:07:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Veriton-Pharma-Limited-Epistatus-25-mg-oromucosal-solution-pre-filled-syringe-PFSThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 recall for a specified batch of Epistatus 2.5mg oromucosal solution, pre-filled syringe (PFS). The recall is due Wed, 30 Aug 2023 14:42:51 GMThttps://www.rpharms.com/news/details//Flu-and-Covid-jab-programme-brought-forwardThe Government has now announced that flu and covid vaccinations will start in September, after having recently pushed the start date back to October. Chair of RPS in England Ms Tase Oputu said: &ldWed, 30 Aug 2023 14:29:00 GMThttps://www.rpharms.com/news/details//Update-on-the-COVID-19-vaccination-programme-for-autumn-2023The Department of Health and Social Care (DHSC) has issued a press release about bringing forward Flu and COVID autumn vaccine programmes as a precautionary measure taken to protect those most vulneraWed, 30 Aug 2023 13:35:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-ahsn-interim-report-on-polypharmacyThe Academic Health Science Network has released its interim evaluation report into polypharmacy. The report covers the period from April 2022 to March 2023 and focuses on addressing the challenges pWed, 30 Aug 2023 08:39:05 GMThttps://www.rpharms.com/news/details//rps-welcomes-nhs-blood-pressure-check-expansionCommunity pharmacies in England delivered over 149,000 blood pressure checks to people over 40 in May 2023, more than double the previous year. Additional funding from the primary care access recoverTue, 29 Aug 2023 10:24:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Galderma-UK-Limited-Loceryl-5-percent-wv-Medicated-Nail-LacquerThe Medicines and Healthcare products Regulatory Agency (MHRA) has published Class 4 Medicines Defect information for Loceryl 5%w/v Medicated Nail Lacquer. Galderma (U.K.) Limited has informed the MHRTue, 29 Aug 2023 09:48:00 GMThttps://www.rpharms.com/news/details//Serious-Shortage-Protocol-SSP-for-Jext-300micrograms03ml-1-in-1000-solution-for-injection-auto-injector-penThe Department of Health and Social Care (DHSC) hasissued Serious Shortage Protocol (SSP) for Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen: Jext® 300micrograThu, 24 Aug 2023 14:16:21 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Accord-Healthcare-Limited-UK-Irinotecan-Hydrochloride-20-mgml-Concentrate-for-Solution-for-InfusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Notification for Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion.Accord HealthcWed, 23 Aug 2023 13:04:52 GMThttps://www.rpharms.com/news/details//Drugs-Related-Deaths-in-ScotlandThe Royal Pharmaceutical Society (RPS) notes statistics released from National Records of Scotland today (22 August)which show 1,051 people died due to drug misuse in Scotland last year, which is the Tue, 22 Aug 2023 15:28:03 GMTRoss Barrowhttps://www.rpharms.com/news/details//MHRA-Device-Safety-Information-Ethypharm-Aurum-pre-filled-syringes-are-incompatible-with-some-manufactured-needle-free-connectors-risk-of-delay-in-administering-potentially-lifesaving-medicationThe Medicines and Healthcare products Regulatory Agency (MHRA) has published Device Safety Information for Ethypharm Aurum pre-filled syringes. Attaching an incompatible needle-free connector (NFC) toTue, 22 Aug 2023 13:49:59 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Notification-Accord-Healthcare-Limited-UK-Olmesartan-Medoxomil-film-coated-tabletsAccord Healthcare Ltd, UK has informed the Medicines and Healthcare products Regulatory Agency (MHRA) about an error with the Patient Information Leaflets (PILs) that have been packaged in the specifiTue, 22 Aug 2023 13:40:03 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Sodiofolin-50-mgml-solution-for-injectioninfusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 recall for further batches of medac GmbH (t/a medac Pharma LLP) Sodiofolin 50 mg/ml solution for injection/infusiMon, 21 Aug 2023 15:33:03 GMThttps://www.rpharms.com/news/details//round-up-of-south-asian-heritage-month-2023Did you catch our celebrations forSouth Asian Heritage Month, which exploresthe history and identity of British South Asians? We collaborated with Female Pharmacy Leaders Network, Pharmacy TechnicianMon, 21 Aug 2023 13:18:06 GMThttps://www.rpharms.com/news/details//rps-england-calls-for-rethink-on-flu-vaccination-delayThe Royal Pharmaceutical Society in England has written to Secretary of State for Health and Social Care Steve Barclay MP, calling on him to intervene over a proposed delay to the start of the flu immThu, 10 Aug 2023 18:00:00 GMThttps://www.rpharms.com/news/details//rps-call-for-protected-learning-time-in-welsh-mediaOur Policy and Practice Lead in Wales, Alwyn Fortune, was recently featured on ITV Wales News calling for protected learning time to be in place for pharmacists across all sectors. The report also hiThu, 10 Aug 2023 08:59:00 GMThttps://www.rpharms.com/news/details//rps-signs-letter-to-pm-on-new-licences-for-oil-and-gasThe RPS has joined other members of the UK Health Alliance on Climate Change to call on the Prime Minister Rishi Sunakto withdraw the decision to approve new licences for oil and gas in the North Sea.Thu, 03 Aug 2023 10:38:24 GMThttps://www.rpharms.com/news/details//pharmacy-supervision-practice-group--update-and-outcomeOrganisations from across the community pharmacy sector, who have come together to look into the future “supervision” in community pharmacy, have produced their final report. Over the couTue, 01 Aug 2023 06:26:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-B-Braun-Medical-Ltd-Various-ProductsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall. B. Braun Medical Limited is recalling the specific product batches as a precautionary measure aMon, 31 Jul 2023 13:57:52 GMThttps://www.rpharms.com/news/details//rps-appoints-diane-ashiru-oredope-as-deputy-chief-scientistThe Royal Pharmaceutical Society has appointed Dr Diane Ashiru-Oredope, MPharm DipClinPharm MPH PhDPFPHFRPharmS FFRPS (consultant), as Deputy Chief Scientist (interim). Dr Ashiru-Oredope will take up Fri, 28 Jul 2023 12:57:00 GMThttps://www.rpharms.com/news/details//Nation-Patient-Safety-Alert-Potent-synthetic-opioids-implicated-in-heroin-overdoses-and-deathsThe Office for Health Improvements and Disparities has issued a National Patient Safety Alert on potent synthetic opioids implicated in heroin overdoses and deaths. In the past 8 weeks there has beeWed, 26 Jul 2023 11:55:56 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Hyoscine-hydrobromide-patches-Scopoderm-15mg-Patch-or-Scopoderm-TTS-Patch-risk-of-anticholinergic-side-effects-including-hyperthermiaThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch). There have been a smTue, 25 Jul 2023 09:21:23 GMThttps://www.rpharms.com/news/details//hscc-report-a-wake-up-call-for-gov-says-rpsCommenting on the Health Select Committee Expert Panel report on its Inquiry into Pharmacy, James Davies, Director for England at the Royal Pharmaceutical Society said: “The Inquiry report makeTue, 25 Jul 2023 07:20:00 GMThttps://www.rpharms.com/news/details//winner-of-the-pjs-opera-award-2023-announcedThe Royal Pharmaceutical Society and The Pharmaceutical Journal today announce the inaugural winner of the 2023 ‘Outstanding Pharmacy Early-Career Researcher Award’ (OPERA), which aims to Fri, 21 Jul 2023 08:14:26 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Sodiofolin-50-mgml-solution-for-injectioninfusion-400mg8ml-vialThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 recall for specified batches of Sodiofolin 50 mg/ml, solution for injection/infusion (400mg/8ml vial),due to particlThu, 20 Jul 2023 13:14:59 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Quantum-PharmaceuticalThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Company led medicines recall for specified batches of Diltiazem HCI 2% Cream [unlicensed medicine]. This is because the consWed, 19 Jul 2023 12:34:18 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-GLP-1-receptor-agonistsA National Patient Safety Alert has been issued due to the shortage of GLP-1 receptor agonists. There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RATue, 18 Jul 2023 11:56:18 GMThttps://www.rpharms.com/news/details//rps-backs-mhra-consultation-on-codeine-linctusRPS has backed The Medicines and Healthcare products Regulatory Agency (MHRA) consultation on the potential reclassification of codeine linctus from P status to a prescription-only medicine. Codeine Mon, 17 Jul 2023 23:00:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Aventis-Pharma-Limited-ta-Sanofi-Sabril-500-mg-film-coated-tablets--Sabril-500-mg-granules-for-oral-solutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall for specified batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection oThu, 13 Jul 2023 14:55:00 GMThttps://www.rpharms.com/news/details//update-from-rps-assembly-july-2023The RPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following key decisiThu, 13 Jul 2023 07:27:00 GMThttps://www.rpharms.com/news/details//rps-assembly-elects-president-and-treasurerRPS Assembly today elected Professor Claire Anderson as President for a further term of two years. Claire was first elected as President in 2021. In her address to the Assembly, Claire said: “TTue, 11 Jul 2023 08:26:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Tillomed-Laboratories-Limited-Labetalol-200mg-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall for a specific batchof Tillomed Laboratories Limited, Labetalol 200mg Tablets. The batch is being recalled duMon, 10 Jul 2023 14:05:08 GMThttps://www.rpharms.com/news/details//rps-highlights-the-dangers-of-sarmsRPS Director for Scotland Laura Wilson and English Pharmacy Board Member Thorrun Govind were on various media outlets today, including BBC World News, BBC Breakfast and BBC Radio 5 Live, highlighting Fri, 07 Jul 2023 09:27:00 GMThttps://www.rpharms.com/news/details//Medicines-Supply-Notification-GLP-1-receptor-agonists-used-in-the-management-if-type-2-diabetesThe Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification for GLP-1 receptor agonists. There are very limited, intermittent supplies of all glucagon-like peptide-1 receWed, 05 Jul 2023 13:00:38 GMThttps://www.rpharms.com/news/details//the-nhs-celebrates-75th-anniversaryThe National Health Service (NHS) reaches a significant milestone today as it celebrates its 75th birthday. This momentous occasion presents an opportunity to recognise the remarkable staff who tireleWed, 05 Jul 2023 06:04:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Dacarbazine-100mg-200mg--500mg-powder-for-solution-for-injection-vialsThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall for specific batches of medac GmbH (t/a medac Pharma LLP), dacarbazine 100mg, 200mg and 500mg powder for soluTue, 04 Jul 2023 14:40:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Strandhaven-Limited-TA-Somex-Pharma-Sildenafil-100mg-Film-coated-TabletsThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 recall for a specific batch of Sildenafil 100mg tablets. Strandhaven Limited T/A Somex Pharma has informed the MHTue, 04 Jul 2023 09:34:47 GMThttps://www.rpharms.com/news/details//rps-england-welcomes-nhs-long-term-workforce-planRPS in England today welcomed the publication of the NHS Long-Term Workforce Plan, setting out modelling of NHS workforce demand and supply for the next 15 years. The plan covers the whole of pharmacFri, 30 Jun 2023 09:10:00 GMThttps://www.rpharms.com/news/details//Non-steroidal-anti-inflammatory-drugs-NSAIDs-potential-risks-following-prolonged-use-after-20-weeks-of-pregnancyThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update on the potential risks of non-steroidal anti-inflammatory drugs (NSAIDs) following prolonged use afterWed, 28 Jun 2023 10:49:29 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Potential-risk-of-underdosing-with-calcium-gluconate-in-severe-hyperkalaemiaA National Patient Safety Alert has been issued on the Potential risk of underdosing with calcium gluconate in severe hyperkalaemia. This alert highlights theAdult Renal Association Clinical Practice Tue, 27 Jun 2023 14:55:41 GMThttps://www.rpharms.com/news/details//Healthcare-Leaders-Unite-to-Call-for-More-Sustainable-Prescribing-Today (27 June), the Royal Pharmaceutical Society and the Royal College of General Practitioners in Scotland will host an event celebrating the collaborative work of the health professions and policy Tue, 27 Jun 2023 11:23:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-proud-to-support-edinburgh-prideOn Saturday 24JuneRPS memberswalked in the Edinburgh Pride Parade as individuals and allies along with APTUK and GHP members to celebrate, raise awarenessand advocate for equal rights for LGBTQIA+ peoMon, 26 Jun 2023 08:53:00 GMThttps://www.rpharms.com/news/details//New-guidance-on-the-use-of-lifesaving-adrenaline-auto-injectors-AAIsThe Medicines and Healthcare products Regulatory Agency (MHRA) has shared new guidance to highlight the latest safety advice on the steps to take during anaphylaxis. This new guidance includes an easyWed, 21 Jun 2023 08:10:44 GMThttps://www.rpharms.com/news/details//elections-to-roles-on-rps-country-boards-and-assembly-2023Elections to positions on the RPS Country Boards and Assembly have now taken place at Board meetings and the results are as follows: English Pharmacy Board Erutase Oputu was elected as Chair of thWed, 21 Jun 2023 08:06:52 GMThttps://www.rpharms.com/news/details//pharmaceutical-press-gets-new-look-website-for-easier-accessPharmaceutical Press is today announcing their new brand strategy, focused on helping health professionals support the safe and effective use of medicines, delivered via the launch of its new website Wed, 21 Jun 2023 07:50:00 GMThttps://www.rpharms.com/news/details//rps-co-host-lecture-on-community-pharmacy-in-the-21st-centuryLast night the University College London School of Pharmacy, the Royal Pharmaceutical Society and the National Pharmacy Association hosted a lecture on the topic of “Community Pharmacy in the 21Fri, 16 Jun 2023 08:42:00 GMThttps://www.rpharms.com/news/details//prescription-charge-victory-for-60-year-olds-says-rpsCommenting on the news that the Government has abandoned plans to align the prescription charge to the State Pension age, and will insteadfreeze the age for eligibility for free prescriptions at 60, CThu, 15 Jun 2023 10:17:00 GMThttps://www.rpharms.com/news/details//rps-pharma-scene-interviews-mp-taiwo-owatemiThe RPS’ Pharma Scene podcast recently had the pleasure of speaking with Taiwo Owatemi (middle), an oncology pharmacist and Labour MP for Coventry North West. Hosted by Ciara Duffy (right) fromThu, 15 Jun 2023 09:40:23 GMThttps://www.rpharms.com/news/details//rps-to-provide-guidance-on-repeat-prescribingThe Royal Pharmaceutical Society (RPS) has been commissioned by NHS England to work in collaboration with The Royal College of General Practitioners (RCGP) to develop tools and guidance to help primarWed, 14 Jun 2023 07:45:00 GMThttps://www.rpharms.com/news/details//tell-your-story-to-the-covid-inquiryThe UK Covid-19 Inquiry is the independent public inquiry set up to examine the UK’s response to and impact of the Covid-19 pandemic, and learn lessons for the future. In order to fully understTue, 13 Jun 2023 08:35:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Tricodent-Limited-supplier-Medical-Oxygen-BP-MEDIGAS-OXYGEN-BPThe Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that falsified medical oxygen has been provided to several dental practices across the UK. The source of the supply hTue, 06 Jun 2023 10:51:37 GMThttps://www.rpharms.com/news/details//RPS-to-refresh-its-Professional-Standards-for-Homecare-ServicesThe Royal Pharmaceutical Society is refreshing its Professional Standards for Homecare Services. The standards were originally published in 2013 and are a framework to support teams providing and comTue, 06 Jun 2023 07:26:00 GMThttps://www.rpharms.com/news/details//rps-england-board-chair-gives-advice-on-bites-and-stingsAs Summer approaches, Chair of RPS in England, Thorrun Govind joined Gethin Jones and Sam Quek on BBC's Morning Liveto speak about insect bites and stings, how to avoid them, how to treat them andMon, 05 Jun 2023 13:09:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-publication-of-workforce-planRPS England has joined with professional bodies, trade unions and patient groups to call on the Government to publish the NHS Long-Term Workforce Plan. A joint letter signed by almost 40 organisationWed, 31 May 2023 07:56:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-2023The RPS Panel of Fellows has designated the following 31 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhTue, 30 May 2023 07:20:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-Pyridostigmine-60mg-tabletsThe Department of Health and Social Care has issued a National Patient Safety Alert due to a shortage of Pyridostigmine 60mg tablets. Pyridostigmine 60mg tablets are out of stock, resupply is expecteWed, 24 May 2023 15:48:27 GMThttps://www.rpharms.com/news/details//rps-election-results-2023Danny Bartlett (left) has been elected to the vacancy on the English Pharmacy Board in this year’s Board elections, and Sarwat (Sorbi) Khattak (middle) has been elected for a period of one year Wed, 24 May 2023 04:59:00 GMThttps://www.rpharms.com/news/details//rps-launches-new-survey-on-inclusion-and-diversity-in-pharmacyThe Royal Pharmaceutical Society has launched a new profession-wide survey to assess inclusion and diversity within the pharmacy sector. The survey will assess the effectiveness of the RPS’s InTue, 23 May 2023 08:54:16 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Orifarm-UK-Ltd-Buccolam-10mg-Oromucosal-solutionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 Medicines Defect Information for Orifarm UK Ltd, Buccolam 10mg Oromucosal solution. Orifarm UK Ltd has informed the Mon, 22 May 2023 15:13:33 GMThttps://www.rpharms.com/news/details//daffodil-standards-on-end-of-life-care-for-community-pharmaciesCommunity pharmacies across the UK can now sign up to the Daffodil Standards for palliative and end of life care, aimed at improving the care provided to patients approaching the end of their life. TMon, 22 May 2023 07:08:00 GMThttps://www.rpharms.com/news/details//-Class-4-Medicines-Defect-Information-Novartis-Pharmaceuticals-Simulect-10mg--20mg-powder-and-solvent-for-Solution-for-injection-or-infusionThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 recall for Novartis Pharmaceuticals, Simulect 10mg & 20mg powder and solvent for Solution for injection or infusThu, 18 May 2023 12:44:24 GMThttps://www.rpharms.com/news/details//rps-and-pharmacist-support-host-wellbeing-roundtableThe Royal Pharmaceutical Society and Pharmacist Support have hosted key stakeholders at a roundtable on the impact of pharmacy workforce wellbeing on patient safety. Held yesterday at RPS in London, Thu, 18 May 2023 08:42:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-Promotes-Net-Zero-Healthcare-Internationally-Climate change is the most significant health threat modern society has ever faced. Governments, organisations and individuals all have a collective responsibility to tackle this growing threat. MedicWed, 17 May 2023 11:17:13 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-to-develop-sustainability-guidance-for-pharmacy-teamsThe Royal Pharmaceutical Society (RPS) is proud to announce it has been commissioned by NHS England to develop guidance that helps community and hospital pharmacy teams across Great Britain to reduce Fri, 12 May 2023 07:59:33 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Hikma-Farmacutica-Portugal-SA-Gemcitabine-1g263ml--2g526ml-Solution-For-Infusion-VialThe Medicines and Healthcare products Regulatory Agency (MHRA) has been informed of a potential issue impacting specific batches of Gemcitabine 1g/26.3ml & 2g/52.6ml Solution For Infusion Vial. DuWed, 10 May 2023 14:30:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Class-1-Medicines-Recall-Notification-Recall-of-Emerade-500-micrograms-and-Emerade-300-micrograms-auto-injectors-due-to-the-potential-for-device-failureThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a National Patient Safety Alert for Emerade 500 micrograms and Emerade 300 micrograms. Pharmaswiss Česka republika s.r.o.Tue, 09 May 2023 13:00:21 GMThttps://www.rpharms.com/news/details//NHS-England-Influenza-season-202223-ending-the-prescribing-and-supply-of-antiviral-medicines-in-primary-careThe most recent surveillance data from UK Health Security Agency (UKHSA) indicates that circulation of influenza in the community has returned to baseline levels. In accordance with NICE guidance aTue, 09 May 2023 12:58:37 GMThttps://www.rpharms.com/news/details//pharmacy-first-scheme-a-game-changer-says-royal-pharmaceutical-societyCommenting on the Government’s investment of £645 million into community pharmacies in England, Chair of the Royal Pharmaceutical Society in England Thorrun Govind said: “We're Tue, 09 May 2023 06:31:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Omega-Pharma-Ltd-Beconase-Hayfever-Nasal-SprayOmega Pharma Ltd has identified that there is text missing in Section 2 of the Patient Information Leaflet (PIL) in packs of Beconase Hayfever Nasal Spray (P). Further information, details of the aWed, 26 Apr 2023 14:44:07 GMThttps://www.rpharms.com/news/details//Drug-Safety-Update-Isotretinoin-Roaccutane-new-safety-measures-to-be-introduced-in-the-coming-months-including-additional-oversight-on-initiation-of-treatment-for-patients-under-18-yearsThe Isotretinoin Expert Working Group of the Commission on Human Medicines has made recommendations to strengthen the safety of isotretinoin treatment. Recommendations include new warnings, the need fWed, 26 Apr 2023 14:34:34 GMThttps://www.rpharms.com/news/details//RPS-Scotland-represented-at-International-Festival-of-Science-in-EdinburghIn April, RPS Scotland was represented at the thanksgiving service for the International Festival of Science in Edinburgh. The Edinburgh Science Festival is an annual event, and the largest Science FTue, 25 Apr 2023 12:08:00 GMThttps://www.rpharms.com/news/details//government-responds-to-workforce-reportThe Health and Social Care Committee has published the Government’s response to its report on Workforce: recruitment, training and retention in health and social care. The response agrees with tTue, 25 Apr 2023 08:11:00 GMThttps://www.rpharms.com/news/details//rps-says-pharmacy-can-impact-the-delivery-of-genomics-across-healthcareRPS has published a position statement on genomics calling for pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic serviMon, 24 Apr 2023 09:16:56 GMThttps://www.rpharms.com/news/details//RPS-Fellows-in-Scotland-collaborate-and-engage-with-Scottish-Board-and-staffRPS Fellows living in Scotland met for an engagement and networking day on 22 March at the home of RPS Scotland on Melville Street, Edinburgh. In the afternoon, Fellows met with Scottish Pharmacy BoaMon, 24 Apr 2023 07:07:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//error-reporting-standards-to-be-updatedA consultation is open from today to inform the update of the UK 'Professional standards for the reporting, learning, sharing, taking action and review of incidents error reporting' by the RoyFri, 21 Apr 2023 08:14:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Limited-Co-amoxiclav-1253125mg5ml-250625mg5ml-powder-for-oral-suspensionSandoz limited has informed theMedicines and Healthcare products Regulatory Agency (MHRA) that Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension are not sugar free despite the caThu, 20 Apr 2023 12:59:48 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Spectrum-Therapeutics-UK-Canopy-AKH-22-Dried-Cannabis-5g-unlicensed-medicineThe importer and distributor of the above products has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of reports that the microbial limit for Total Microbial Aerobic Count (TAThu, 20 Apr 2023 09:59:21 GMThttps://www.rpharms.com/news/details//rps-welcomes-provision-of-oral-contraception-in-community-pharmaciesCommenting on the news from NHS England that a new service to provide the Pill through community pharmacies will start on 24 April, Ms Thorrun Govind, Chair of the RPS English Pharmacy Board, said: Mon, 17 Apr 2023 08:15:00 GMThttps://www.rpharms.com/news/details//RPS-England-responds-to-Hewitt-ReviewCommenting on the Hewitt Review of Integrated Care Systems, RPS Director for England James Davies said: “This review highlights the potential for Integrated Care Systems to drive collaboration Tue, 04 Apr 2023 12:59:55 GMThttps://www.rpharms.com/news/details//president-writes-to-the-times-about-e-cigarettesRPS President Professor Claire Anderson has written in The Times (1 April)in response to an article published last week which said experts have warned that the government’s plans to clamp down oMon, 03 Apr 2023 13:07:39 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Ethigen-Limited-Briviact-75mg--100mg-film-coated-tabletsEthigen Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the Patient Information Leaflet (PIL) in Briviact 75mg and Briviact 100mg film coated tablets contains Thu, 30 Mar 2023 14:01:21 GMThttps://www.rpharms.com/news/details//update-from-rps-assembly-march-2023The RPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following key decisiThu, 30 Mar 2023 08:13:00 GMTJessica Clelandhttps://www.rpharms.com/news/details//Michael-Matheson-MSP-appointed-Cabinet-Secretary-for-NHS-Recovery-Health-and-Social-CareScotland’s First Minister, Humza Yousaf, has appointed Michael Matheson MSP to be Cabinet Secretary for NHS Recovery, Health and Social Care. Commenting on the announcement Laura Wilson, DirectWed, 29 Mar 2023 14:09:32 GMTRoss Barrowhttps://www.rpharms.com/news/details//daniel-thomas-award-nominations-now-openWe know pharmacists tragically passed away during the pandemic in active service to their profession. Before and after the pandemic we know lives were cut short and we want to recognise those pharmacWed, 29 Mar 2023 11:19:46 GMTJessica Clelandhttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Ferring-Pharmaceuticals-Limited-GONAPEPTYL-Depot-375mg-Powder-and-solvent-for-suspension-for-injectionFerring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked 30-millimeter (30mm) needle for subThu, 23 Mar 2023 12:11:57 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Rosemont-Pharmaceuticals-Limited-Sildenafil-10mgml-Oral-SuspensionThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 recall for a specific batch of Rosemont Pharmaceuticals Limited, Sildenafil 10mg/ml Oral Suspension. Rosemont PhaTue, 21 Mar 2023 15:05:50 GMThttps://www.rpharms.com/news/details//Healthcare-Professionals-Call-for-Action-with-Sustainable-Greener-Prescribing-Today the Royal College of General Practitioners Scotland and the Royal Pharmaceutical Society Scotland hosted a virtual roundtable event, discussing how to further promote sustainable prescribing witThu, 16 Mar 2023 15:59:50 GMTRoss Barrowhttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Macarthys-Laboratories-ta-Martindale-Pharma-Venlafaxine-XL-150mg-225mg-300mg-prolonged-release-tabletsAdditional to the batches included in the previous Class 4 Medicines Notification from 16th November 2022. Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed varThu, 16 Mar 2023 13:05:29 GMThttps://www.rpharms.com/news/details//rps-advice-on-withdrawal-of-pholcodineFollowing advice from the Commission on Human Medicines, the MHRA has requested products containing pholcodine are withdrawn from pharmacies. Commenting on the move, RPS President Professor Claire AndTue, 14 Mar 2023 12:50:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-and-Drug-Safety-Update-All-pholcodine-containing-medicinesThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 drug recall for all pholcodine-containing medicines. All pholcodine-containing medicines are being recalled and withTue, 14 Mar 2023 11:20:04 GMThttps://www.rpharms.com/news/details//rps-re-joins-fipWe'repleased to announce we've re-joined the International Pharmaceutical Federation (FIP), the global federation of national pharmaceutical associations. The decision reflects our commitment Mon, 13 Mar 2023 10:11:35 GMThttps://www.rpharms.com/news/details//rps-condemns-prescription-price-increase-in-englandCommenting onthe Department of Health and Social Care announcing an increase in prescription charges to £9.65, Board Chair for England at RPS, Thorrun Govindsaid: “This is a kick in the tFri, 10 Mar 2023 10:50:45 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Drugsrus-Limited-Clexane-10000-IU-100mg--1ml-SyringesDrugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the leaflet. Thu, 09 Mar 2023 11:20:39 GMThttps://www.rpharms.com/news/details//rps-hee-and-cppe-collaborate-on-pathway-to-advanced-pharmacist-practice-recognition-The first participants in a fully funded, supported e-portfolio pathway to recognise advanced pharmacist practice in England will get underway in March 2023 The pathway will be delivered by the RoyalThu, 09 Mar 2023 10:02:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Thornton--Ross-Ltd-Methadone-1mgmL-Oral-Solution-BP---Sugar-Free-Methadone-Mixture-1mgml-Thornton & Ross Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that specific batches of Methadone 1mg/mL Oral Solution BP Sugar Free have been packaged with the inTue, 07 Mar 2023 14:43:51 GMThttps://www.rpharms.com/news/details//MPs-warn-of-impact-of-prescription-chargesMPs yesterday debated Government proposals in England to raise the qualifying age for free prescriptions from 60 to over 65 years old, following a consultation in 2021, warning about the potential impTue, 07 Mar 2023 11:04:00 GMThttps://www.rpharms.com/news/details//protected-learning-time-essential-for-the-professions-future-says-rpsAs the pharmacy workforce continues to deliver under immense pressure, RPS is calling on employers, governments and NHS organisations to provide pharmacists with regular protected learning time (PLT) Mon, 06 Mar 2023 11:34:00 GMThttps://www.rpharms.com/news/details//rps-england-backs-plan-to-tackle-addictive-medicinesCommenting on a new framework from NHS England to reduce inappropriate prescribing of addiction-causing medicines, Director for England at RPS, James Davies said: “Pharmacists are well-placed tThu, 02 Mar 2023 12:26:00 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-Teva-UK-Limited-Levothyroxine-125mcg-TabletsTeva UK Limited is recalling one batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing. Further information, advice and Thu, 02 Mar 2023 11:59:19 GMThttps://www.rpharms.com/news/details//rps-joins-commitments-to-mitigate-climate-changeTogether with a number of fellow members of the UK Health Alliance on Climate Change, the Royal Pharmaceutical Society has signed up to a list of ten commitments to mitigate and adapt to climate changWed, 01 Mar 2023 12:25:00 GMThttps://www.rpharms.com/news/details//Extension-to-Serious-Shortage-Protocols-for-phenoxymethylpenicillinThe eight Serious Shortage Protocols (SSPs) for phenoxymethylpenicillin products have been extended. They have been extended for a further month and are now due to expire on Friday 31 March 2023. STue, 28 Feb 2023 16:43:09 GMThttps://www.rpharms.com/news/details//rps-to-review-constitution-and-governance-structuresThe RPS will commission a full review of its constitution and supporting governance structures as part of its evolution as the professional leadership body for pharmacy. An invitation to tender to prTue, 28 Feb 2023 13:03:00 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Vertical-Pharma-Resources-Ltd-TA-IPS-Pharma-Levothyroxine-Oral-Suspension-Various-Strengths-unlicensed-medicineIPS Pharma is recalling specific batches of levothyroxine oral suspension from pharmacies and impacted patients due to the concentration of levothyroxine being greater than the amount stated on the laMon, 27 Feb 2023 17:14:59 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Atnahs-Pharma-UK-Zestoretic-20mg125mg-TabletsAtnahs Pharma UK has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the Patient Information Leaflet (PIL) packaged in specific batches of Zestoretic 20mg/12.5mg tablets cMon, 27 Feb 2023 13:28:29 GMThttps://www.rpharms.com/news/details//RPS-core-participant-of-UK-Covid-19-InquiryThe RPS has been designated as a Core Participant in Module 3 of the UK Covid-19 Inquiry, which will examine the impact of Covid-19 on healthcare across the United Kingdom. A Core Participant is a peFri, 24 Feb 2023 16:00:31 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Reckitt-Benckiser-Healthcare-UK-Limited-Lemsip-Max-Cold-and-Flu-CapsulesReckitt Benckiser Healthcare (UK) Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that a typographical error has been identified on the end flap of the outer cartonThu, 23 Feb 2023 10:00:01 GMThttps://www.rpharms.com/news/details//hrt-prepayment-certificate-in-england-due-in-aprilToday the Government announcedthat from April 1 patients in England will be able to buy an £18.70 annual prepayment certificate for HRT, reducing the cost and increasing access to a range of medTue, 21 Feb 2023 15:34:32 GMThttps://www.rpharms.com/news/details//MHRA-Device-Safety-Information-BD-BodyGuard-MicroSets-and-residual-ethylene-oxideThe Medicines and Healthcare products Regulatory Agency (MHRA) has issued a device safety information for BD BodyGuard MicroSets and residual ethylene oxide. Devices may continue to be used to treat pTue, 21 Feb 2023 14:07:30 GMThttps://www.rpharms.com/news/details//Group-A-Streptococcus-reinstatement-of-NICE-sore-throat-guidance-for-children-and-young-people-and-withdrawal-of-NHS-England-interim-guidanceThe NHS England/UKHSA Incident Management Team Group A Streptococcus interim clinical guidance for primary and community care settings has been retired as of 15 February 2023. This guidance asked heaThu, 16 Feb 2023 13:12:27 GMThttps://www.rpharms.com/news/details//digital-medicines-ethics-and-practice-now-liveMedicines, Ethics and Practice (MEP) has moved­ from a once-a-year print edition to a digital version enabling access to a new, easily searchable and constantly updated guide that’s availablTue, 14 Feb 2023 12:01:51 GMThttps://www.rpharms.com/news/details//catch-up-with-prescription-charges-in-the-media-Chair of RPS in England Thorrun Govind has followed up the RPS survey released today showing that the cost of living is having a real impact on patients’ ability to afford their prescription medMon, 13 Feb 2023 15:14:00 GMThttps://www.rpharms.com/news/details//the-cost-of-living-impacts-access-to-prescription-medicines-says-rpsThe Royal Pharmaceutical Society (RPS) has released the results of a survey showing that pharmacists say the cost of living is having an impact on whether people can afford prescription medicines in EMon, 13 Feb 2023 08:34:00 GMThttps://www.rpharms.com/news/details//our-initial-response-to-the-commission-on-pharmacy-professional-leadershipRPS recognises the challenges for professional leadership that lie ahead and we are pleased to read that the Co- chairs share our ambition for a more inclusive, supportive and collaborative approach. Mon, 06 Feb 2023 08:59:00 GMThttps://www.rpharms.com/news/details//Jonathan-Burton-Receives-RPS-Charter-AwardThe 2022 RPS Charter Award is to be presented to Jonathan Burton,MBE FRPharmS,in recognition of his outstanding work for the Society and the wider profession in promoting the interests of pharmacy. ThFri, 03 Feb 2023 09:32:00 GMThttps://www.rpharms.com/news/details//Changes-and-extension-to-Serious-Shortage-Protocols-for--phenoxymethylpenicillin-products-The eight Serious Shortage Protocols (SSPs) for phenoxymethylpenicillin products have been extended. The revised date is now 28 February 2023. Phenoxymethylpenicillin 125mg/5ml oral solution sugar Wed, 01 Feb 2023 10:56:00 GMThttps://www.rpharms.com/news/details//rps-reiterates-call-for-ban-on-dangerous-dnpCommenting on the news that the Home Office will include DNP (2,4-Dinitrophenol) in the 1972 Poisons Act, President of RPS Professor Claire Anderson said: “DNP is unfit for human consumption anMon, 30 Jan 2023 10:31:00 GMThttps://www.rpharms.com/news/details//rps-wales-highlight-developing-role-of-prescribing-pharmacists-to-members-of-the-seneddRPS Wales has been highlighting to Members of the Senedd about the developing role of prescribing pharmacists and how their skills can benefit patients and the NHS. All members of the Senedd were invThu, 26 Jan 2023 11:14:00 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Prulab-Pharma-Limited-Clopidogrel-Oral-Solution-75mg-in-5ml-unlicensed-medicinePrulab Pharma Limited is recalling a batch of Cloipidogrel Oral Solution 75mg in 5ml due to a discrepancy with the product labelling that could result in an incorrect volume to be administered to the Thu, 26 Jan 2023 11:09:47 GMThttps://www.rpharms.com/news/details//recognising-pregnancy-parents-and-carer-related-microaggressions-referenceWe’ve launched a guide to highlight the microaggressions experienced by individuals who are parents and carers, pregnant, going on or returning from maternity, paternity, adoption or extended caThu, 26 Jan 2023 09:36:00 GMThttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Supply-of-Licensed-and-Unlicensed-Epidural-Infusion-BagsThe Department of Health and Social Care (DHSC) has issued a National Patient Safety Alert for the supply of licensed and unlicensed epidural infusion bags. There are supply issues impacting FreseniusMon, 23 Jan 2023 17:07:34 GMThttps://www.rpharms.com/news/details//RPS-England-in-Parliament-for-report-launchRPS England Chair Thorrun Govind and Director for England James Davies joined pharmacists and pharmacy organisations in Parliament today for the launch of a new report by the All-Party Parliamentary GMon, 23 Jan 2023 16:03:00 GMThttps://www.rpharms.com/news/details//donate-to-pharmacist-support-when-you-join-rpsYou can now donate to Pharmacist Support when you join or renew your membership of RPS. Pharmacist Support has been supporting pharmacists, former pharmacists, trainees and MPharm students for over 1Fri, 20 Jan 2023 10:47:00 GMThttps://www.rpharms.com/news/details//Class-3-Medicines-Recall-Dr-Reddys-Laboratories-UK-Ltd-Lacidipine-4-mg-Film-Coated-TabletsDr Reddy’s Laboratories (UK) Limited is recalling two batches of Lacidipine 4 mg Film-Coated Tablets as a precautionary measure due to the presence of an unknown solvent-like odour. Further infThu, 19 Jan 2023 14:48:27 GMThttps://www.rpharms.com/news/details//Class-2-Medicines-Recall-UCB-Pharma-Ltd-Dioctyl-100-mg-CapsulesUCB Pharma Ltd is recalling one batch of Dioctyl 100 mg Capsules as a precautionary measure due to the presence of a foreign capsule being found in a sealed pack. The Marketing Authorisation Holder&rsWed, 18 Jan 2023 15:26:49 GMThttps://www.rpharms.com/news/details//laura-wilson-appointed-rps-director-for-scotlandLaura Wilson has been appointed as the Royal Pharmaceutical Society’s (RPS) Director for Scotland commencing 23rdJanuary 2023. Laura, who is currently Policy and Practice Lead for RPS in ScotlaMon, 16 Jan 2023 13:04:00 GMThttps://www.rpharms.com/news/details//RPS-and-BMA-call-for-improvements-to-the-pharmacotherapy-serviceRPS Scotland the BMA’s Scottish GP Committee have today (Friday 13 January 2022) released a joint statement calling for improvements to the pharmacotherapy service. The statement recognises thaFri, 13 Jan 2023 13:02:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-product-launched---drug-compatibility-checkerPharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business is today announcing the launch of a new product Drug Compatibility Checker, now available through MedicinesComplete. Fri, 13 Jan 2023 12:17:48 GMThttps://www.rpharms.com/news/details//Company-led-medicines-recall-Mawdsley-Brooks--Company-Limited-Fluphenazin-neuraxpharm-D-25--100-mgml-Solution-for-InjectionMawdsley-Brooks & Company Limited is recalling specific batches of Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for injection as a precautionary measure, due to validation tests demoThu, 12 Jan 2023 15:12:20 GMThttps://www.rpharms.com/news/details//rps-workforce-wellbeing-survey-results-highlight-pharmacy-pressuresAs winter pressures mount, RPS is calling for workforce planning for pharmacy to address skill mix and staffing levels so that workloads can be effectively managed as its annual Workforce Wellbeing suThu, 12 Jan 2023 14:21:00 GMThttps://www.rpharms.com/news/details//New-paper-helps-pharmacy-teams-to-tackle-health-inequalitiesHow pharmacy can do more to tackle health inequalities is set out in a new position paper launched today by the Royal Pharmaceutical Society (RPS). With the cost of living crisis adding to already wiWed, 11 Jan 2023 12:58:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//National-Patient-Safety-Alert-Use-of-oxygen-cylinders-where-patients-do-not-have-access-to-medical-gas-pipeline-systemsNHS England has published a National Patient Safety Alert on the use of oxygen cylinders where patients do not have access to medical gas pipeline systems. To help NHS organisations prevent risks assoTue, 10 Jan 2023 15:58:32 GMThttps://www.rpharms.com/news/details//joint-letter-calls-for-workforce-plan-to-include-whole-of-pharmacyPharmacy leaders have warned the Government about a lack of engagement with stakeholders around the development of its long-term workforce plan in England. A joint letter signed by representatives frTue, 10 Jan 2023 09:04:00 GMThttps://www.rpharms.com/news/details//rps-and-academy-of-medical-royal-colleges-agree-statement-of-strategic-intentRoyal Pharmaceutical Society and Academy of Medical Royal Colleges agree Statement of Strategic Intent The AoMRC and RPS have agreed a statement of strategic intent that reflects the shared vision thFri, 06 Jan 2023 11:05:00 GMThttps://www.rpharms.com/news/details//Updated-illustration-summarising-the-substitution-options-provided-by-the-SSPs-for-phenoxymethylpenicillin-products-We have updated ourillustration(Version 7)that summarises thesubstitution options provided by the SSPs for phenoxymethylpenicillin products. This follows a number of enquiries that our professional suWed, 04 Jan 2023 14:52:00 GMThttps://www.rpharms.com/news/details//pressure-is-immense-on-pharmacy-teams-says-rps-englandAs winter pressures grow across the health service, Chair of the Royal Pharmaceutical Society in England Ms Thorrun Govind has called for Government action to support pharmacy teams currently experienWed, 04 Jan 2023 09:23:00 GMThttps://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Albireo-AB-Bylvay-1200-micrograms-Hard-CapsulesAlbireo AB has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that there is a typographical error with the text on the side panel of the bottle label for a specific batch of BTue, 03 Jan 2023 15:03:50 GMThttps://www.rpharms.com/news/details//rps-upgrades-to-level-2-disability-confident-employerWe are proud to announce that we have renewed our Disability Confident certificate at level 2. In November 2019 we signed up to level 1 of the Government’s Disability Confident scheme. This heTue, 03 Jan 2023 14:07:00 GMThttps://www.rpharms.com/news/details//UKHSA--Urgent-Public-Health-Message-Enhanced-genome-sequencing-for-hospitalised-patients-returning-from-ChinaThe UK Health Security Agency (UKHSA) has published an urgent public health message for enhanced genome sequencing for hospitalised patients returning from China. China is currently experiencing its Tue, 03 Jan 2023 11:59:22 GMThttps://www.rpharms.com/news/details//Updated-illustration-summarising-the-substitution-options-provided-by-the-SSPs-for-phenoxymethylpenicillin-productsWe have updated our illustration that summarises thesubstitution options provided by the SSPs for phenoxymethylpenicillin products. This is following two amendements that were made on 23 December 2022Wed, 28 Dec 2022 16:42:00 GMThttps://www.rpharms.com/news/details//Pharmacy-leaders-across-Scotland-ask-the-public-to-be-kind-this-winterPharmacy and healthcare leaders from across Scotland have rallied behind a campaign, which is reminding the public to be kind to their pharmacy teams this winter. As pressures on pharmacy services inWed, 21 Dec 2022 12:48:42 GMTRoss Barrowhttps://www.rpharms.com/news/details//we-urge-government-to-allow-pharmacists-to-amend-prescriptionsReacting to the news that a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care to cover three kinds of penicillin solution, President of the RPS Professor ClaiFri, 16 Dec 2022 11:18:00 GMThttps://www.rpharms.com/news/details//new-product-launch---drug-compatibility-checkerDrug Compatibility Checker– the only source of injectable compatibility knowledge that combines published literature with real-world clinical practice. Pharmaceutical Press, the Royal PharmaceThu, 15 Dec 2022 11:00:00 GMThttps://www.rpharms.com/news/details//rps-in-england-publishes-ten-year-vision-for-pharmacyThe Royal Pharmaceutical Society (RPS) has today published ‘A vision for pharmacy professional practice’ in partnership with The King’s Fund, which outlines key ambitions for the futWed, 14 Dec 2022 09:18:00 GMThttps://www.rpharms.com/news/details//president-writes-to-the-telegraph-about-antibiotic-prescribing-and-nhs-strikesRPS President Professor Claire Anderson has written in The Sunday Telegraph (11 December)in response to an articlepublished last week suggesting pharmacists would be allowed to treat patients with minMon, 12 Dec 2022 15:35:10 GMThttps://www.rpharms.com/news/details//medicines-ethics-and-practice-goes-digitalMedicines, Ethics and Practice (MEP) is moving from a once-a-year print edition to a digital version from January 2023 enabling access to a new, easily searchable and constantly updated guide that&rsqMon, 12 Dec 2022 13:01:57 GMThttps://www.rpharms.com/news/details//Pharmacists-and-teams-work-hard-to-resolve-stock-issues-around-antibioticsThe situation around rising cases of Strep A and obtaining antibiotics has been challenging for patients, parents and carers, pharmacists and all those in our health system working to help patients. Fri, 09 Dec 2022 17:00:00 GMThttps://www.rpharms.com/news/details//medicines-safety-event-returns-to-walesRPS Wales has joined forces with the All Wales Medicines Safety Network to lead a renewed focus on medicines safety. The All Wales Medicines Safety Symposium, held in Cardiff on Friday 2 December, brFri, 02 Dec 2022 10:18:32 GMThttps://www.rpharms.com/news/details//Pharmacy-and-pharmacy-technician-leaders-agree-actions-to-support-pharmacists-with-disabilitiesLast month, pharmacists and pharmacy technicians from across Scotland met at the Scottish Parliament to discuss how to better enable people with disabilities to work in pharmacy. This followed a surveTue, 29 Nov 2022 14:25:04 GMTRoss Barrowhttps://www.rpharms.com/news/details//Pharmacists-celebrated-in-the-home-of-pharmacy-in-ScotlandPharmacists across Scotland were celebrated this week for their distinction in the practice of pharmacy by Royal Pharmaceutical Society (RPS) Scotland, the professional leadership body for pharmacistsFri, 25 Nov 2022 10:38:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-to-undertake-independent-review-of-the-future-of-clinical-pharmacy-services-in-nhs-hospitals-in-walesThe Welsh Government has commissioned the Royal Pharmaceutical Society to undertake an independent review of the future of clinical pharmacy services provided in NHS hospitals in Wales. Building on tThu, 24 Nov 2022 12:37:17 GMThttps://www.rpharms.com/news/details//rps-wales-joins-calls-for-mental-health-transformationRPS Wales has joined ten other Royal Colleges and professional bodies to call for the urgent transformation of mental health services to address the increasing demands on the NHS in Wales. RepresentaWed, 23 Nov 2022 11:14:00 GMThttps://www.rpharms.com/news/details//new-rps-fellows-november-2022­The RPS Panel of Fellows has designated the following 24 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the RoyMon, 21 Nov 2022 12:11:45 GMThttps://www.rpharms.com/news/details//update-on-rps-assembly-november-2022The RPS Assemblyis the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following key decisiThu, 17 Nov 2022 10:18:51 GMThttps://www.rpharms.com/news/details//revised-rps-professional-standards-for-hospital-pharmacyNew revised RPS Professional Standards for Hospital Pharmacy Services are now available. Launched at today’s RPS Annual Conference, the Standards provide a framework for providers of hospital phFri, 11 Nov 2022 10:14:02 GMThttps://www.rpharms.com/news/details//director-for-scotland-clare-morrison-moves-to-healthcare-improvement-scotlandAfter over two years as RPS Director for Scotland, Clare Morrison will be leaving RPS in January to return to NHS Scotland. Clare has been appointed Director of Community Engagement at Healthcare ImprThu, 10 Nov 2022 14:37:00 GMThttps://www.rpharms.com/news/details//pharmacys-role-in-sustainability-highlighted-at-seneddPictured from left to right: Meryl Davies, Elen Jones, Jack Sargeant MS and Nicholas Reed by Sophie Baxter Photography. RPS Wales have been informing members of the Senedd (MSs) about the action takeThu, 10 Nov 2022 11:43:00 GMThttps://www.rpharms.com/news/details//new-rps-toolkit-helps-providers-set-up-an-antibiotic-amnestyAhead of World Antibiotic Awareness Week (18-24 November) the Royal Pharmaceutical Society (RPS) is encouraging local NHS organisations to set up an ‘antibiotic amnesty’ to ensure unwantedWed, 09 Nov 2022 09:59:11 GMThttps://www.rpharms.com/news/details//Collaboration-on-health-data-sharing-to-improve-patient-outcomes-in-ScotlandScottish Government, MSPs, healthcare professional leadership bodies and healthcare regulators have met to discuss how to improve the sharing of health data to achieve better patient outcomes. Last mWed, 09 Nov 2022 08:30:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-core-advanced-e-portfolio-now-liveThe Royal Pharmaceutical Society Core Advanced e-portfolio is now available on the RPS website and can be accessed by RPS members and non-members. Non-members will need to become a registered user to Tue, 08 Nov 2022 13:02:00 GMThttps://www.rpharms.com/news/details//cop27-rps-president-writes-to-cop26-president-alok-sharmaTogether with other health leaders, Royal Pharmaceutical Society President, Professor Claire Anderson, has called on COP26 President Alok Sharma to use his leadership at COP27 to put health at the forMon, 07 Nov 2022 11:52:00 GMThttps://www.rpharms.com/news/details//consultation-on-professional-standards-for-palliative-and-end-of-life-care-now-openConsultation on professional standards for palliative and end of life care for community pharmacy, developed by The Royal Pharmaceutical Society (RPS) and end of life charity Marie Curie, is now open Tue, 01 Nov 2022 11:05:00 GMThttps://www.rpharms.com/news/details//September-update-on-national-boards-meetingRPS Boards from England, Scotland and Wales came together for a joint board meeting today. They were joined by members who could observe remotely. Key agenda items included: Updates on the RPS comSat, 29 Oct 2022 22:00:00 GMThttps://www.rpharms.com/news/details//new-plans-for-the-pharmacy-vision-in-walesNew plans to further transform pharmacy services in Wales over the next three years are being launched today (Thursday 27October) in Cardiff. The plans are a key part of delivering the aspirations foThu, 27 Oct 2022 12:10:05 GMThttps://www.rpharms.com/news/details//Government-must-act-on-workforce-plan-says-RPS-EnglandCommenting on theappointment of Rt Hon Steve BarclayMP as the new Secretary of State for Health and Social Care, Chair of RPS inEngland Thorrun Govind said: “Following the changes over the lastWed, 26 Oct 2022 14:54:46 GMThttps://www.rpharms.com/news/details//new-research-e-learning-for-pharmacy-professionalsThe Royal Pharmaceutical Society (RPS) and the National Institute for Health Research (NIHR), supported by the Association of Pharmacy Technicians UK (APTUK), have launched the first e-learning moduleWed, 26 Oct 2022 09:28:00 GMThttps://www.rpharms.com/news/details//president-writes-in-the-times-about-antibiotic-prescribingRPS President Professor Claire Anderson has written in today's Times about the expertise and clinical skills of pharmacists who either prescribe or provide antimicrobials under patient group direcTue, 18 Oct 2022 05:50:00 GMThttps://www.rpharms.com/news/details//rps-president-joins-health-leaders-cycle-to-inspire-climate-actionRPS President Professor Claire Anderson today joined thirty other health leaders including presidents, directors and chairs from a number of health organisations for a cycle across London to inspire aThu, 13 Oct 2022 12:16:00 GMThttps://www.rpharms.com/news/details//Update-on-our-vision-for-pharmacy-practice-in-England-Our exciting work with leading health charity The King's Fund is moving forward to develop a Vision for Pharmacy Practice in England. We saw a great response to our open consultation in SeptemberWed, 12 Oct 2022 09:58:00 GMThttps://www.rpharms.com/news/details//Where-do-people-keep-their-household-medicinesToday we've released new research with You Govrevealing that one in five of us (19%) keep our medicines in the bathroom.Almost one in two (45%) of us keep our medicines in the kitchen, which couldWed, 12 Oct 2022 08:38:00 GMThttps://www.rpharms.com/news/details//New-research-fellowship-for-precision-medicine-researchA new research fellowship scheme for early-career pharmacists is now open to provide a route into precision medicine research, supporting clinical pharmacists to pursue their research interests for paTue, 11 Oct 2022 10:11:00 GMThttps://www.rpharms.com/news/details//Cabinet-Secretary-commits-to-achieving-protected-learning-time-for-health-professionalsThe Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals, during a panel discussion on tackling the workforce crisis at the SNP conferenMon, 10 Oct 2022 07:05:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//we-commit-to-changes-following-review-of-member-participationToday we receivedthe report of the independent review of member participation and RPS communications. This report considers decisions we take on behalf of the profession through our Governance boards.Fri, 07 Oct 2022 12:01:00 GMThttps://www.rpharms.com/news/details//james-davies-joins-rps-as-director-for-englandJames Davies has been appointed as the Royal Pharmaceutical Society's (RPS) Director of England starting in January 2023. James will drive professional leadership for the pharmacy profession in EThu, 06 Oct 2022 08:54:40 GMThttps://www.rpharms.com/news/details//-Pharmacy-commits-to-bold-actions-on-disabilityPharmacists and pharmacy technicians from across Scotland met at the Scottish Parliament on Monday (3 October) and committed to bold actions to support people living with seen and unseen disabilities Wed, 05 Oct 2022 11:53:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Our-vision-for-the-future-of-pharmacy-professional-leadershipBy Paul Bennett, RPS Chief Executive Today I’m proud to share with you the statement we submittedto the UK Commission on Pharmacy Professional Leadership in which we set out what professional lWed, 05 Oct 2022 07:52:00 GMTPaul Bennetthttps://www.rpharms.com/news/details//government-must-commit-to-reduce-health-inequalitiesAs a member of the Inequalities in Health Alliance (IHA), a group of over 200 organisations convened by the Royal College of Physicians, we’ve written to Therese Coffey,Secretary of State for HeFri, 30 Sep 2022 07:48:00 GMThttps://www.rpharms.com/news/details//our-new-open-access-journal-for-pharmacy-and-pharmacology-researchWorking in partnership with Oxford University Press, we've strengthened our research journal portfolio with the launch of RPS Pharmacy and Pharmacology Reports. RPS Pharmacy and Pharmacology RepoTue, 27 Sep 2022 06:50:00 GMThttps://www.rpharms.com/news/details//supporting-parents-and-carers-in-pharmacyToday our new campaign kicks offto help parents and carers in pharmacy get the support they need in the workplace as part of our inclusion and diversity work. Matching the needs of those you care forMon, 26 Sep 2022 07:41:12 GMThttps://www.rpharms.com/news/details//Meeting-of-the-RPS-Assembly-Participation-and-communications-review-from-Luther-PendragonIn April 2022 we committed to an independent review of member participation and RPS communications concerning decisions we take on behalf of the profession through our Governance boards. The scope ofFri, 23 Sep 2022 11:47:00 GMThttps://www.rpharms.com/news/details//rps-in-england-responds-to-health-secretary-plans-for-nhsResponding to the Secretary of State for Health and Social Care’s announcement about priorities for the NHS in England, Chair of the Royal Pharmaceutical Society in England Ms Thorrun Govind saiThu, 22 Sep 2022 08:46:00 GMT John Lunnyhttps://www.rpharms.com/news/details//complete-our-workforce-wellbeing-survey-2022Our fourth annual Workforce Wellbeing survey, in partnership with Pharmacist Support, is now live as part of our long-running programme to support the mental health and wellbeing of pharmacists. ThisTue, 20 Sep 2022 06:56:00 GMThttps://www.rpharms.com/news/details//the-death-of-queen-elizabeth-IIIt is with great regret that we learnt of the death of our Patron, Queen Elizabeth II. Her Majesty gave 70 years of public service to this country. She was the much-valued Patron of the Royal PharmacThu, 08 Sep 2022 14:55:00 GMThttps://www.rpharms.com/news/details//RPS-England-urges-new-Health-Secretary-to-make-the-most-of-pharmacy-workforceCommenting on theappointment of Rt Hon Therese Coffey MP as the new Secretary of State for Health and Social Care, Chair of RPS inEngland Thorrun Govind said: “The new Secretary of State is facWed, 07 Sep 2022 09:00:49 GMThttps://www.rpharms.com/news/details//putting-the-patient-first-how-pharmacy-can-get-it-right-Pharmacy is under significant pressure. Pharmacists across all sectors of the NHS have remained accessible to the public and provided essential services throughout theCovid-19 pandemic. The challengesTue, 06 Sep 2022 11:05:02 GMThttps://www.rpharms.com/news/details//rps-completes-divestment-from-fossil-fuelsOne year on from ourdeclaration of the climate and ecological emergency, we havenow fully divested from fossil fuels. Divestment in fossil fuels is when an organisation sells any direct financial invThu, 01 Sep 2022 05:44:00 GMThttps://www.rpharms.com/news/details//Join-our-Membership-and-Fellows-committeesWe’ve got opportunities for you to help guide and support us in our decision-making through our Membership committee and Panel of Fellows. There are now vacancies in both of these committees anWed, 31 Aug 2022 06:30:00 GMThttps://www.rpharms.com/news/details//pharmaceutical-press-partners-with-datapharm-ltdPharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business and Datapharm Ltd are today announcing an exciting new partnership. Electronic Medicines Compendium (emc) is the lateTue, 30 Aug 2022 11:19:00 GMThttps://www.rpharms.com/news/details//Shaping-the-future-of-pharmacy-in-Wales-Have-your-say-New plans to steer pharmacy towards its 2030 vision in Wales have been published and we are inviting you to have your say. The plans focus on what can be achieved by the end of 2025 and will play an Tue, 23 Aug 2022 15:16:58 GMThttps://www.rpharms.com/news/details//we-welcome-opportunity-to-submit-evidence-to-independent-commission-into-pharmacy-professional-leadershipThe Royal Pharmaceutical Society (RPS) welcomes the scrutiny of pharmacy professional leadership and the opportunity presented by the Independent Commission following a very positive and productive fiWed, 17 Aug 2022 12:36:00 GMThttps://www.rpharms.com/news/details//celebrating-south-asian-heritage-month-2022Did you catch our celebrations forSouth Asian Heritage Month, which exploresthe history and identity of British South Asians? We collaborated with Pharmacy Technicians of Colour, APTUK, Boots and othWed, 17 Aug 2022 08:34:00 GMThttps://www.rpharms.com/news/details//NHS-Scotlands-new-sustainability-strategy-aligned-to-RPS-Scotlands-policyNHS Scotland’s Climate Emergency and Sustainability Strategy, which has been published today, aligns firmly with RPS Scotland’s sustainability policies. As the professional leadership bodTue, 16 Aug 2022 10:12:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//sibby-buckle-confirmed-as-rps-treasurerSharon Isobel Tait Buckle, known as Sibby, a member of the English Pharmacy Board and RPS Assembly, has been elected unopposed as the Treasurer of the Royal Pharmaceutical Society. Sibby takes over thTue, 16 Aug 2022 09:14:00 GMThttps://www.rpharms.com/news/details//help-shape-the-future-of-pharmacy-in-englandWe’re inviting you to contribute your views on the future of pharmacy in England over the next decade. Our project with The King's Fund, transforming pharmacy practice, is developing a visiMon, 15 Aug 2022 09:55:12 GMThttps://www.rpharms.com/news/details//-RPS-Scotland-launches-online-pharmacy-best-practice-hubA brand new pharmacy best practice hub, hosted on the RPS Scotland website, has gone live today (Thursday 11 August). Pharmacy teams across Scotland are undertaking fantastic work right now, in a vThu, 11 Aug 2022 14:33:50 GMTRoss Barrowhttps://www.rpharms.com/news/details//RPS-welcomes-new-Chair-of-the-Pharmacy-Schools-CouncilResponding to the announcement that Prof. Katie Maddock is the new Chair of the Pharmacy Schools Council, Professor Claire Anderson, RPS President said: “We warmly welcome Professor Maddock&rsqThu, 11 Aug 2022 14:11:00 GMThttps://www.rpharms.com/news/details//neville-carter-appointed-rps-chief-education-and-membership-officerThe Royal Pharmaceutical Society is delighted to announce the appointment ofNeville Carter as its new Chief Education and Membership Officer. After a rigorous selection process and chosen from amongsWed, 27 Jul 2022 10:27:00 GMThttps://www.rpharms.com/news/details//ravi-sharma-director-for-england-departs-in-an-exciting-career-moveAfter nearly four years as Director for England, Ravi Sharma will be leaving RPS in October to pursue a career change. Hehas been appointed Head of Pharmacy for Luton and Dunstable University HospitalMon, 25 Jul 2022 11:00:00 GMThttps://www.rpharms.com/news/details//rps-in-england-calls-for-urgent-pharmacy-workforce-planThe House of Commons Health Committee has called for a pharmacy workforce plan in a new reportinto the recruitment, training and retention of the health and care workforce. The report makes a number Mon, 25 Jul 2022 05:07:00 GMThttps://www.rpharms.com/news/details//update-on-rps-assembly-july-2022The RPS Assembly is the key decision-making body of RPS which is responsible for setting strategic direction, financial management and organisational governance. Commenting on the following decisionsThu, 21 Jul 2022 11:12:00 GMThttps://www.rpharms.com/news/details//RPS-comments-on-Scottish-Drug-Deaths-Taskforce-Final-ReportThe Scottish Drug Deaths Taskforce has today published its final report following four years of work developing and implementing a programme of actions to tackle the rising number of drug deaths in ScThu, 21 Jul 2022 06:46:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//get-involved-celebrating-south-asian-heritage-monthWe’recelebrating South Asian Heritage Month18 July-17 August and we'd love you to get involved! South Asian Heritage Month highlights the history and identity of British South Asians to betMon, 18 Jul 2022 06:54:00 GMThttps://www.rpharms.com/news/details//update-on-our-vision-for-pharmacy-practice-in-englandWe’ve had a huge response to our exciting project with The King’s Fund to set out a vision for transforming pharmacy practicein England over the next decade. Consulting with you and key oWed, 13 Jul 2022 07:05:00 GMThttps://www.rpharms.com/news/details//rps-calls-on-gphc-to-arrange-early-resit-opportunityCommenting on the issues and subsequent trauma experienced by some Foundation trainees following the recent GPhC examination, RPS President Professor Claire Anderson said: “We remain deeply conTue, 12 Jul 2022 10:00:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-plans-for-prep-in-wales-and-calls-for-further-action--RPS has welcomed proposals from the Welsh Government to increase access to pre-exposure prophylaxis (PrEP) via community pharmacies for people at risk of HIV. The new HIV Action Plan for Wales publisMon, 11 Jul 2022 10:43:06 GMThttps://www.rpharms.com/news/details//New-Chair-of-our-Education-and-Standards-CommitteeDr Anthony R Cox FRPharmSfrom the University of Birminghamhas been appointed as the new Chair of the RPS Education and Standards Committee. Anthony is Head of the School of Pharmacy and a Reader in CThu, 07 Jul 2022 07:27:00 GMThttps://www.rpharms.com/news/details//RPS-warns-MPs-about-future-of-community-pharmacy-in-EnglandRPS England co-hosted a ‘Future of Pharmacy’ event in Parliament on Tuesday to highlight the vital contribution of pharmacists and pharmacy teams to the health of the nation. MPs and PeerWed, 06 Jul 2022 14:04:15 GMThttps://www.rpharms.com/news/details//back-pharmacy-workforce-to-boost-patient-care-says-rps-englandCommenting on theappointment of Rt Hon Steve BarclayMP as the new Secretary of State for Health and Social Care, Chair of RPS inEngland Thorrun Govind said: “This is a crucial time for the futuWed, 06 Jul 2022 11:02:00 GMThttps://www.rpharms.com/news/details//how-to-act-on-your-climate-change-charter-pledgeAre you looking for inspiration to help you action your personal commitment to our climate change charter? Working again with Pharmacy Declares we’ve come up with a whole set of suggestions to hTue, 05 Jul 2022 11:09:53 GMThttps://www.rpharms.com/news/details//pharmacists-parade-at-pride-in-londonOur fantastic team of pharmacy folk walked in this year’s Pride in London parade on 02 July to celebrate everything LGBTQI+ alongside colleagues and friends in an estimated crowd of a million peSat, 02 Jul 2022 12:23:00 GMThttps://www.rpharms.com/news/details//foundation-registration-exam-problems-appalling-says-presidentCommenting on the difficulties and delays experienced by candidates in five centres in England yesterday sitting the foundation registration exam, RPS President Professor Claire Anderson said: &ldquoThu, 30 Jun 2022 11:00:00 GMThttps://www.rpharms.com/news/details//Reducing-the-environmental-impact-of-prescribingHealthcare leaders from across Scotland have today issued a rallying call for bold action to reduce the environmental impact caused by medicine prescribing. Medicines account for around 25% of carboThu, 30 Jun 2022 09:00:00 GMThttps://www.rpharms.com/news/details//rps-in-england-comments-on-gp-workforce-studyReacting to a study from the Health Foundation todaythat GP shortages will worsen in England over the next decade, Chair of RPS in England Thorrun Govind said: “Teams are under pressure right aThu, 30 Jun 2022 09:00:00 GMThttps://www.rpharms.com/news/details//June-update-on-national-board-meeting-RPS Boards from England, Scotland and Wales came together for a virtual board meeting today. They were joined by members across GB who could observe remotely and hear first-hand the updates and discusThu, 30 Jun 2022 08:27:03 GMThttps://www.rpharms.com/news/details//new-rps-core-advanced-curriculum-publishedThe Royal Pharmaceutical Society has published its new Core Advanced Pharmacist Curriculum to enable professional development towards advanced pharmacist practice. This follows an intensive programme Mon, 27 Jun 2022 03:55:00 GMThttps://www.rpharms.com/news/details//appointments-by-rps-boards-in-juneAt the recent RPS Board meetings in England, Scotland and Wales, the following Board members were appointed to the Assembly, or appointed as Vice-Chair: English Pharmacy Board Mary Evans was appoiFri, 24 Jun 2022 09:48:00 GMThttps://www.rpharms.com/news/details//use-of-multi-compartment-compliance-aidsThe RPS believes that supporting the best use of medicines involves identifying problems with medicines-use, medication review and consideration of patient characteristics to find the best solution.PeWed, 22 Jun 2022 07:27:00 GMThttps://www.rpharms.com/news/details//dealing-with-age-microaggressionsOur latest guide in our inclusion and diversity series on microaggressions tackles the topic of ageism, or being treated unfairly because of your age. The guide outlines the effects of ageism, how to Wed, 22 Jun 2022 07:04:00 GMThttps://www.rpharms.com/news/details//New-Scottish-Pharmacy-Board-FormedA new Scottish Pharmacy Boardhas been formed. There are three new faces on the Board: Josh Miller, Richard Shearer and Jill Swan. In addition, the Board co-opted Kelsey Drummond to a newly created EaFri, 17 Jun 2022 08:34:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//can-you-help-shape-a-vision-for-pharmacy-practiceCommenting on RPS work with the King's Fund to develop a vision for pharmacy practice in England, Chair of the English Pharmacy Board Thorrun Govind said: "It's been fantastic to see theThu, 16 Jun 2022 12:22:03 GMThttps://www.rpharms.com/news/details//rps-and-gphc-joint-statement-on-professional-and-regulatory-standardsRPS and the General Pharmaceutical Council (GPhC) have today published an updated joint statement highlighting the importance of regulatory and professional standards and guidance to ensure patient-ceWed, 15 Jun 2022 08:00:00 GMThttps://www.rpharms.com/news/details//pharmacists-are-well-placed-to-help-with-early-cancer-detectionSpeaking about plans for a pilot study in community pharmacies in England to improve the early detection of cancer, Chair of the RPS English Board Ms Thorrun Govind said: “Pharmacists and theirWed, 15 Jun 2022 07:43:00 GMThttps://www.rpharms.com/news/details//take-our-survey-on-member-participationWe've opened our survey or you to tell us how you want to take part in and learn about decisions made by us. This is a core part of the independent review of member participation and communicatioTue, 14 Jun 2022 11:27:43 GMThttps://www.rpharms.com/news/details//sign-up-to-bold-action-on-climate-change-The Royal Pharmaceutical Society (RPS) and Pharmacy Declares have today published a Climate Change Charter andare inviting pharmacy teams from around the world to sign up and commit to action on climaMon, 13 Jun 2022 11:48:04 GMThttps://www.rpharms.com/news/details//hub-and-spoke-legislation-must-benefit-patient-careRPS has welcomed the opportunity provided by a change in legislation to enable community pharmacies to make use of hub and spoke dispensing but reaffirmed that patient care must be at the heart of futFri, 10 Jun 2022 11:47:00 GMThttps://www.rpharms.com/news/details//Fit-notes-in-pharmacies---fit-for-the-futureResponding to confirmation from the Department of Work and Pensions today that new legislation will allow a wider range of healthcare professionals, including pharmacists, to certify fit notes across Thu, 09 Jun 2022 09:02:00 GMThttps://www.rpharms.com/news/details//Pharmacy-2030-vision-highlighted-at-Scottish-Parliamentary-ReceptionYesterday evening, a Parliamentary reception, ‘Pharmacy 2030: A vision for the future of pharmacy’ was held at Holyrood to raise awareness and highlight the importance of Pharmacy 2030, anThu, 09 Jun 2022 08:18:43 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-standards-on-end-of-life-care-with-cancer-charity-marie-curieWe've teamed up with the UK’s leading end of life charityMarie Curie to launch a partnership to develop professional standards in end of life care for community pharmacy. The Standards wilWed, 08 Jun 2022 06:19:00 GMThttps://www.rpharms.com/news/details//rps-president-welcomes-detail-on-professional-leadership-commissionCommenting on the formal announcement of the UK Commission on Pharmacy Professional Leadership, RPS President Professor Claire Anderson said: “We welcome the announcement of further informationTue, 07 Jun 2022 05:25:00 GMThttps://www.rpharms.com/news/details//new-national-guidance-for-expanding-scope-of-prescribing-practice-We've published newprofessional guidance for independent prescribers today. This guidance has been commissioned by Welsh Government, for the benefit of all prescribers across the UK. Based on collMon, 06 Jun 2022 12:11:00 GMThttps://www.rpharms.com/news/details//Pharmacist-wins-best-practice-award-at-RPS-Scotland-eventA pharmacist from NHS Tayside was the winner of a prestigious best practice award at an event yesterday which celebrated pharmacy practice across Scotland. Organised by pharmacists’ professionaMon, 30 May 2022 12:42:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-england-responds-to-nhs-primary-care-reportCommenting on the publication of the Fuller Stocktake report, ‘Next steps for integrating primary care’, RPS England Chair Thorrun Govind said: “Today’s report is a significantFri, 27 May 2022 08:19:49 GMThttps://www.rpharms.com/news/details//New-RPS-Fellows-2022The RPS Panel of Fellows has designated the following 13 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhThu, 26 May 2022 10:10:00 GMThttps://www.rpharms.com/news/details//please-share-your-equality-diversity-and-inclusion-data-with-usOur annual survey giving you the opportunity to share your equality, diversity and inclusion data is now live! The survey collects data on race, sex, sexual orientation, gender reassignment, religionWed, 25 May 2022 09:42:00 GMThttps://www.rpharms.com/news/details//RPS-England-tells-MPs-support-for-workforce-is-crucialDirector for England Ravi Sharma spoke to MPs in Parliament today at the Health and Social Care Select Committee’s inquiry on workforce. Alongside a panel of professional leadership bodies, he Tue, 24 May 2022 15:51:23 GMThttps://www.rpharms.com/news/details//rps-announces-harrison-memorial-medal-winnerProfessor Abdul Basit has been awarded the RPS Harrison Memorial Medal by RPS. The Harrison Memorial Medal is awarded every two years, in memory ofthe distinguished pharmaceutical chemist Col EF HarrTue, 24 May 2022 10:54:00 GMThttps://www.rpharms.com/news/details//raising-concerns---updated-pharmacy-guideDo you and your teams feel confident in raising a concern when things go wrong? As a pharmacist, you and your teams have a professional duty to report any concerns and speak up when things go wrong. Mon, 23 May 2022 14:50:24 GMThttps://www.rpharms.com/news/details//more-ssps-for-hrt-medicinesReacting to the news thatmore Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care to cover HRT products, Professor Claire Anderson, President of the Royal PhFri, 20 May 2022 11:02:00 GMThttps://www.rpharms.com/news/details//walk-with-us-in-the-pride-london-paradePride is back bigger and better than ever! We’re delighted to announce we have places again in the walking parade at LondonPride, which is celebrating the 50th anniversary of the UK’s firThu, 19 May 2022 06:34:11 GMThttps://www.rpharms.com/news/details//pharmacists-must-be-central-to-the-pharmacogenomics-revolutionWe've issued a position statementcalling for pharmacists to play a leading role in the fast-approaching pharmacogenomics revolution which is set to transform prescribing and patient outcomes. We aWed, 18 May 2022 06:55:23 GMThttps://www.rpharms.com/news/details//Exciting-opportunity-to-join-SIGN-CouncilThere is currently an exciting opportunityfor a Royal Pharmaceutical Society (RPS) Member to represent RPS on SIGN council as a Deputy Member. SIGN develop evidence-based clinical guidelines which heWed, 18 May 2022 05:59:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-appoints-professor-parastou-donyai-as-new-chief-scientistThe Royal Pharmaceutical Society has appointed Professor Parastou Donyai, BPharm (Hons), BSc (Hons) Psych (Open), PhD, PGCertEBM, PGCertPsychTher, PGCertTLHE, PGDPRM (Open), MRPharmS, FHEA, MBPsS as CTue, 17 May 2022 12:56:00 GMThttps://www.rpharms.com/news/details//rps-museum-reopens-in-east-smithfieldFrom the informative to the fascinating, the collection of exhibits that make up the Royal Pharmaceutical Society’s (RPS) museum collection reopens at the Society’s London headquarters todMon, 16 May 2022 08:53:09 GMThttps://www.rpharms.com/news/details//rps-welcomes-commission-into-professional-leadership-in-pharmacyThe future for pharmacists and pharmacy technicians is exciting and filled with opportunity to improve care for patients and the public. We welcome the recognition from the four Chief Pharmaceutical OFri, 13 May 2022 13:01:00 GMThttps://www.rpharms.com/news/details//fill-out-hub-and-spoke-surveyRPS would like to hear your views on the hub and spoke models being proposed by Department of Health and Social Care. Hub and spoke dispensing is where parts of the dispensing process are undertaken Tue, 10 May 2022 16:01:17 GMThttps://www.rpharms.com/news/details//Results-of-RPS-national-Pharmacy-Board-elections-2022Commenting on the results of the elections to the three RPS national Pharmacy Boards, RPS President Professor Claire Anderson said: “I’m delighted to welcome our new Board members across Tue, 10 May 2022 14:48:00 GMThttps://www.rpharms.com/news/details//rps-appoints-luther-pendragon-to-review-member-participation-and-communicationsWe've appointed communications consultancy Luther Pendragon to carry out an independent review of the participation of members and of our communications concerning decisions we take on behalf of tTue, 10 May 2022 08:26:43 GMThttps://www.rpharms.com/news/details//rps-recommends-not-working-if-covid-19-positivePharmacies are health care environments which are accessed by patients who may be vulnerable to Covid infection. It is essential that mitigations are observed to prevent the spread of Covid by both thFri, 06 May 2022 15:05:59 GMThttps://www.rpharms.com/news/details//rps-represented-at-community-pharmacist-reception-with-prince-charlesRPS President Professor Claire Anderson and Chair of the English Pharmacy Board Thorrun Govind attended the reception for community pharmacists hosted by The Prince of Wales onWednesday, May 4. The PFri, 06 May 2022 09:20:00 GMThttps://www.rpharms.com/news/details//rps-publishes-its-2021-annual-peportWe've today published our Annual Report for 2021, which outlines financial statements and membership numbers, as well as a letter from the President and Chief Executive. The financial performanceThu, 05 May 2022 14:05:00 GMThttps://www.rpharms.com/news/details//rps-member-appointed-to-bpcRPS member James Rickard has been appointed as a member of the British Pharmacopoeia Commission (BPC). Mr Rickard is the Chief Scientific Officer at Biotherapy Services Ltd, and says he is ‘humWed, 04 May 2022 08:41:00 GMThttps://www.rpharms.com/news/details//scottish-board-member-invited-to-madrid-this-weekA member of the RPS Scottish Pharmacy Board has been invited to an international meeting of pharmacists in Madrid on Thursday 5 May, to share experiences of community pharmacy from Scotland. PharmacisTue, 03 May 2022 14:33:31 GMThttps://www.rpharms.com/news/details//-Education-on-environmentally-sustainable-prescribing-is-vitalEnvironmentally sustainable prescribing should be embedded in undergraduate and postgraduate health care education. This was one of the conclusions from a session co-hosted by RPS Scotland and the ScoFri, 29 Apr 2022 08:42:20 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-president-addresses-new-hrt-appointmentFollowing reports of shortages of HRT medicines, the Secretary of State for Health Sajid Javid is set toappoint a tsar to tackle shortages. Commenting on the Secretary of State for Health’s intMon, 25 Apr 2022 10:59:00 GMThttps://www.rpharms.com/news/details//Pharmacys-role-in-reducing-harms-and-deaths-from-antimicrobial-resistanceMSPs in the Scottish Parliament are today debating The Scottish Approach to Managing the Global Risk of Antimicrobial Resistance. Antimicrobial resistance (AMR) is predicted by scientists to be the lThu, 21 Apr 2022 12:49:30 GMTRoss Barrowhttps://www.rpharms.com/news/details//nhs-education-for-scotland-sign-multi-year-contract-with-pharmaceutical-press-NHS Education for Scotland (NES) has signed a new three-year contract with Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business to continue the supply of trusted medicinesThu, 21 Apr 2022 06:02:00 GMThttps://www.rpharms.com/news/details//transforming-the-future-of-pharmacy-practice-in-englandWe’re starting an exciting new project with the King’s Fund to transform the future of pharmacy practice in England over the next 10 years. And we need your help. We want to build a visioWed, 20 Apr 2022 08:01:19 GMThttps://www.rpharms.com/news/details//rps-england-responds-to-nhs-review-of-primary-careRPS England has responded to the NHS ‘Fuller Stocktake’ review, which is looking at how primary care can help meet the health needs of local populations, working within new Integrated CareThu, 14 Apr 2022 10:54:47 GMThttps://www.rpharms.com/news/details//recognition-for-pharmacys-role-in-reducing-waiting-times-in-walesThe important role of pharmacy in reducing NHS waiting times has been recognised in a report published by the Senedd’s Health and Social Care Committee. The report Waiting Well? The impact of tFri, 08 Apr 2022 13:34:35 GMThttps://www.rpharms.com/news/details//Our-re-shaped-Executive-TeamOurfinal executive team structure has now been decided to deliver the five-year RPS Strategydetermined by the Assembly. While the team's structure is an operational matter, the Assembly, includinThu, 07 Apr 2022 10:00:00 GMThttps://www.rpharms.com/news/details//Womens-History-Month-round-upOur month celebrating women in pharmacy began on International Women’s Day, whose theme this year was #breakthebias. RPS President Professor Claire Anderson shared her own experiences as someonWed, 06 Apr 2022 10:15:00 GMThttps://www.rpharms.com/news/details//disability-campaign-round-upWe want to ensure pharmacy can attract and retain talented individuals with disabilities and have had a special focus on this over the past three months. Our Disability campaign raises awareness of vTue, 05 Apr 2022 11:26:00 GMThttps://www.rpharms.com/news/details//welsh-senedd-show-support-for-pharmacyA debate on how best to support pharmacists was held at the Senedd this week which saw Members of the Senedd (MSs) in full agreement on the vital role pharmacists play across the health service in WalFri, 01 Apr 2022 13:22:51 GMThttps://www.rpharms.com/news/details//rps-responds-to-lateral-flow-tests-costing-in-pharmaciesFrom today, April 1, Lateral Flow Tests (LFTs) will cost in pharmacies in England. They were previously available for free. Commenting on the LFTs costing in pharmacies in England from today, RPS EnFri, 01 Apr 2022 11:14:13 GMThttps://www.rpharms.com/news/details//our-independent-review-of-participation-and-communicationsWe will be undertaking an independent review of member participation and RPS communications concerning decisions we take on behalf of the profession through our Governance boards. The transparency ofFri, 01 Apr 2022 07:39:00 GMThttps://www.rpharms.com/news/details//further-update-on-our-executive-team-structureRPS Chief Executive Paul Bennett said: “On the 4th March we announced that we were proposing some changes to our executive structure. “Further to my updateon the 24th of MarchI can annouThu, 31 Mar 2022 16:30:51 GMThttps://www.rpharms.com/news/details//use-of-the-title-consultant-pharmacistOn behalf of the NHS, the RPS is the delegated body which administers the approval of new consultant pharmacist posts and the credentialing of individuals, as set out in the NHS consultant pharmacist Thu, 31 Mar 2022 13:10:00 GMThttps://www.rpharms.com/news/details//rps-talks-about-welsh-restrictions-easing-on-bbc-WalesWith rules on face masks changing and the legal requirement for self-isolation coming to an end in Wales this week, RPS Wales have been responding to these changes in the Welsh media. Appearing on BBThu, 31 Mar 2022 10:56:57 GMThttps://www.rpharms.com/news/details//Healthcare-professions-join-forces-on-sustainabilityHealthcare professionals from across Scotland met today to discuss the environmental impact of prescribing and explore how prescribers can support NHS Scotland’s target to achieve net zero by 20Thu, 31 Mar 2022 08:54:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//important-pharmacogenomics-report-published-todayPersonalised prescribing: using pharmacogenomics to improve patient outcomes,a report explaining how pharmacogenomic testing should be deployed across the NHS to ensure all patients have an equal chanTue, 29 Mar 2022 09:36:00 GMThttps://www.rpharms.com/news/details//rps-calls-for-mandatory-reporting-of-workforce-disability-dataWe’re calling for mandatory reporting of workforce disability data to create more inclusive practices in the workplace. We believe the reporting of such data is key to tackling the disability eMon, 28 Mar 2022 08:47:00 GMThttps://www.rpharms.com/news/details//Update-on-our-proposed-executive-team-structure-Paul Bennett, RPS Chief Executive said: “On the 4th March we announced that we were proposing some changes to our executive structure. “I can now announce that Robbie Turner has decided Thu, 24 Mar 2022 17:00:00 GMThttps://www.rpharms.com/news/details//rps-warns-of-misleading-reports-of-drug-recall--Following reports that blood pressure drugs amlodipine and olmesartan have been recalled, RPS has confirmed that this is not the case in the UK. It was published online in both the Daily Record and DThu, 24 Mar 2022 16:27:48 GMThttps://www.rpharms.com/news/details//take-part-in-our-agmThank you if you’ve been in touch with me about Assembly decisions on Royal College status and leaving the International Pharmaceutical Federation, known as FIP. Each of you will get a personal Thu, 24 Mar 2022 14:42:37 GMThttps://www.rpharms.com/news/details//Call-to-celebrate-and-share-best-practice-at-RPS-May-eventCelebrating the fantastic work of pharmacy teams across Scotland is the aim of an RPS Scotland event to take place on 29 May 2022. After the challenges of the Covid pandemic, RPS hopes this event wiThu, 24 Mar 2022 10:36:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//wellbeing-concerns-taken-to-the-welsh-parliamentThe health and wellbeing of the pharmacy profession was brought into sharp focus this month when RPS Wales met with Members of the Senedd/Welsh Parliament. In the first face-to-face engagement in neaThu, 24 Mar 2022 10:35:41 GMThttps://www.rpharms.com/news/details//Scottish-Pharmacists-Celebrated-for-Inspirational-WorkPharmacists across Scotland were celebrated today for their inspirational work by Royal Pharmaceutical Society (RPS) Scotland, the professional leadership body for pharmacists across all sectors. TweWed, 23 Mar 2022 18:21:09 GMTRoss Barrowhttps://www.rpharms.com/news/details//RPS-England-responds-to-Chancellors-Spring-StatementRPS England Board Chair Thorrun Govind has respondedto the Chancellor’s Spring Statement, made today, March 23. Thorrun commented: “With the rise in National Insurance next month, patientWed, 23 Mar 2022 14:02:35 GMThttps://www.rpharms.com/news/details//rps-ahead-of-disinvestment-deadline-In 2021, we published our Declaration of Climate and Ecological Emergency. As part of this declaration, we made the decision to cease all remaining financial investments in fossil fuels as soon as poWed, 23 Mar 2022 10:46:56 GMThttps://www.rpharms.com/news/details//delay-to-prepayment-scheme-for-hrt-disappointingIn October 2021, the Government announced that women in England would only have to pay one charge of £18.70 for up to a 12-month supply of hormone replacement therapy (HRT). Pharmacy Minister MaTue, 22 Mar 2022 13:43:29 GMThttps://www.rpharms.com/news/details//RPS-President-hails-Independent-Prescribers-in-WalesRPS President Claire Anderson visited Independent Prescribers in Wales on Friday, March 18. Claire and the RPS Wales team visited Adrian Jankowski at his Community Pharmacy in Pontyates, which is proMon, 21 Mar 2022 15:52:18 GMThttps://www.rpharms.com/news/details//RPS-appoints-Avril-Chester-as-new-Chief-Technology-OfficerAfter an extensive search and appointment process, The Royal Pharmaceutical Society is delighted to announce Avril Chester as its new Chief Technology Officer. The use of technology by pharmacists anMon, 21 Mar 2022 15:07:07 GMThttps://www.rpharms.com/news/details//Marking-the-International-Day-for-the-Elimination-of-Racial-DiscriminationWe'retoday marking the International Day for the Elimination of Racial Discrimination. The event happens every year onthe day that police in Sharpeville, South Africa, opened fire and killed 69 pMon, 21 Mar 2022 14:08:57 GMThttps://www.rpharms.com/news/details//RPS-Assembly-decisions-on-FIP-membership-and-Royal-College-statusDear Members and Fellows, I want to speak to all of you about decisions taken by the RPS Assembly. These decisions relate to our organisational membership of FIP and changing the name of our organisFri, 18 Mar 2022 17:32:00 GMThttps://www.rpharms.com/news/details//Early-Careers-Pharmacist-welcomed-onto-Scottish-Pharmacy-BoardAn exciting opportunity has arisen for Kelsey Drummond, an Early Careers Pharmacist from Fife, to become a Member of Royal Pharmaceutical Society’s Scottish Pharmacy Board. Engaging with pharmaFri, 18 Mar 2022 14:57:06 GMTRoss Barrowhttps://www.rpharms.com/news/details//new-guide-to-support-those-who-will-be-fastingWith Ramadan approaching, we’ve created a new resource to support people who will be fasting. People fast for many reasons, including for medical, wellbeing or religious reasons. This guide wilThu, 17 Mar 2022 14:49:00 GMThttps://www.rpharms.com/news/details//rps-leaves-fip-membershipWe've decided not to renew our organisational membership of FIP in 2022. We have carefully considered how best to serve our members and meet our Charter obligations and believe, at the current timThu, 17 Mar 2022 10:43:46 GMThttps://www.rpharms.com/news/details//rps-joins-the-vaccinatetheworld-campaignWe're proud to have today joined the #VaccinateTheWorld campaign, signing a letter to Prime Minister Boris Johnson alongside fellow healthcare professionals, senior NHS leaders and a wide range ofThu, 17 Mar 2022 09:46:34 GMThttps://www.rpharms.com/news/details//Pharmacy-can-deliver-even-more-RPS-Scotland-advises-Parliamentary-CommitteeToday, Clare Morrison, Director for Scotland at Royal Pharmaceutical Society, provided evidence to the Scottish Parliament’s Health, Social Care and Sport Committee as part of their Alternative Tue, 15 Mar 2022 14:22:05 GMThttps://www.rpharms.com/news/details//first-anniversary-of-inclusive-pharmacy-practiceWe’re marking the first anniversary of the Joint National Plan for Inclusive Pharmacy Practice (IPP) in England today alongside The Association of Pharmacy Technicians UK (APTUK) and NHS EnglandThu, 10 Mar 2022 16:18:00 GMThttps://www.rpharms.com/news/details//Royal-Pharmaceutical-Society-calls-on-Home-Office-to-ban-dangerous-diet-drug-DNPWe're calling on the Home Office to ban the industrial chemical 2,4-Dinitrophenol (DNP), which can also cause weight loss. DNP has led to 32 deaths since 2007in those taking it after having been sThu, 10 Mar 2022 11:48:00 GMThttps://www.rpharms.com/news/details//RPS-England-responds-to-healthcare-reform-speechHealth and Social Care Secretary Sajid Javid today delivered a speech on healthcare reform, highlighting a range of challenges facing the NHS and the need to support prevention, enhance personalised cWed, 09 Mar 2022 09:28:00 GMThttps://www.rpharms.com/news/details//Scottish-public-supports-expansion-of-pharmacy-roles-Pharmacy teams across Scotland are working towards taking on a wider range of roles by 2030, and a new survey from Ipsos-MORI shows that the Scottish public supports this. Most people have received cTue, 08 Mar 2022 09:38:42 GMTRoss Barrowhttps://www.rpharms.com/news/details//free-access-for-ukraine-to-medicines-complete-and-the-pharmaceutical-journalCommenting on invasion of Ukraine by Russia, RPS President Professor Claire Anderson said “We are deeply troubledbythedevastatingcrisis in Ukraine and our thoughts are with all those affected. Tue, 08 Mar 2022 08:11:00 GMThttps://www.rpharms.com/news/details//update-on-rps-proposed-executive-structureCommenting on a proposed change to the Executive structure, RPS President Professor Claire Anderson said: “I deeply regret seeing so much speculation in the public domain about a proposed changFri, 04 Mar 2022 16:20:05 GMThttps://www.rpharms.com/news/details//Community-Pharmacy-Ventilation-Funding-in-ScotlandScottish Government has announced that funding is being made available to help community pharmacy contractors purchase air extraction equipment for their premises. This funding will support both stafFri, 04 Mar 2022 08:04:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Help-shape-the-future-of-pharmacy-and-integrated-careWe’re hosting two sessions for members to help shape our response to an NHS review of primary care in England. The ‘Fuller Stocktake’ review is looking at how primary care can help Tue, 01 Mar 2022 13:47:00 GMThttps://www.rpharms.com/news/details//take-a-look-back-at-our-LGBTQIA-History-Month-contentThroughout February we celebrated LGBTQIA History Month. Take a look: Our brand new guide to LGBTQIA+ microaggressions highlights discrimination based on someone’s sexual orientation and theirFri, 25 Feb 2022 12:52:00 GMThttps://www.rpharms.com/news/details//RPS-England-responds-to-NAO-reportFollowing publication of the National Audit Office report on the rollout of the COVID-19 vaccination programme in England, Chair of RPS in England Thorrun Govind said: “This report highlights tFri, 25 Feb 2022 12:13:00 GMThttps://www.rpharms.com/news/details//RPS-joins-UK-Health-Alliance-on-Climate-ChangeWe've joined the UK Health Alliance on Climate Change (UKHACC). The Alliance brings together a number of organisations including many Royal Colleges, Faculties of Health, the British Medical JourWed, 23 Feb 2022 11:22:00 GMThttps://www.rpharms.com/news/details//post-registration-foundation-pharmacist-programmeHealth Education and Improvement Wales (HEIW) and Cardiff University will be offering a post-registration foundation pharmacist programme to newly registered pharmacists in Wales, which will use the nTue, 22 Feb 2022 12:02:00 GMThttps://www.rpharms.com/news/details//RPS-England-Chair-talks-about-restrictions-easing-on-BBC-NewsThe Government announced that the easing of COVID restrictions in England would be brought forward from the original date of March 24. This would include no longer having to legally self-isolate. RPMon, 21 Feb 2022 16:45:00 GMThttps://www.rpharms.com/news/details//Recognising-LGBTQIA-microaggressionsWe’ve launched a guide to LGBTQIA+ related microaggressionsas part of our Inclusion and Diversity workstream. It joins others in the series, which examine race, disability and gender microaggresWed, 16 Feb 2022 15:09:00 GMThttps://www.rpharms.com/news/details//Response-to-NHS-Race-and-Health-Observatory-reviewWe've responded to a major review into ethnic inequalities in healthcare. Commenting on the recent report from the NHS Race and Health Observatory into ethnic inequalities across healthcare, RPS Tue, 15 Feb 2022 16:27:20 GMThttps://www.rpharms.com/news/details//Parliamentary-Motion-Pharmacy-2030A Parliamentary Motion has been lodged in the Scottish Parliament to celebrate the publication of Pharmacy 2030, Royal Pharmaceutical Society (RPS) Scotland’s brand new professional vision for tTue, 15 Feb 2022 14:26:23 GMTRoss Barrowhttps://www.rpharms.com/news/details//rps-responds-to-delivery-plan-for-tackling-covid-19-backlogWe've responded to the NHS England delivery plan for tackling the COVID-19 backlog of elective care, published this week. Thorrun Govind, Chair of RPS England, commented on the plan:“PharmaWed, 09 Feb 2022 13:49:00 GMThttps://www.rpharms.com/news/details//rps-congratulates-queen-on-her-platinum-jubileeWe've written a letter to our Patron, Her Majesty The Queen, congratulating her on her Platinum Jubilee. The Platinum Jubilee marks 70 years since the accession of Queen Elizabeth II on 6 FebruarSun, 06 Feb 2022 09:00:00 GMThttps://www.rpharms.com/news/details//rps-welcomes-new-psnc-ceoRPS England has welcomed the appointment of Janet Morrison OBE as the new CEO of PSNC. Janet has previously led Independent Age and was the founder and Chair of the Campaign to End Loneliness She wiFri, 04 Feb 2022 13:33:00 GMThttps://www.rpharms.com/news/details//rps-responds-to-news-hrt-could-be-available-at-pharmaciesThe MHRA has launched a public consultation on a set of proposals to make Gina 10 mcg tabletsavailable from pharmacies. HRT could be made available at pharmacies. Thorrun Govind, Chair of RPS in EnglThu, 03 Feb 2022 16:25:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-publishes-Pharmacy-2030The Royal Pharmaceutical Society (RPS) has today published Pharmacy 2030, which outlines an exciting new vision for the future of pharmacy in Scotland. It describes a future in which pharmacy teams wWed, 02 Feb 2022 12:00:00 GMTRoss Barrowhttps://www.rpharms.com/news/details//Mandatory-vaccinations-being-reconsidered-in-EnglandNHS England has published an update following news that the Government is reconsidering legislation requiring vaccination as a condition of deployment, which was due to come into effect from April 1 2Tue, 01 Feb 2022 10:40:00 GMThttps://www.rpharms.com/news/details//HEE-launches-new-independent-prescriber-training-for-pharmacistsHealth Education England has announced new funded Independent Prescriber courses for pharmacists, which will be available before March 2022. There are places available for both Independent PrescribinThu, 27 Jan 2022 15:41:00 GMThttps://www.rpharms.com/news/details//Drug-Monitoring-Checker-now-available-through-MedicinesCompletePharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, is announcing the release of Drug Monitoring Checker. Available online through MedicinesComplete, Drug Monitoring CheWed, 26 Jan 2022 10:32:00 GMThttps://www.rpharms.com/news/details//health-social-care-and-sport-committee-inquiry-into-alternative-pathways-into-primary-careThe Royal Pharmaceutical Society (RPS) in Scotland today welcomes the Health, Social Care and Sport Committee inquiry into alternative pathways into primary care. Pharmacists provide face to face heaMon, 24 Jan 2022 16:23:00 GMThttps://www.rpharms.com/news/details//helping-you-put-your-inclusion-and-wellbeing-pledge-into-actionWe’ve created a set of ideas to help individuals, teams and organisation put our inclusion and wellbeing pledge into action. They range from practical short-term steps like knowing where to sigMon, 24 Jan 2022 14:11:00 GMThttps://www.rpharms.com/news/details//challenging-barriers-for-pharmacists-with-disabilitiesWe’ve launched a campaign to challenge barriers to working in pharmacy for those with disabilities as part of our ongoinginclusion and diversity strategy. Our profession-wide survey on inclusiWed, 19 Jan 2022 09:00:00 GMThttps://www.rpharms.com/news/details//Investment-to-tackle-NHS-pressures-in-WalesWelsh patients are to benefit from an additional £2.5 million investment in community pharmacy services this winter, the Welsh Government has revealed. The funding announced today will be part Tue, 11 Jan 2022 11:09:00 GMThttps://www.rpharms.com/news/details//RPS-England-welcomes-new-Chief-Pharmaceutical-OfficerRPS England has welcomed the news that the NHS in England has today confirmed the appointment of the next Chief Pharmaceutical Officer for England: David Webb. Davidis currently the Chief Pharmacist Fri, 07 Jan 2022 17:03:43 GMThttps://www.rpharms.com/news/details//RPS-England-responds-to-Health-Committee-reportThe House of Commons Health and Social Care Committee has published a new report on ‘Clearing the backlog caused by the pandemic’, which includes calls for a national health and care recovThu, 06 Jan 2022 11:21:00 GMThttps://www.rpharms.com/news/details//RPS-English-Board-Chair-addresses-lateral-flow-shortageFollowing a recent statement from RPS President Claire Anderson calling on the public to be patient in pharmacies which are running out of lateral flow test kits, RPS English Pharmacy Board Chair ThorTue, 04 Jan 2022 15:27:00 GMThttps://www.rpharms.com/news/details//RPS-urges-government-and-NHS-to-address-lateral-flow-testing-supplyThe RPS is calling on the public to be patient in pharmacies which are running out of rapid lateral flow testing kits, amid the current surge in COVID-19 cases caused by the Omicron variant. RPS PresWed, 29 Dec 2021 09:00:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-protection-for-pharmacy-teams-against-OmicronUpdated guidance on infection protection and control issued by the UK Health Security Agency reinforces the actions needed to prevent transmission of COVID-19 and other respiratory viruses. InfectionWed, 22 Dec 2021 13:32:00 GMThttps://www.rpharms.com/news/details//An-open-letter-to-our-pharmacy-colleagues-Thank you. Thank you for everything you are doing and continue to do over this extremely busy period. Wherever you work or volunteer we appreciate the impact you are having on patient care. Patients Wed, 22 Dec 2021 11:00:12 GMThttps://www.rpharms.com/news/details//RPS-announces-lease-of-London-office-floorsFurther to our announcement in April that RPS was re-evaluating the use of our office space in order to maximise value from our properties, we are delighted to announce that we will be leasing two floTue, 21 Dec 2021 10:23:42 GMThttps://www.rpharms.com/news/details//Contract-with-NIHR-to-develop-e-learning-on-researchWe'vesecured a contract with the National Institute for Health Research (NIHR) to deliver a suite of e-learning modules to improve pharmacy professionals’ awareness, knowledge and skills in Mon, 20 Dec 2021 15:22:43 GMThttps://www.rpharms.com/news/details//Step-back-in-time-with-the-podcast-Christmas-specialTo celebrate the opening of the new RPS museum microsite, we have released an extra special festive edition of the RPS Pharma Scene podcast! In this episode, we have a rare and remarkable Christmas tFri, 17 Dec 2021 14:57:33 GMThttps://www.rpharms.com/news/details//Be-patient-in-pharmacies-says-RPS-PresidentPharmacies have put patients first throughout the COVID-19 pandemic, offering the public rapid access to essential medicines, expert care and life-saving vaccinations during a national crisis. PharmaThu, 16 Dec 2021 14:16:00 GMThttps://www.rpharms.com/news/details//RPS-Wales-welcomes-clinically-focused-community-contractToday, we've welcomed a new community pharmacy contractual framework for Wales that will make greater use of the clinical skills of community pharmacists. Placing a much greater focus on the provThu, 16 Dec 2021 09:56:37 GMThttps://www.rpharms.com/news/details//Explore-the-new-RPS-museum-micrositeFrom the weird and wonderful, to the interesting and intriguing: around since 1842, the RPS museum has over 2,000 items to view. Now is your chance to explore some of these wacky and quirky items in Wed, 15 Dec 2021 16:15:01 GMThttps://www.rpharms.com/news/details//New-measures-to-ease-the-pressure-in-pharmaciesWe've responded to new measuresto cut bureaucracy and help ease immediate pressures on community pharmacies. Commenting on the Covid booster programme and today’s announcement from the PSNCWed, 15 Dec 2021 14:32:00 GMThttps://www.rpharms.com/news/details//Understanding-the-impact-of-Gender-MicroaggressionsWe’ve created a guide to gender microaggressions with volunteers from our Action in Belonging Culture and Diversity (ABCD) group, as part of our work on inclusion and diversity. Gender related Wed, 15 Dec 2021 10:27:00 GMThttps://www.rpharms.com/news/details//RPS-responds-to-further-booster-rolloutFollowing on from the Prime Minister’s announcement yesterday that booster jabs will be offered to everyone over 18 in England from this week, Thorrun Govind, Chair of RPS in England said: &ldquMon, 13 Dec 2021 13:56:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-action-to-reduce-harm-from-drugsWe're calling for urgent action to tackle the record number of drug related deaths in Great Britain. Proposals include beginning trials of supervised drug injecting facilities in specialist centreMon, 13 Dec 2021 10:22:54 GMThttps://www.rpharms.com/news/details//New-Chair-and-members-for-RPS-AMR-Expert-Advisory-GroupMark Gilchrist FRPharmS has been appointed as the new Chair of the RPS Antimicrobial Expert Advisory Group, alongside other new members of the group. The RPS Antimicrobial Expert Advisory Group advisFri, 10 Dec 2021 12:10:53 GMThttps://www.rpharms.com/news/details//RPS-Scotland-calls-for-immediate-action-to-address-workforce-wellbeingRPSScotlandis calling for urgent action following publication of its annual workforce wellbeing survey in partnership with the charity Pharmacist Support. Nine out of ten (89%) respondents wereat highThu, 09 Dec 2021 10:42:00 GMTAnonymoushttps://www.rpharms.com/news/details//Immediate-action-needed-to-address-workforce-wellbeingWe're calling for urgent action following publication of ourannual workforce wellbeing survey in partnership with the charity Pharmacist Support. Nine out of ten (89%) respondents wereat high riThu, 09 Dec 2021 09:50:00 GMThttps://www.rpharms.com/news/details//Accessing-wellbeing-supportRPS Scotland is delighted to have been a co-signatory alongside the Chief Pharmaceutical Officer, GPhC, CPS, the Directors of Pharmacy and the National Pharmacy Technicians Group on a letter to all phWed, 08 Dec 2021 16:56:45 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-condemns-abuse-towards-pharmacy-staffDuring the pandemic many pharmacy teams have reported an increase in abuse, violence and aggression from some members of the public. RPS has consistently highlighted abuse as intolerable and condemnsThu, 02 Dec 2021 10:25:00 GMThttps://www.rpharms.com/news/details//Increased-role-for-community-pharmacies-in-providing-booster-vaccinesCommenting on the increased role for community pharmacies in England in delivering the Covid-19 booster vaccination programme, Chair of the Royal Pharmaceutical Society in England, Ms Thorrun Govind, Wed, 01 Dec 2021 12:32:00 GMThttps://www.rpharms.com/news/details//Pre-exposure-prophylaxis-should-be-available-from-community-pharmaciesAhead of World AIDS Day, the Royal Pharmaceutical Society is calling on the Government to widen access to pre-exposure prophylaxis (PrEP) by making it available through community pharmacies across GreMon, 29 Nov 2021 10:06:40 GMThttps://www.rpharms.com/news/details//New-variant-Covid-precautions-must-be-stepped-upThe Royal Pharmaceutical Society is warning that public health measures to protect people against Covid-19 must be stepped up in the face of the discovery of the new variant, B.1.1.529. RPS is callinFri, 26 Nov 2021 16:56:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-congratulates-new-Fellows-from-ScotlandRPS Scotland is delighted that four pharmacists from Scotland received Fellowships this month. Clare Morrison, Director for Scotland, said: “Each member has made a significant contribution to thFri, 26 Nov 2021 15:17:09 GMTAnonymoushttps://www.rpharms.com/news/details//We-highlight-workforce-pressures-to-the-SeneddThe Welsh Parliament has been told of the pressures facing pharmacy teams and of the need for the workforce’s wellbeing and training requirements to be prioritised in covid recovery plans. GiviWed, 24 Nov 2021 11:51:00 GMThttps://www.rpharms.com/news/details//RPS-calls-on-GPhc-to-remove-2-year-wait-to-prescribeWe'recalling on the General Pharmaceutical Council (GPhC) to remove the two-year wait post-qualification for pharmacists to train to become independent prescribers. We propose that entry to trainTue, 23 Nov 2021 10:10:50 GMThttps://www.rpharms.com/news/details//New-RPS-Fellows-appointed-November-2021The RPS Panel of Fellows has designated the following 19 members as Fellows of the Royal Pharmaceutical Society for Distinction in the Profession of Pharmacy. Being appointed a Fellow of the Royal PhMon, 22 Nov 2021 09:07:00 GMThttps://www.rpharms.com/news/details//RPS-AMR-expert-Jacqui-Sneddon-talks-to-BBC-News-for-World-Antibiotic-Awareness-WeekTo coincide with World Antimicrobial Awareness Week, RPS Antimicrobial Expert Advisory Group Chair Dr Jacqui Sneddon has appeared on BBC's News Channel. Dr Sneddon offered her expert opinion on tThu, 18 Nov 2021 12:46:00 GMThttps://www.rpharms.com/news/details//RCGP-and-RPS-publish-CPCS-reportWe've, along with Royal College of GPs, published a series of recommendations on the roll-out of the GP Community Pharmacist Consultation Service (GP CPCS). This follows a workshop which brought Thu, 18 Nov 2021 09:26:00 GMThttps://www.rpharms.com/news/details//Royal-Pharmaceutical-Society-divests-from-fossil-fuelsThe Royal Pharmaceutical Society has taken the decision to cease all remaining financial investments in fossil fuels as soon as possible and by the end of 2022 at the latest. Previously RPS has takenWed, 17 Nov 2021 10:48:00 GMThttps://www.rpharms.com/news/details//Informed-choice-better-than-compulsory-vaccination-for-healthcare-workersWe're concerned about the Government’s decision to make COVID-19 vaccines mandatory for all patient-facing health and care workers in England from April 2022. Vaccination is a key pillar inTue, 09 Nov 2021 15:00:19 GMThttps://www.rpharms.com/news/details//RPS-welcomes-training-investment-from-HEEWe've welcomed today’s announcement from Health Education England (HEE) that investment of up to £15.9m will be made in training and workforce development for pharmacists and pharmacy Mon, 08 Nov 2021 15:33:00 GMThttps://www.rpharms.com/news/details//Look-back-at-our-Black-History-Month-content1Throughout October we celebrated Black History Month with blogs, live streams, podcasts and profiles of black pharmacists from across Great Britain. Now you can read, watch, listen, and learn with soFri, 05 Nov 2021 14:09:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-publishes-response-to-the-National-Care-Service-consultationWe have submitted our response to the Scottish Government’s consultation on a new National Care Service (NCS) for Scotland. Alongside this we have also published a policy statement outlining ourThu, 04 Nov 2021 09:52:45 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-joins-forces-with-FIP-in-climate-fightWe'vesigned a letter with The International Pharmaceutical Federation (FIP) showing our commitment to tacking climate change and to voice our support for COP26. The letter, which has been sent toMon, 01 Nov 2021 09:31:49 GMThttps://www.rpharms.com/news/details//RPS-calls-for-free-HRT-in-EnglandFollowing news that women may only have to pay one charge for up to a 12-month supply of HRT, the RPS is calling on the Government to scrap prescription charges in England altogether. This is a welcoFri, 29 Oct 2021 12:35:00 GMThttps://www.rpharms.com/news/details//Listen-to-the-RPS-Pharma-Scene-podcast-6This week on the RPS Pharma Scene podcast, RPS Chief Scientist Professor Gino Martini gets insight into the UK COVID-19 vaccine programme throughspeaking to a very special guest. Gino is joined by SiFri, 29 Oct 2021 11:04:32 GMThttps://www.rpharms.com/news/details//RPS-in-Wales-welcomes-free-flu-jabs-for-pharmacistsWe have long campaigned for free flu vaccinations for pharmacists. We'redelighted with today’s move by the Welsh Government that pharmacy teams across primary care, including locums, will beFri, 29 Oct 2021 09:34:51 GMThttps://www.rpharms.com/news/details//Pharmacys-Role-in-Climate-Action-and-Sustainable-HealthcareAhead of COP26, we've created a series of policies calling on industry, Governments across Great Britain and pharmacy teams to implement change to reduce the environmental impact of medicines. MeThu, 28 Oct 2021 02:14:00 GMThttps://www.rpharms.com/news/details//RPS-England-Chair-respond-to-BudgetThe RPS English Pharmacy Board Chair has responded to today's Budget, which highlighted the vaccination programme and the crucial role of pharmacists, announced a further investment in the NHS, anWed, 27 Oct 2021 13:23:00 GMThttps://www.rpharms.com/news/details//Mandatory-Covid-19-and-flu-vaccinations-for-NHS-staffThe Royal Pharmaceutical Society (RPS) has re-affirmed its view that Covid-19 and flu vaccinations for health and care staff should not be made mandatory. RPS has responded to a Government consultatiMon, 25 Oct 2021 09:50:37 GMThttps://www.rpharms.com/news/details//Listen-to-the-RPS-Pharma-Scene-podcast-5This month, we are celebrating Black History Month with blogs, live events and profiles. Now we are championing black pharmacists on our RPS Pharma Scene podcast. This episode, RPS President Claire Fri, 22 Oct 2021 10:19:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-self-care-strategyWe are among leading healthcare bodies urging the Government to implement a national self-care strategy as the NHS seeks to recover from the COVID-19 pandemic. The proposal is set out in a new documeTue, 19 Oct 2021 09:21:10 GMThttps://www.rpharms.com/news/details//RPS-England-welcomes-greater-use-of-pharmacistsRPS England has welcomed the news that Sajid Javid has announced an expansion of the Community Pharmacist Consultation Service. NHS England is providing support to help practices use the new service Thu, 14 Oct 2021 04:34:00 GMThttps://www.rpharms.com/news/details//Take-a-look-back-at-our-sustainability-blogsAt the start of September, we released our Declaration of Climate and Ecological Emergency. As health professionals, climate change will fundamentally impact our roles. Ourdeclaration callson the phaFri, 08 Oct 2021 14:40:00 GMThttps://www.rpharms.com/news/details//Listen-to-the-RPS-Pharma-Scene-podcast-4Looking for something to do this weekend? Why not tune in to the RPS Pharma Scene podcast? This week, RPS Head of Professional Belonging Aman Dollchats withMike Maguire and Farzana Haq. The pair formFri, 08 Oct 2021 13:23:16 GMThttps://www.rpharms.com/news/details//Hear-Wales-Director-Elen-Jones-on-BBC-Radio-4You can now hear our Director for Wales Elen Jones speak on the BBC Radio 4 PM programme from Wednesday, October 6 about independent prescribing. Pharmacists are able to have a consultation with a paThu, 07 Oct 2021 12:01:00 GMThttps://www.rpharms.com/news/details//RPS-announces-backing-of-Climate-Action-CharterWe are pleased to announce that we are a signatory of the Professional Bodies Climate Action Charter that hasbeenlaunched today, October 7. Developed by the Professional Associations Research NetworkThu, 07 Oct 2021 10:34:00 GMThttps://www.rpharms.com/news/details//RPS-England-welcomes-contraceptive-pilotWe've responded to news that community pharmacies will be able to offer contraceptive pill checks as part of a pilot scheme from NHS England. The pilot will give patients better access to contracMon, 04 Oct 2021 08:03:00 GMThttps://www.rpharms.com/news/details//Listen-to-this-weeks-RPS-Pharma-Scene-podcastLooking for some weekend listening? TheRPS Pharma Scene podcast is back for its third instalment. This week RPS Chief Scientist Gino Martini is joined by co-hostSunayana Shah, chair of the RPS IndustFri, 01 Oct 2021 11:27:00 GMThttps://www.rpharms.com/news/details//RCGP-and-RPS-host-roundtable-on-primary-careRPS England and the Royal College of GPs have brought together pharmacy and GP colleagues to discuss collaboration across primary care to better support you, with a focus on community pharmacy’sThu, 30 Sep 2021 10:28:00 GMThttps://www.rpharms.com/news/details//RPS-England-chair-hails-flu-jabs-for-pharmacistsWe'vehailed a victory for you and your colleagues acrossEngland after the NHS reversed its position and agreed to provide free flu jabs to pharmacy teams across primary care. Thorrun Govind, ChaiThu, 30 Sep 2021 07:21:00 GMThttps://www.rpharms.com/news/details//RPS-release-survey-on-mandatory-vaccinationsWe need your opinion on mandatory flu and COVID vaccinations. That's why we'vereleasedsurvey with APTUK for pharmacists and pharmacy technicians to inform a review of the RPS position statemeThu, 30 Sep 2021 05:17:00 GMThttps://www.rpharms.com/news/details//Help-develop-the-RPS-Scotland-position-statement-on-workforceWorkforce pressures and shortages are being widely discussed across pharmacy. However, views differ on whether there are widespread shortages, the causes of pressures and what potential actions are neTue, 28 Sep 2021 10:35:00 GMTAnonymoushttps://www.rpharms.com/news/details//Medicine-deliveries-continue-despite-fuel-shortageSpeaking about media reports today that there is uncertainty about deliveries of medicines due to the fuel crisis, RPS President Professor Claire Anderson said: “Patient care is the top prioritMon, 27 Sep 2021 09:36:00 GMThttps://www.rpharms.com/news/details//RPS-England-welcomes-new-Health-MinisterRPS England has written to Maria Caulfield MP on her appointment as Parliamentary Under-Secretary of State for Health. Her ministerial responsibilities will include primary care, patient safety and loFri, 24 Sep 2021 08:09:00 GMThttps://www.rpharms.com/news/details//Third-RPS-Workforce-Wellbeing-Survey-launchedTodaywe have launched our third annual Workforce Wellbeing survey, in partnership with Pharmacist Support, as part of our campaign to champion the mental health and wellbeing of pharmacists. We need Thu, 23 Sep 2021 06:00:00 GMThttps://www.rpharms.com/news/details//We-welcome-review-into-overprescribing-The Royal Pharmaceutical Society has today welcomed a Government report into overprescribingled by the Chief Pharmaceutical Officer for England, Dr Keith Ridge. The report sets out a series of practiWed, 22 Sep 2021 06:02:00 GMThttps://www.rpharms.com/news/details//RPS-Wales-welcomes-electronic-prescribing-plansRPS Wales has welcomed an announcement by the Welsh Government to push ahead with plans for a national electronic prescribing programme. The announcement follows the findings of an independent reviewTue, 21 Sep 2021 11:32:13 GMThttps://www.rpharms.com/news/details//RPS-position-on-vaccinating-healthy-children-12-15-yearsThe Covid vaccination programme forunder 16s begins today. TheRPS is supportive of the UK's Chief Medical Officers’ position to offer a single dose of COVID-19 vaccine to all children aged bMon, 20 Sep 2021 09:26:04 GMThttps://www.rpharms.com/news/details//RPS-calls-for-free-flu-jabs-for-pharmacistsRPS is calling on the NHS to offer free flu jabs for all pharmacists in England and Wales following reports that pharmacy teams across primary care, including locum staff, would not be given access toThu, 16 Sep 2021 15:41:00 GMThttps://www.rpharms.com/news/details//Access-to-emergency-contraception-in-pharmaciesBBC3 online recently reported the cases of two women who were unable to access emergency contraception from their local pharmacy. Responding to the piece, RPS President Professor Claire Anderson said:Thu, 16 Sep 2021 11:58:00 GMThttps://www.rpharms.com/news/details//RPS-signs-letter-opposing-Vectura-takeover-newsRPS President Claire Anderson has signed a letter written to Jo Churchill, Minister for Prevention, Public Health and Primary Care, from Asthma UK and the British Lung Foundation to express deep conceThu, 16 Sep 2021 09:58:00 GMThttps://www.rpharms.com/news/details//Listen-to-the-latest-RPS-Pharma-Scene-podcastTechnology and pharmacy: this week's instalment of the new RPS Pharma Scene podcast sees Chief Scientist Gino Martini interview Dr. Hirkirit Virdee to find out what Blockchain technology is. GinoFri, 10 Sep 2021 12:46:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-meets-Minister-for-Public-Health-Womens-Health-and-SportDigital transformation and women’s health were the focus of a positive meeting between RPS Scotland and the Minister for Public Health, Women’s Health and Sport, Maree Todd MSP, on 8 SepteWed, 08 Sep 2021 14:53:59 GMTAnonymoushttps://www.rpharms.com/news/details//Share-your-views-on-the-proposed-new-National-Care-ServiceRPS Scotland is holding a focus group to hear members’ views on the Scottish Government’s consultation on a new National Care Service. This online event will take place onTuesday 14th SepTue, 07 Sep 2021 09:03:03 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-Competency-Framework-for-all-Prescribers-updatedThe Royal Pharmaceutical Society has updated its Competency Framework for all Prescribers, which sets out what good prescribing looks like across all health professions. The frameworkis forall regulaTue, 07 Sep 2021 08:01:05 GMThttps://www.rpharms.com/news/details//New-rebrand-for-BPSAToday RPS unveils a rebrand for the British Pharmaceutical Students’ Association (BPSA) to celebrate the organisation’s 80th year. The new brandupdates BPSA’s look, and will be phaseMon, 06 Sep 2021 06:04:00 GMThttps://www.rpharms.com/news/details//RPS-welcomes-nitrous-oxide-reviewRPS has welcomed the news that unlawful possession of nitrous oxide (laughing gas) could be made a crime. The supply of nitrous oxide as a drug is illegal but it is readily available to buy online inFri, 03 Sep 2021 10:41:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-meets-with-Minister-for-Drugs-PolicyRPS Scotland met with the Minister for Drugs Policy, Angela Constance MSP, on 1 September to discuss pharmacy’s role in reducing harm from drugs. Key topics discussed were improving availabilitThu, 02 Sep 2021 08:07:12 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-signs-letter-opposing-new-prescription-chargesRPS English Pharmacy Board Chair Thorrun Govind has signed a letter calling for the retention of free prescriptions for patients aged 60 to 66. It comes after the Government announced people in this Thu, 02 Sep 2021 07:12:00 GMThttps://www.rpharms.com/news/details//RPS-commits-to-tackling-climate-emergencyThe climate crisis is the biggest threat modern society has ever faced. That’s why the Royal Pharmaceutical Society’s three national boards and Assembly have made a climate change declaraWed, 01 Sep 2021 06:00:00 GMThttps://www.rpharms.com/news/details//RPS-Pharma-Scene-Podcast-out-today-with-Dame-Sally-Davies“Please pharmacists round the world help us,” asks Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance (AMR), and the first special guest on the new RPS Pharma Scene PodcasFri, 27 Aug 2021 09:46:52 GMThttps://www.rpharms.com/news/details//Understanding-impact-of-Disability-MicroaggressionRPS have created a Disability Microaggression Reference with volunteers from the Action in Belonging Culture and Diversity (ABCD) group as part of its Inclusion and Diversity workstream. Disability rTue, 24 Aug 2021 10:38:00 GMThttps://www.rpharms.com/news/details//RPS-responds-to-CPCF-funding-updateFunding for the Community Pharmacy Contractual Framework (CPCF) has been announced for the year 2021/22, year 3 of the 5-year deal. The key announcements include: Funding will remain at £2.5Mon, 23 Aug 2021 10:52:00 GMThttps://www.rpharms.com/news/details//NHS-access-to-BNF-content-secured-for-a-further-12-yearsPharmaceutical Press and BMJ, joint publishers of BNF Publications and their partner Royal College of Paediatrics and Child Health, have been awarded a 12-year contract from National Institute for HeaMon, 23 Aug 2021 07:58:41 GMThttps://www.rpharms.com/news/details//RPS-shows-support-for-long-COVID-sufferersPharmacy teams in all settings can play an important role in the support of long COVID patients. RPS has set out key principles and recommendations for pharmaceutical care in the management of the ilThu, 19 Aug 2021 13:58:24 GMThttps://www.rpharms.com/news/details//Minister-expresses-his-thanks-to-PharmacistsThe Minister for Mental Wellbeing and Social Care, Kevin Stewart MSP, has asked RPS Scotland to pass on his thanks and best wishes to pharmacists across Scotland for their hard work both during the CoThu, 19 Aug 2021 09:25:00 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-Scotland-publishes-hospital-pharmacy-vision-for-consultationRPS Scotland has published its vision for the future of hospital pharmacy. It is now seeking views on the vision, which has been created with hospital pharmacists and pharmacy teams across Scotland. Wed, 18 Aug 2021 23:00:00 GMTAnonymoushttps://www.rpharms.com/news/details//Look-back-at-South-Asian-Heritage-Month-highlightsSouth Asian Heritage Month, which exploresthe history and identity of British South Asians, ends today. We’ve celebrated in style in collaboration with Pharmacy Technicians of Colour, APTUK and Tue, 17 Aug 2021 15:29:00 GMThttps://www.rpharms.com/news/details//RPS-concerned-about-potential-Vectura-takeoverRPS has written to Lord Bethell, Parliamentary Under Secretary of State for Innovation, to express ethical concerns about the proposed takeover of Vectura. Tobacco company Philip Morris InternationalFri, 13 Aug 2021 15:27:55 GMThttps://www.rpharms.com/news/details//New-post-registration-foundation-curriculum-announcedFollowing a wide consultation with the profession, the Royal Pharmaceutical Society has launched its newpost-registration foundation pharmacist curriculum to inform professional development training aFri, 13 Aug 2021 09:09:22 GMThttps://www.rpharms.com/news/details//Help-shape-our-work-on-the-NHS-in-EnglandDo you have a great example of how pharmacy teams are working in the NHS? Then we want to hear from you! The NHS in England is changing and new Integrated Care Systems will aim to promote more integrThu, 12 Aug 2021 07:00:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-welcomes-new-Chief-Pharmaceutical-OfficerRPSDirector for Scotland, Clare Morrison, has congratulated Professor Alison Strath FRPharmS on her appointment to the role of Chief Pharmaceutical Officer for Scotland. Clare said: "Alisonhas bWed, 11 Aug 2021 15:47:10 GMTAnonymoushttps://www.rpharms.com/news/details//Listen-to-the-new-PharmSci-podcast-episodeThe RPS PharmSci podcast with Chief Pharmacist Gino Martini is back for its thirtiethinstalment. This week Gino catches up withJames Rickard, Chief Scientific Officer atBiotherapy Services. James, aMon, 09 Aug 2021 14:25:01 GMThttps://www.rpharms.com/news/details//RPS-writes-letter-to-GPhC-after-assessment-technical-faultsRPS has written a letter to GPhC to express its concerns about the recent technical issues experienced by a number of trainees during the GPhC registration assessment, and to seek a fair and timely reFri, 06 Aug 2021 13:26:00 GMThttps://www.rpharms.com/news/details//Pharmacys-role-in-reducing-harm-from-drugsWe are calling on the Scottish Government, pharmacy organisations, contractors and members of the profession to work together to reduce harm from drugs and improve the health of people who use drugs. Fri, 30 Jul 2021 11:04:18 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-wins-e-portfolio-training-contractRPS has been awarded a contract to deliver a new e-portfolio for HEE’s Trainee Pharmacist Foundation Year Programme. The e-portfolio will enable trainees to document their learning and developmFri, 30 Jul 2021 09:51:56 GMThttps://www.rpharms.com/news/details//RPS-responds-to-NHS-Data-Strategy-surveyRPS England has responded to the NHSX survey on the draft Data Strategy for Health and Social Care. We strongly support the development of this data strategy for England and welcome the wider sharingThu, 29 Jul 2021 14:37:54 GMThttps://www.rpharms.com/news/details//RPS-England-welcomes-appointment-of-Amanda-PritchardRPS welcomes the news that Amanda Pritchard has been appointed as the first female chief executive of NHS England. Ms Pritchard, who is currently NHS England's chief operating officer, will startThu, 29 Jul 2021 09:48:00 GMThttps://www.rpharms.com/news/details//RPS-England-urges-Government-to-think-again-on-COVID-19-vaccine-indemnityRPS England has called on the Government to review a decision to discontinue state-backed indemnity for community pharmacists delivering COVID-19 vaccinations in England. RPS England Chair Thorrun GoMon, 26 Jul 2021 12:41:07 GMThttps://www.rpharms.com/news/details//RPS-and-NHS-join-forces-to-support-colleagues-abroad-during-Covid-crisisThe Royal Pharmaceutical Society and NHS England have come together to support countries in the fight against Covid-19. RPS and NHS England are working with pharmacy colleagues internationally in couFri, 23 Jul 2021 07:19:00 GMThttps://www.rpharms.com/news/details//The-new-RPS-MEP-is-out-todayUPDATE:Medicines, Ethics and Practice Edition 45was published in July 2022. ---- Edition 44 of RPS Medicines, Ethics and Practice is now available, with new sections responding to current events aloThu, 22 Jul 2021 06:04:00 GMThttps://www.rpharms.com/news/details//RPS-calls-for-reduction-in-inequalities-in-womens-healthRPS is calling for measures to tackle the health inequalities experienced by women across Great Britain. Many women’s health issues are associated with stigma, which may result in women feelingMon, 19 Jul 2021 13:37:00 GMThttps://www.rpharms.com/news/details//Its-South-Asian-Heritage-MonthWe’re celebrating South Asian Heritage Month 18 July-17 August with profiles of South Asian pharmacy professionals, livestream events, webinars and more. South Asian Heritage Month highlights tMon, 19 Jul 2021 07:39:00 GMThttps://www.rpharms.com/news/details//RPS-welcomes-UK-Life-Sciences-VisionRPS has welcomed the new Government UK Life Sciences Vision, which outlines seven critical healthcare missions – from cancer treatment, to tackling dementia. The Government, industry, the NHS, Thu, 15 Jul 2021 09:29:45 GMThttps://www.rpharms.com/news/details//Professor-Peter-Kopelman-1951--2021It was with great sadness that RPS learned Professor Peter Kopelman has passed away. As well as being a strong advocate for high quality health education, Peter worked with RPS for many years, offeriWed, 14 Jul 2021 13:16:46 GMThttps://www.rpharms.com/news/details//RPS-reports-Equality-Inclusion-and-Diversity-dataThe Royal Pharmaceutical Society has published the findings of its first Equality, Diversity and Inclusion (EDI) survey of members as part of its five-year inclusion and diversity strategy. The resulWed, 14 Jul 2021 11:50:11 GMThttps://www.rpharms.com/news/details//Healthcare-organisations-call-for-mandatory-facemasksHealthcare organisations from across England have written a letter to Prime Minister Boris Johnson calling for face masks to be mandatory in healthcare settings. From July 19 it will no longer be manWed, 14 Jul 2021 09:16:00 GMThttps://www.rpharms.com/news/details//RPS-calls-on-GPhC-to-provide-action-and-accountability-on-inclusion-and-diversityRPS has responded to the GPhC’s consultation on its equality, diversity and inclusion strategy, calling for clear accountability measures for its delivery. RPS Head of Professional Belonging AmTue, 13 Jul 2021 10:10:00 GMThttps://www.rpharms.com/news/details//RPS-Scotland-seeks-views--on-vision-for-GP-practice-pharmacyRPS Scotland is seeking views on the next phase in its vision for pharmacy in 2030 series, which has been developed in partnership with the profession. We are seeking views on the consultation documeThu, 08 Jul 2021 15:00:00 GMTAnonymoushttps://www.rpharms.com/news/details//RPS-backs-contraceptive-pill-without-prescriptionThe Royal Pharmaceutical Society today welcomed the move by the Medicines and Healthcare products Regulatory Agency (MHRA) to allow progestogen-only contraceptive pills to be provided in pharmacies foThu, 08 Jul 2021 14:51:00 GMThttps://www.rpharms.com/news/details//Working-together-with-GPs-to-improve-patient-careRPS England Chair Thorrun Govind has written an open letter to the pharmacy profession calling on GPs and community pharmacists to work together for better patient care. See her letter below: As a pThu, 08 Jul 2021 09:16:00 GMThttps://www.rpharms.com/news/details//Protected-learning-pilot-should-be-GB-wide-says-RPSThe Royal Pharmaceutical Society is calling for a new pilot on protected learning time led by Health Education and Improvement Wales (HEIW) to be extended across Great Britain. The new 12 month pilotWed, 07 Jul 2021 10:10:48 GMThttps://www.rpharms.com/news/details//RPS-England-calls-for-action-on-pharmacist-independent-prescribersThe RPS in England is calling on the NHS to help improve patient care through greater use of pharmacist independent prescribers (PIPs). RPS England Chair Thorrun Govind said: “Growing the numbeTue, 06 Jul 2021 14:05:36 GMThttps://www.rpharms.com/news/details//RPS-England-calls-for-mask-wearing-to-continue-in-pharmaciesFollowing the Government announcement yesterday, July 5, RPS England hasresponded by saying that it will remain ‘vital’ for mask-wearing to continue in pharmacies and other healthcare settTue, 06 Jul 2021 10:30:01 GMThttps://www.rpharms.com/news/details//Rapid-growth-of-independent-prescribing-showcased-in-WalesRPS Wales has joined forces with Welsh Government, NHS Wales, and Community Pharmacy Wales in publishing a graphic illustration of the importance and growth in independent prescribing across the WelshFri, 02 Jul 2021 14:44:41 GMThttps://www.rpharms.com/news/details//RPS-Director-responds-to-booster-vaccine-newsFollowing a Government announcement, RPS has said that pharmacists 'must' be involved with delivering the Covid booster vaccine from September. The boosters will aim to protect the most vulneFri, 02 Jul 2021 12:29:00 GMThttps://www.rpharms.com/news/details//Over-60s-in-England-could-face-prescription-charges--The Government has issued a consultation about increasing the age at which people in England qualify for free prescriptions. Chair of RPS in England Thorrun Govind said: “The proposal to raise Thu, 01 Jul 2021 14:58:00 GMThttps://www.rpharms.com/news/details//Welsh-Chief-Pharmacists-commit-to-RPS-PledgeEvery Chief Pharmacist in Wales has committed to sign up to the RPS Inclusion and Wellbeing Pledge. The importance of the Pledge was discussed at a recent meeting of the All Wales Chief Pharmacists GrThu, 01 Jul 2021 11:39:35 GMThttps://www.rpharms.com/news/details//RPS-in-England-urges-Sajid-Javid-to-consider-pharmacys-long-term-futureChair of the RPS in England Thorrun Govind has written to the new Secretary of State for Health Sajid Javid urging him to build on the contribution and leadership shown by the profession during the paMon, 28 Jun 2021 09:41:00 GMThttps://www.rpharms.com/news/details//RPS-CEO-responds-to-disingenuous-article-about-MP-and-pharmacist-Taiwo-OwatemiRPS CEO Paul Bennett has written a letter responding to the political blogsite Guido Fawkes writing a 'disingenuous' article about pharmacist and MPTaiwo Owatemi entitled'Serving Labour MPFri, 25 Jun 2021 13:36:06 GMThttps://www.rpharms.com/news/details//Listen-to-final-PrezCast-with-outgoing-RPS-President-Sandra-GidleyListen to RPS President Sandra Gidley's final PrezCast, now available online. Accompanied by RPS Chief Exec Paul Bennett, Sandra shares some ofthe highs and lows of being President of the Royal PFri, 25 Jun 2021 09:47:10 GMThttps://www.rpharms.com/news/details//Hear-RPS-England-Chair-Thorrun-Govind-speak-to-the-BBC-about-hay-fever-and-cetirizine-shortagesRPSEnglish Pharmacy Board Chair Thorrun Govind featured on BBC Radio 5 Live and BBC radio stations across the country yesterday, June 24, after pharmacists reportedshortages of cetirizine. The antihiFri, 25 Jun 2021 09:12:00 GMThttps://www.rpharms.com/news/details//RPS-to-shape-pharmacists-of-tomorrow-with-Northern-Ireland-Foundation-training-contractThe Royal Pharmaceutical Society has been awarded a new contract to deliver clinical training and registration assessment support for Foundation Trainee Pharmacists, formerly Pre-Registration TraineesThu, 24 Jun 2021 12:49:56 GMThttps://www.rpharms.com/news/details//National-Pharmacy-Boards--June-updateThe joint June meeting of the RPS national Pharmacy Boards involved wide ranging discussions about the profession. Key issues covered included medicines and sustainability, the expanding role of pharmThu, 24 Jun 2021 10:00:44 GMThttps://www.rpharms.com/news/details//New-RPS-national-Pharmacy-Board-election-results-announcedElections have taken place for positions on the three national Pharmacy Boards today. The newly elected members will take up the positions immediately. For the English Pharmacy Board, Thorrun GovindTue, 22 Jun 2021 04:48:00 GMThttps://www.rpharms.com/news/details//RPS-responds-to-Government-consultation-on-regulator-powersThe Government have consulted on the reform of regulators that oversee professionals working in health and social care. We support many of the proposals, which will provide greater transparency and eFri, 18 Jun 2021 10:15:11 GMT